mirId Cancer Profile PubMed Article hsa-let-7a breast cancer down MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7. hsa-let-7a breast cancer down The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer. hsa-let-7a breast cancer down Lin28 induces epithelial-to-mesenchymal transition and stemness via downregulation of let-7a in breast cancer cells. hsa-let-7a chondrosarcoma down Analysis of microRNAs expressions in chondrosarcoma. hsa-let-7a colorectal cancer down Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. hsa-let-7a colorectal cancer up Circulating Exosomal microRNAs as Biomarkers of Colon Cancer. hsa-let-7a esophageal squamous cell carcinoma down [Expressions and correlations of let-7a and IL-6 in esophageal squamous cell carcinoma]. hsa-let-7a gastric cancer down Circulating microRNAs in plasma of patients with gastric cancers. hsa-let-7a gastric cancer down Lentiviral vector-mediated upregulation of let-7a inhibits gastric carcinoma cell growth in vitro and in vivo. hsa-let-7a gastric cancer down Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C. hsa-let-7a gastric cancer down miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-let-7a gastric cancer down Investigation and identification of let-7a related functional proteins in gastric carcinoma by proteomics. hsa-let-7a gastric cancer down Differentially expressed proteins identified in overexpressed let-7a gastric carcinoma cells by two-dimensional polyacrylamide gel electrophoresis. hsa-let-7a glioma down Overexpressed let-7a inhibits glioma cell malignancy by directly targeting K-ras, independently of PTEN. hsa-let-7a nasopharyngeal carcinoma down Let-7a inhibits proliferation and induces apoptosis by targeting EZH2 in nasopharyngeal carcinoma cells. hsa-let-7a non-small cell lung cancer down Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. hsa-let-7a osteosarcoma down Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells. hsa-let-7a pancreatic ductal adenocarcinoma down XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism. hsa-let-7a renal cell carcinoma down Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting c-myc. hsa-let-7a-1 breast cancer down Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122. hsa-let-7a-1 bronchioloalveolar carcinoma down let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis. hsa-let-7a-1 colon cancer down let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. hsa-let-7a-1 esophageal squamous cell carcinoma down Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. hsa-let-7a-1 esophageal squamous cell carcinoma down Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma. hsa-let-7a-1 hepatocellular carcinoma down MicroRNAs in Hepatobiliary and Pancreatic Cancers. hsa-let-7a-1 lung cancer down Reduced expression of Dicer associated with poor prognosis in lung cancer patients. hsa-let-7a-1 lung cancer down Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells. hsa-let-7a-1 lung cancer down Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. hsa-let-7a-1 nasopharyngeal carcinoma down MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. hsa-let-7a-1 neuroblastoma down LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. hsa-let-7a-1 pancreatic ductal adenocarcinoma down let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. hsa-let-7a-2 breast cancer down Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122. hsa-let-7a-2 bronchioloalveolar carcinoma down let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis. hsa-let-7a-2 colon cancer down let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. hsa-let-7a-2 esophageal squamous cell carcinoma down Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. hsa-let-7a-2 esophageal squamous cell carcinoma down Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma. hsa-let-7a-2 hepatocellular carcinoma down MicroRNAs in Hepatobiliary and Pancreatic Cancers. hsa-let-7a-2 lung cancer down Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. hsa-let-7a-2 lung cancer down Reduced expression of Dicer associated with poor prognosis in lung cancer patients. hsa-let-7a-2 lung cancer down Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells. hsa-let-7a-2 nasopharyngeal carcinoma down MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. hsa-let-7a-2 neuroblastoma down LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. hsa-let-7a-2 pancreatic ductal adenocarcinoma down let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. hsa-let-7a-3 breast cancer down Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122. hsa-let-7a-3 bronchioloalveolar carcinoma down let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis. hsa-let-7a-3 colon cancer down let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. hsa-let-7a-3 esophageal squamous cell carcinoma down Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma. hsa-let-7a-3 esophageal squamous cell carcinoma down Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. hsa-let-7a-3 hepatocellular carcinoma down MicroRNAs in Hepatobiliary and Pancreatic Cancers. hsa-let-7a-3 lung cancer down Reduced expression of Dicer associated with poor prognosis in lung cancer patients. hsa-let-7a-3 lung cancer down Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells. hsa-let-7a-3 lung cancer down Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. hsa-let-7a-3 nasopharyngeal carcinoma down MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. hsa-let-7a-3 neuroblastoma down LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. hsa-let-7a-3 pancreatic ductal adenocarcinoma down let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. hsa-let-7a-3p prostate cancer down The miRNA let-7a1 inhibits the expression of insulin-like growth factor 1 receptor (IGF1R) in prostate cancer PC-3 cells. hsa-let-7b acute lymphoblastic leukemia down Suppression of the let-7b microRNA pathway by DNA hypermethylation in infant acute lymphoblastic leukemia with MLL gene rearrangements. hsa-let-7b breast cancer down The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer. hsa-let-7b breast cancer down Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. hsa-let-7b breast cancer down Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122. hsa-let-7b bronchioloalveolar carcinoma down let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis. hsa-let-7b colon cancer down let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. hsa-let-7b esophageal squamous cell carcinoma down Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. hsa-let-7b esophageal squamous cell carcinoma down Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma. hsa-let-7b gastric cancer down let-7b/g silencing activates AKT signaling to promote gastric carcinogenesis. hsa-let-7b gastric cancer down Let-7b inhibits cell proliferation, migration, and invasion through targeting Cthrc1 in gastric cancer. hsa-let-7b gastric cancer down MicroRNA let-7b suppresses human gastric cancer malignancy by targeting ING1. hsa-let-7b hepatocellular carcinoma down MicroRNAs in Hepatobiliary and Pancreatic Cancers. hsa-let-7b lung cancer down Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. hsa-let-7b lung cancer down Reduced expression of Dicer associated with poor prognosis in lung cancer patients. hsa-let-7b lung cancer down Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells. hsa-let-7b malignant melanoma down MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. hsa-let-7b nasopharyngeal carcinoma down MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. hsa-let-7b neuroblastoma down LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. hsa-let-7b pancreatic ductal adenocarcinoma down let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. hsa-let-7b renal clear cell carcinoma down let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma. hsa-let-7c acute myeloid leukemia down miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia. hsa-let-7c acute promyelocytic leukemia down A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes. hsa-let-7c breast cancer down Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122. hsa-let-7c bronchioloalveolar carcinoma down let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis. hsa-let-7c colon cancer down let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. hsa-let-7c esophageal squamous cell carcinoma down Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. hsa-let-7c esophageal squamous cell carcinoma down Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma. hsa-let-7c hepatocellular carcinoma down MicroRNAs in Hepatobiliary and Pancreatic Cancers. hsa-let-7c hepatocellular carcinoma down MicroRNA let-7c Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma. hsa-let-7c lung cancer down Reduced expression of Dicer associated with poor prognosis in lung cancer patients. hsa-let-7c lung cancer down Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells. hsa-let-7c lung cancer down Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. hsa-let-7c nasopharyngeal carcinoma down MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. hsa-let-7c nasopharyngeal carcinoma down Knocking down CDK4 mediates the elevation of let-7c suppressing cell growth in nasopharyngeal carcinoma. hsa-let-7c neuroblastoma down LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. hsa-let-7c non-small cell lung cancer down MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3. hsa-let-7c pancreatic ductal adenocarcinoma down let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. hsa-let-7c prostate cancer down MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells. hsa-let-7c prostate cancer down MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth. hsa-let-7c renal clear cell carcinoma down let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma. hsa-let-7d breast cancer down Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122. hsa-let-7d bronchioloalveolar carcinoma down let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis. hsa-let-7d colon cancer down let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. hsa-let-7d esophageal squamous cell carcinoma down Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma. hsa-let-7d esophageal squamous cell carcinoma down Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. hsa-let-7d head and neck squamous cell carcinoma down Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. hsa-let-7d hepatocellular carcinoma down MicroRNAs in Hepatobiliary and Pancreatic Cancers. hsa-let-7d lung cancer down Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. hsa-let-7d lung cancer down Reduced expression of Dicer associated with poor prognosis in lung cancer patients. hsa-let-7d lung cancer down Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells. hsa-let-7d nasopharyngeal carcinoma down MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. hsa-let-7d neuroblastoma down LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. hsa-let-7d oral cancer down Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer. hsa-let-7d pancreatic ductal adenocarcinoma down MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors. hsa-let-7d pancreatic ductal adenocarcinoma down let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. hsa-let-7d renal cell carcinoma down Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7. hsa-let-7e breast cancer down Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122. hsa-let-7e bronchioloalveolar carcinoma down let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis. hsa-let-7e colon cancer down let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. hsa-let-7e esophageal squamous cell carcinoma down Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. hsa-let-7e esophageal squamous cell carcinoma down Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma. hsa-let-7e hepatocellular carcinoma down MicroRNAs in Hepatobiliary and Pancreatic Cancers. hsa-let-7e lung cancer down Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. hsa-let-7e lung cancer down Reduced expression of Dicer associated with poor prognosis in lung cancer patients. hsa-let-7e lung cancer down Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells. hsa-let-7e nasopharyngeal carcinoma down MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. hsa-let-7e neuroblastoma down LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. hsa-let-7e pancreatic ductal adenocarcinoma down let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. hsa-let-7e papillary thyroid carcinoma up Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma. hsa-let-7f glioma down Let-7f Inhibits Glioma Cell Proliferation, Migration, and Invasion by Targeting Periostin. hsa-let-7f hepatocellular carcinoma down Expression of serum miR-16, let-7f, and miR-21 in patients with hepatocellular carcinoma and their clinical significances. hsa-let-7f-1 breast cancer down Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122. hsa-let-7f-1 bronchioloalveolar carcinoma down let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis. hsa-let-7f-1 colon cancer down let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. hsa-let-7f-1 esophageal squamous cell carcinoma down Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. hsa-let-7f-1 esophageal squamous cell carcinoma down Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma. hsa-let-7f-1 hepatocellular carcinoma down MicroRNAs in Hepatobiliary and Pancreatic Cancers. hsa-let-7f-1 lung cancer down Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. hsa-let-7f-1 lung cancer down Reduced expression of Dicer associated with poor prognosis in lung cancer patients. hsa-let-7f-1 lung cancer down Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells. hsa-let-7f-1 nasopharyngeal carcinoma down MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. hsa-let-7f-1 neuroblastoma down LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. hsa-let-7f-1 pancreatic ductal adenocarcinoma down let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. hsa-let-7f-2 breast cancer down Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122. hsa-let-7f-2 bronchioloalveolar carcinoma down let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis. hsa-let-7f-2 colon cancer down let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. hsa-let-7f-2 esophageal squamous cell carcinoma down Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma. hsa-let-7f-2 esophageal squamous cell carcinoma down Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. hsa-let-7f-2 hepatocellular carcinoma down MicroRNAs in Hepatobiliary and Pancreatic Cancers. hsa-let-7f-2 lung cancer down Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. hsa-let-7f-2 lung cancer down Reduced expression of Dicer associated with poor prognosis in lung cancer patients. hsa-let-7f-2 lung cancer down Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells. hsa-let-7f-2 nasopharyngeal carcinoma down MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. hsa-let-7f-2 neuroblastoma down LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. hsa-let-7f-2 pancreatic ductal adenocarcinoma down let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. hsa-let-7g breast cancer down The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer. hsa-let-7g breast cancer down Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122. hsa-let-7g bronchioloalveolar carcinoma down let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis. hsa-let-7g colon cancer down let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. hsa-let-7g esophageal squamous cell carcinoma down Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. hsa-let-7g esophageal squamous cell carcinoma down Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma. hsa-let-7g gastric cancer down let-7b/g silencing activates AKT signaling to promote gastric carcinogenesis. hsa-let-7g hepatocellular carcinoma down MicroRNA let-7g and let-7i inhibit hepatoma cell growth concurrently via downregulation of the anti-apoptotic protein B-cell lymphoma-extra large. hsa-let-7g hepatocellular carcinoma down MicroRNAs in Hepatobiliary and Pancreatic Cancers. hsa-let-7g lung cancer down Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. hsa-let-7g lung cancer down Reduced expression of Dicer associated with poor prognosis in lung cancer patients. hsa-let-7g lung cancer down Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells. hsa-let-7g nasopharyngeal carcinoma down MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. hsa-let-7g neuroblastoma down LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. hsa-let-7g pancreatic ductal adenocarcinoma down let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. hsa-let-7g-5p glioblastoma down miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients. hsa-let-7i breast cancer down Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122. hsa-let-7i bronchioloalveolar carcinoma down let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis. hsa-let-7i colon cancer down let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. hsa-let-7i esophageal squamous cell carcinoma down Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. hsa-let-7i esophageal squamous cell carcinoma down Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma. hsa-let-7i hepatocellular carcinoma down MicroRNAs in Hepatobiliary and Pancreatic Cancers. hsa-let-7i hepatocellular carcinoma down MicroRNA let-7g and let-7i inhibit hepatoma cell growth concurrently via downregulation of the anti-apoptotic protein B-cell lymphoma-extra large. hsa-let-7i lung cancer down Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. hsa-let-7i lung cancer down Reduced expression of Dicer associated with poor prognosis in lung cancer patients. hsa-let-7i lung cancer down Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells. hsa-let-7i nasopharyngeal carcinoma down MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. hsa-let-7i neuroblastoma down LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. hsa-let-7i ovarian cancer down Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research. hsa-let-7i pancreatic ductal adenocarcinoma down let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. hsa-mir-1 bladder cancer down The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. hsa-mir-1 bladder cancer down Hsa-miR-1 downregulates long non-coding RNA urothelial cancer associated 1 in bladder cancer. hsa-mir-1 breast cancer down Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1. hsa-mir-1 chordoma down Prognostic significance of miRNA-1 (miR-1) expression in patients with chordoma. hsa-mir-1 chordoma down MicroRNA-1 (miR-1) inhibits chordoma cell migration and invasion by targeting slug. hsa-mir-1 colorectal cancer down Tumor suppressor miR-1 restrains epithelial-mesenchymal transition and metastasis of colorectal carcinoma via the MAPK and PI3K/AKT pathway. hsa-mir-1 esophageal squamous cell carcinoma down Downregulation of microRNA-1 in esophageal squamous cell carcinoma correlates with an advanced clinical stage and its overexpression inhibits cell migration and invasion. hsa-mir-1 gastric cancer down MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET. hsa-mir-1 head and neck squamous cell carcinoma down miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma. hsa-mir-1 head and neck squamous cell carcinoma down Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. hsa-mir-1 hepatocellular carcinoma down MicroRNA-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1. hsa-mir-1 kidney cancer down MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis. hsa-mir-1 lung cancer down Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. hsa-mir-1 nasopharyngeal carcinoma down EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma. hsa-mir-1 non-small cell lung cancer down MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells. hsa-mir-1 osteosarcoma down MicroRNA-1 functions as a potential tumor suppressor in osteosarcoma by targeting Med1 and Med31. hsa-mir-1 renal cell carcinoma down The functional significance of miR-1 and miR-133a in renal cell carcinoma. hsa-mir-100 breast cancer down miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling. hsa-mir-100 breast cancer down miR-100 Induces Epithelial-Mesenchymal Transition but Suppresses Tumorigenesis, Migration and Invasion. hsa-mir-100 cervical carcinoma down miR-99 inhibits cervical carcinoma cell proliferation by targeting TRIB2. hsa-mir-100 chondrosarcoma down Analysis of microRNAs expressions in chondrosarcoma. hsa-mir-100 chondrosarcoma down MicroRNA-100 Resensitizes Resistant Chondrosarcoma Cells to Cisplatin through Direct Targeting of mTOR. hsa-mir-100 colon cancer down MicroRNA-100 functions as a tumor suppressor by inhibiting Lgr5 expression in colon cancer cells. hsa-mir-100 colorectal cancer down Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in colorectal cancer. hsa-mir-100 colorectal cancer down MicroRNA-100 regulates SW620 colorectal cancer cell proliferation and invasion by targeting RAP1B. hsa-mir-100 esophageal squamous cell carcinoma down MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma. hsa-mir-100 esophageal squamous cell carcinoma up MicroRNA-100 promotes migration and invasion through mammalian target of rapamycin in esophageal squamous cell carcinoma. hsa-mir-100 esophageal squamous cell carcinoma down Prognostic value of microRNA-100 in esophageal squamous cell carcinoma. hsa-mir-100 gastric cancer up miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-mir-100 glioblastoma down microRNA-100 Targets SMRT/NCOR2, Reduces Proliferation, and Improves Survival in Glioblastoma Animal Models. hsa-mir-100 hepatocellular carcinoma down Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression. hsa-mir-100 hepatocellular carcinoma down Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma. hsa-mir-100 mesenchymal cancer down MicroRNA Expression Profiles in Kaposi's Sarcoma. hsa-mir-100 non-small cell lung cancer down MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1. hsa-mir-100 non-small cell lung cancer down Overexpression of miR-100 inhibits cancer growth, migration, and chemosensitivity in human NSCLC cells through fibroblast growth factor receptor 3. hsa-mir-100 oral squamous cell carcinoma down Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. hsa-mir-100 osteosarcoma down MicroRNA-100 inhibits osteosarcoma cell proliferation by targeting Cyr61. hsa-mir-100 osteosarcoma down MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR. hsa-mir-100 ovarian cancer down Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research. hsa-mir-100 ovarian carcinoma down Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer. hsa-mir-100 prostate cancer down Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2. hsa-mir-100 renal cell carcinoma up Overexpression of microRNA-100 predicts an unfavorable prognosis in renal cell carcinoma. hsa-mir-100-5p gastric cancer down Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer. hsa-mir-101 bladder cancer down MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met. hsa-mir-101 bladder cancer down miR-101 Suppresses Vascular Endothelial Growth Factor C That Inhibits Migration and Invasion and Enhances Cisplatin Chemosensitivity of Bladder Cancer Cells. hsa-mir-101 cervical carcinoma down MicroRNA-101 inhibits cell proliferation, invasion, and promotes apoptosis by regulating cyclooxygenase-2 in Hela cervical carcinoma cells. hsa-mir-101 cholangiocarcinoma down miR-101 inhibits cholangiocarcinoma angiogenesis through targeting vascular endothelial growth factor (VEGF). hsa-mir-101 cholangiocarcinoma down miR-101 inhibits cholangiocarcinoma angiogenesis through targeting vascular endothelial growth factor (VEGF). hsa-mir-101 colon cancer down MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase. hsa-mir-101 colon cancer down Loss of miR-101 Expression Promotes Wnt/?-Catenin Signalling Pathway Activation and Malignancy in Colon Cancer Cells. hsa-mir-101 colorectal cancer down Gene module based regulator inference identifying miR-139 as a tumor suppressor in colorectal cancer. hsa-mir-101 colorectal cancer down MicroRNA-101 down-regulates sphingosine kinase 1 in colorectal cancer cells. hsa-mir-101 endometrial cancer down MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells. hsa-mir-101 endometrial cancer down MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells. hsa-mir-101 esophageal cancer up Differential expression of miRNAs in esophageal cancer tissue. hsa-mir-101 esophageal squamous cell carcinoma down miR-101 suppresses tumor proliferation and migration, and induces apoptosis by targeting EZH2 in esophageal cancer cells. hsa-mir-101 gastric cancer down MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. hsa-mir-101 gastric cancer down MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. hsa-mir-101 gastric cancer down Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer. hsa-mir-101 gastric cancer down Down-regulation of miR-101 in gastric cancer correlates with COX-2 overexpression and tumor growth. hsa-mir-101 glioblastoma down Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III. hsa-mir-101 glioblastoma down miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis. hsa-mir-101 hepatocellular carcinoma down PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells. hsa-mir-101 hepatocellular carcinoma down MicroRNAs in Hepatobiliary and Pancreatic Cancers. hsa-mir-101 hepatocellular carcinoma down miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells. hsa-mir-101 hepatocellular carcinoma down MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity. hsa-mir-101 hepatocellular carcinoma down Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets. hsa-mir-101 laryngeal squamous cell carcinoma down MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8. hsa-mir-101 liver cancer down MiR-101 functions as a tumor suppressor by directly targeting nemo-like kinase in liver cancer. hsa-mir-101 lung cancer down microRNA-101 inhibits lung cancer invasion through the regulation of enhancer of zeste homolog 2. hsa-mir-101 malignant melanoma down MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2. hsa-mir-101 nasopharyngeal carcinoma down miR-101 sensitizes human nasopharyngeal carcinoma cells to radiation by targeting stathmin 1. hsa-mir-101 non-small cell lung cancer down MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance. hsa-mir-101 non-small cell lung cancer down MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2. hsa-mir-101 osteosarcoma down Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR. hsa-mir-101 ovarian carcinoma down MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma. hsa-mir-101 pancreatic cancer down miRNA-101 suppresses epithelial-to-mesenchymal transition by targeting HMGA2 in pancreatic cancer cells. hsa-mir-101 papillary thyroid carcinoma down miR-101 inhibits cell proliferation by targeting Rac1 in papillary thyroid carcinoma. hsa-mir-101 papillary thyroid carcinoma down Hsa-microRNA-101 suppresses migration and invasion by targeting Rac1 in thyroid cancer cells. hsa-mir-101 prostate cancer down Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo. hsa-mir-101 retinoblastoma down miR-101, downregulated in retinoblastoma, functions as a tumor suppressor in human retinoblastoma cells by targeting EZH2. hsa-mir-103 colorectal cancer up PER3, a novel target of miR-103, plays a suppressive role in colorectal cancer in vitro. hsa-mir-103 colorectal cancer up MicroRNA-103 Promotes Colorectal Cancer by Targeting Tumor Suppressor DICER and PTEN. hsa-mir-103 gastric cancer up miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-mir-103a gastric cancer down MicroRNA-103a inhibits gastric cancer cell proliferation, migration and invasion by targeting c-Myb. hsa-mir-103a-3p bladder cancer up Micro-RNA profiling in kidney and bladder cancers. hsa-mir-105 hepatocellular carcinoma down MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma. hsa-mir-105 prostate cancer down miR-105 Inhibits Prostate Tumour Growth by Suppressing CDK6 Levels. hsa-mir-106a cervical squamous cell carcinoma down MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma. hsa-mir-106a colorectal cancer up [Expression of plasma miR-106a in colorectal cancer and its clinical significance]. hsa-mir-106a colorectal cancer up Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation. hsa-mir-106a endometrial cancer up TSA Suppresses miR-106b-93-25 Cluster Expression through Downregulation of MYC and Inhibits Proliferation and Induces Apoptosis in Human EMC. hsa-mir-106a gastric cancer up miR-106a confers cisplatin resistance by regulating PTEN/Akt pathway in gastric cancer cells. hsa-mir-106a gastric cancer up MicroRNA-106a targets TIMP2 to regulate invasion and metastasis of gastric cancer. hsa-mir-106a gastric cancer up Circulating microRNAs in plasma of patients with gastric cancers. hsa-mir-106a gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-106a gastric cancer up miR-106a Is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS. hsa-mir-106a gastric cancer up Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma. hsa-mir-106a glioblastoma down Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM. hsa-mir-106a glioma down MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status. hsa-mir-106a non-small cell lung cancer down Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. hsa-mir-106a ovarian cancer up Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells. hsa-mir-106a* renal cell carcinoma down miR-106a* inhibits the proliferation of renal carcinoma cells by targeting IRS-2. hsa-mir-106a-5p clear cell renal cell cancer down Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles. hsa-mir-106b colorectal cancer up MicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1. hsa-mir-106b gastric cancer up Circulating microRNAs in plasma of patients with gastric cancers. hsa-mir-106b gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-106b gastric cancer up Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma. hsa-mir-106b glioma up Down-regulation of miR-106b suppresses the growth of human glioma cells. hsa-mir-106b head and neck squamous cell carcinoma up Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. hsa-mir-106b hepatocellular carcinoma up Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process. hsa-mir-106b hepatocellular carcinoma up Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma. hsa-mir-106b laryngeal carcinoma up MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma. hsa-mir-106b laryngeal carcinoma up MicroRNA-106b regulates the tumor suppressor RUNX3 in laryngeal carcinoma cells. hsa-mir-106b medulloblastoma up miR-106b is overexpressed in medulloblastomas and interacts directly with PTEN. hsa-mir-106b pituitary carcinoma up MicroRNA involvement in a metastatic non-functioning pituitary carcinoma. hsa-mir-106b thyroid cancer down microRNA-106b-mediated down-regulation of C1orf24 expression induces apoptosis and suppresses invasion of thyroid cancer. hsa-mir-106b-5p glioma up MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes. hsa-mir-107 acute promyelocytic leukemia down A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes. hsa-mir-107 breast cancer down MiRNA-107 inhibits proliferation and migration by targeting CDK8 in breast cancer. hsa-mir-107 gastric cancer up miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-mir-107 gastric cancer up Upregulation of MicroRNA-107 induces proliferation in human gastric cancer cells by targeting the transcription factor FOXO1. hsa-mir-107 gastric cancer up MicroRNA-107 promotes proliferation of gastric cancer cells by targeting cyclin dependent kinase 8. hsa-mir-107 gastric cancer up MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer. hsa-mir-107 glioma down MicroRNA-107 inhibits glioma cell migration and invasion by modulating Notch2 expression. hsa-mir-107 glioma down Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4. hsa-mir-107 glioma down Upregulation of miR-107 Inhibits Glioma Angiogenesis and VEGF Expression. hsa-mir-107 glioma down P53-induced microRNA-107 inhibits proliferation of glioma cells and down-regulates the expression of CDK6 and Notch-2. hsa-mir-107 head and neck squamous cell carcinoma down microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase C? hsa-mir-107 head and neck squamous cell carcinoma down Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma. hsa-mir-107 hepatocellular carcinoma up miR-107 promotes hepatocellular carcinoma cell proliferation by targeting Axin2. hsa-mir-107 non-small cell lung cancer down Clinicopathological and prognostic significance of microRNA-107 in human non small cell lung cancer. hsa-mir-107 prostate carcinoma down Dysregulation of the mitogen granulin in human cancer through the miR-15/107 microRNA gene group. hsa-mir-10a breast cancer down MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid. hsa-mir-10a cervical cancer up MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells. hsa-mir-10a chronic myelogenous leukemia down Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. hsa-mir-10a gastric cancer up miRNA expression profile in primary gastric cancers and paired lymph node metastases indicates that miR-10a plays a role in metastasis from primary gastric cancer to lymph nodes. hsa-mir-10a gastric cancer down MicroRNA-10a Is Down-Regulated by DNA Methylation and Functions as a Tumor Suppressor in Gastric Cancer Cells. hsa-mir-10a non-small cell lung cancer up MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN. hsa-mir-10a pancreatic cancer up MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene. hsa-mir-10b bladder cancer up MicroRNA-10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer. hsa-mir-10b breast cancer down Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. hsa-mir-10b breast cancer up Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. hsa-mir-10b colorectal cancer up MicroRNA-10b is upregulated and has an invasive role in colorectal cancer through enhanced Rhoc expression. hsa-mir-10b esophageal cancer up MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. hsa-mir-10b gastric cancer up Clinicopathologic significance of miR-10b expression in gastric carcinoma. hsa-mir-10b gastric cancer down DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. hsa-mir-10b gastric cancer up Augmented miR-10b expression associated with depressed expression of its target gene KLF4 involved in gastric carcinoma. hsa-mir-10b gastric cancer up MicroRNA-10b promotes migration and invasion through Hoxd10 in human gastric cancer. hsa-mir-10b gastric cancer up miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer. hsa-mir-10b glioblastoma up Oncogenic effects of miR-10b in glioblastoma stem cells. hsa-mir-10b glioblastoma up Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III. hsa-mir-10b glioma up MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. hsa-mir-10b hepatocellular carcinoma up MicroRNA-10b promotes migration and invasion through CADM1 in human hepatocellular carcinoma cells. hsa-mir-10b hepatocellular carcinoma up miR-10b is overexpressed in hepatocellular carcinoma and promotes cell proliferation, migration and invasion through RhoC, uPAR and MMPs. hsa-mir-10b lung cancer up microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells. hsa-mir-10b nasopharyngeal carcinoma up miR-10b Promotes Migration and Invasion in Nasopharyngeal Carcinoma Cells. hsa-mir-10b nasopharyngeal carcinoma up Over-expression of miR-10b in NPC patients: correlation with LMP1 and Twist1. hsa-mir-10b non-small cell lung cancer up MicroRNA-10b indicates a poor prognosis of non-small cell lung cancer and targets E-cadherin. hsa-mir-10b non-small cell lung cancer up microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells. hsa-mir-10b oral cancer up Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling. hsa-mir-10b pancreatic cancer up MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. hsa-mir-10b pancreatic cancer up MicroRNA-10b is overexpressed in pancreatic cancer. hsa-mir-10b pancreatic ductal adenocarcinoma up microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinoma. hsa-mir-10b pancreatic ductal adenocarcinoma up microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-? actions. hsa-mir-1179 colorectal cancer up MicroRNA expression profiles in human colorectal cancers with liver metastases. hsa-mir-1179 esophageal squamous cell carcinoma up miR-1179 promotes cell invasion through SLIT2/ROBO1 axis in esophageal squamous cell carcinoma. hsa-mir-1180 bladder cancer down Up-regulation of p21(WAF1/CIP1) by miRNAs and its implications in bladder cancer cells. hsa-mir-1181 ovarian cancer up Activation of ARK5/miR-1181/HOXA10 axis promotes epithelial-mesenchymal transition in ovarian cancer. hsa-mir-1181 pancreatic cancer down MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer. hsa-mir-1207 ovarian cancer up MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/?-catenin signaling pathway. hsa-mir-1207-5p gastric cancer down miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase. hsa-mir-122 breast cancer down MiR-122 Inhibits Cell Proliferation and Tumorigenesis of Breast Cancer by Targeting IGF1R. hsa-mir-122 breast cancer down Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122. hsa-mir-122 gastric cancer down Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer. hsa-mir-122 glioma down miR-122/Wnt/?-catenin regulatory circuitry sustains glioma progression. hsa-mir-122 hepatocellular carcinoma up Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno hsa-mir-122 hepatocellular carcinoma down miR-122 affects the viability and apoptosis of hepatocellular carcinoma cells. hsa-mir-122 hepatocellular carcinoma down MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/?-catenin pathway. hsa-mir-122 hepatocellular carcinoma down microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma. hsa-mir-122 hepatocellular carcinoma down MicroRNAs in Hepatobiliary and Pancreatic Cancers. hsa-mir-122 hepatocellular carcinoma down A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma. hsa-mir-122 hepatocellular carcinoma up Epigenetic regulation of miR-122 by PPAR? and hepatitis B virus X protein in hepatocellular carcinoma cells. hsa-mir-122 hepatocellular carcinoma up Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. hsa-mir-122 hepatocellular carcinoma down miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3. hsa-mir-122 hepatocellular carcinoma down MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest. hsa-mir-122 hepatocellular carcinoma down MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. hsa-mir-122 liver cancer down MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. hsa-mir-122 osteosarcoma down Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements. hsa-mir-122 pituitary carcinoma up MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas. hsa-mir-122 renal clear cell carcinoma up miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. hsa-mir-1228 breast cancer up MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein. hsa-mir-1228 hepatocellular carcinoma up miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop. hsa-mir-1228* gastric cancer down Restoration of miR-1228* expression suppresses epithelial-mesenchymal transition in gastric cancer. hsa-mir-1229 colorectal cancer up Circulating Exosomal microRNAs as Biomarkers of Colon Cancer. hsa-mir-122a gastrointestinal cancer down MicroRNA-122a functions as a novel tumor suppressor downstream of adenomatous polyposis coli in gastrointestinal cancers. hsa-mir-122a hepatocellular carcinoma down Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. hsa-mir-122a hepatocellular carcinoma down [MicroRNA profiling in patients with hepatocellular carcinoma]. hsa-mir-122a hepatocellular carcinoma down Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma. hsa-mir-1233 renal cell carcinoma up MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels. hsa-mir-1236 bladder cancer down Up-regulation of p21(WAF1/CIP1) by miRNAs and its implications in bladder cancer cells. hsa-mir-1236 hepatocellular carcinoma down miR-1236 down-regulates alpha-fetoprotein, thus causing PTEN accumulation, which inhibits the PI3K/Akt pathway and malignant phenotype in hepatoma cells. hsa-mir-1238 non-small cell lung cancer down miR-1238 inhibits cell proliferation by targeting LHX2 in non-small cell lung cancer. hsa-mir-124 anaplastic astrocytoma down miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. hsa-mir-124 bladder cancer down MiR-124 exerts tumor suppressive functions on the cell proliferation, motility and angiogenesis of bladder cancer by fine-tuning UHRF1. hsa-mir-124 breast cancer down miR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4. hsa-mir-124 breast cancer down Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer. hsa-mir-124 breast cancer down MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer. hsa-mir-124 breast cancer down MicroRNA-124 suppresses breast cancer cell growth and motility by targeting CD151. hsa-mir-124 breast cancer down Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer. hsa-mir-124 breast cancer down MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer. hsa-mir-124 breast cancer down miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro. hsa-mir-124 cervical squamous cell carcinoma down Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK. hsa-mir-124 colorectal cancer down MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer. hsa-mir-124 colorectal cancer down MicroRNA-124 Regulates the Proliferation of Colorectal Cancer Cells by Targeting iASPP. hsa-mir-124 colorectal cancer down Downregulation of rho-associated protein kinase 1 by miR-124 in colorectal cancer. hsa-mir-124 colorectal cancer down MiR-124 Suppresses Growth of Human Colorectal Cancer by Inhibiting STAT3. hsa-mir-124 colorectal cancer down MicroRNA-124 Reduces Pentose Phosphate Pathway and Proliferation by Targeting PRPS1 and RPIA mRNAs in Human Colorectal Cancer Cells. hsa-mir-124 colorectal cancer down MiR-124 Radiosensitizes Human Colorectal Cancer Cells by Targeting PRRX1. hsa-mir-124 colorectal cancer down KITENIN-targeting MicroRNA-124 Suppresses Colorectal Cancer Cell Motility and Tumorigenesis. hsa-mir-124 colorectal cancer down Gene module based regulator inference identifying miR-139 as a tumor suppressor in colorectal cancer. hsa-mir-124 colorectal cancer down Downregulation of microRNA-124 is an independent prognostic factor in patients with colorectal cancer. hsa-mir-124 esophageal cancer down STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells. hsa-mir-124 gastric cancer down miR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1. hsa-mir-124 gastric cancer down [miR-124 suppresses cell proliferation and invasion in gastric carcinoma and its mechanism]. hsa-mir-124 gastric cancer down microRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer. hsa-mir-124 glioblastoma down miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. hsa-mir-124 glioblastoma down Downregulation of miR-124 promotes the growth and invasiveness of glioblastoma cells involving upregulation of PPP1R13L. hsa-mir-124 glioma down MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras. hsa-mir-124 glioma down Downregulation of microRNA-124 predicts poor prognosis in glioma patients. hsa-mir-124 glioma down microRNA-124 Inhibits Migration and Invasion by Down-Regulating ROCK1 in Glioma. hsa-mir-124 hepatocellular carcinoma down MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3. hsa-mir-124 hepatocellular carcinoma down The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. hsa-mir-124 hepatocellular carcinoma down MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA. hsa-mir-124 medulloblastoma down miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. hsa-mir-124 nasopharyngeal carcinoma down MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma. hsa-mir-124 neuroblastoma down Silencing of miR-124 induces neuroblastoma SK-N-SH cell differentiation, cell cycle arrest and apoptosis through promoting AHR. hsa-mir-124 non-small cell lung cancer down miRNA-124 down-regulates SOX8 expression and suppresses cell proliferation in non-small cell lung cancer. hsa-mir-124 non-small cell lung cancer down miRNA-124 down-regulates SOX8 expression and suppresses cell proliferation in non-small cell lung cancer. hsa-mir-124 non-small cell lung cancer down Down-regulation of microRNA-124 is correlated with tumor metastasis and poor prognosis in patients with lung cancer. hsa-mir-124 oral squamous cell carcinoma down MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1. hsa-mir-124 osteosarcoma down The tumor suppressor role of miR-124 in osteosarcoma. hsa-mir-124 osteosarcoma down MicroRNA-124 functions as a tumor suppressor and indicates prognosis in human osteosarcoma. hsa-mir-124 ovarian cancer down MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1. hsa-mir-124 pancreatic cancer down Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1. hsa-mir-124 prostate cancer down MiR-124 suppresses cell motility and adhesion by targeting talin 1 in prostate cancer cells. hsa-mir-124-3p astrocytoma down Reductions in the expression of miR-124-3p, miR-128-1, and miR-221-3p in pediatric astrocytomas are related to high-grade supratentorial, and recurrent tumors in Mexican children. hsa-mir-124-3p bladder cancer down MicroRNA-124-3p inhibits cell migration and invasion in bladder cancer cells by targeting ROCK1. hsa-mir-124-3p gastric cancer down The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis. hsa-mir-124-5p glioma down MiR-124-5p inhibits the growth of high-grade gliomas through posttranscriptional regulation of LAMB1. hsa-mir-1246 cervical cancer down Down-regulation of miR-1246 in cervical cancer tissues and its clinical significance. hsa-mir-1246 colorectal cancer up Circulating Exosomal microRNAs as Biomarkers of Colon Cancer. hsa-mir-1246 non-small cell lung cancer up The microRNA-1246 promotes metastasis in non-small cell lung cancer by targeting cytoplasmic polyadenylation element-binding protein 4. hsa-mir-1247 pancreatic cancer down miR-1247 is Correlated with Prognosis of Pancreatic Cancer and Inhibits Cell Proliferation by Targeting Neuropilins. hsa-mir-124a acute lymphoblastic leukemia down Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. hsa-mir-124a epithelial ovarian cancer down Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells. hsa-mir-124a glioblastoma down miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion. hsa-mir-124a glioma down miR-124a restoration inhibits glioma cell proliferation and invasion by suppressing IQGAP1 and ?-catenin. hsa-mir-124a mantle cell lymphoma up microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. hsa-mir-1250 oral squamous cell carcinoma down Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer. hsa-mir-1258 breast cancer down MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase. hsa-mir-1258 breast cancer down The expression and clinical significance of microRNA-1258 and heparanase in human breast cancer. hsa-mir-1259 gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-125a breast cancer up MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the hippo signaling pathway. hsa-mir-125a colorectal cancer down Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation. hsa-mir-125a glioblastoma down miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma. hsa-mir-125a-3p gastric cancer down Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance. hsa-mir-125a-3p non-small cell lung cancer down miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion. hsa-mir-125a-3p non-small cell lung cancer down Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. hsa-mir-125a-5p breast cancer down Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. hsa-mir-125a-5p colon cancer down miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1. hsa-mir-125a-5p glioblastoma down MiRNA-125a-5p inhibits glioblastoma cell proliferation and promotes cell differentiation by targeting TAZ. hsa-mir-125a-5p malignant melanoma down Lin28B promotes melanoma growth by mediating a microRNA regulatory circuit. hsa-mir-125a-5p non-small cell lung cancer down Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. hsa-mir-125a-5p non-small cell lung cancer up Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer. hsa-mir-125b acute myeloid leukemia up [miR-125b promotes proliferation of human acute myeloid leukemia cells by targeting Bak1]. hsa-mir-125b bladder cancer down MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. hsa-mir-125b bladder cancer down microRNA-125b inhibits cell migration and invasion by targeting matrix metallopeptidase 13 in bladder cancer. hsa-mir-125b breast cancer down miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. hsa-mir-125b breast cancer down MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells. hsa-mir-125b breast cancer down Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue. hsa-mir-125b breast cancer down The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer. hsa-mir-125b breast cancer down MUCIN 1 ONCOPROTEIN EXPRESSION IS SUPPRESSED BY THE miR-125b ONCOMIR. hsa-mir-125b chronic lymphocytic leukemia down The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. hsa-mir-125b colorectal cancer up MicroRNA miR-125b is a prognostic marker in human colorectal cancer. hsa-mir-125b follicular cancer up MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer. hsa-mir-125b gastric cancer up miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-mir-125b gastric cancer up MiR-125b promotes cell migration and invasion by targeting PPP1CA-Rb signal pathways in gastric cancer, resulting in a poor prognosis. hsa-mir-125b glioblastoma down Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma. hsa-mir-125b glioblastoma up miR-125b promotes cell proliferation by directly targeting Lin28 in glioblastoma stem cells with low expression levels of miR-125b. hsa-mir-125b glioma down Serum MicroRNA-125b as a Potential Biomarker for Glioma Diagnosis. hsa-mir-125b glioma up MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf. hsa-mir-125b glioma up miR-125b Inhibits Connexin43 and Promotes Glioma Growth. hsa-mir-125b hepatocellular carcinoma down Overexpression of microRNA-125b sensitizes human hepatocellular carcinoma cells to 5-fluorouracil through inhibition of glycolysis by targeting hexokinase II. hsa-mir-125b hepatocellular carcinoma down Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. hsa-mir-125b hepatocellular carcinoma down Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer. hsa-mir-125b hepatocellular carcinoma down MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R. hsa-mir-125b hepatocellular carcinoma down MicroRNA-125b Functions as a Tumor Suppressor in Hepatocellular Carcinoma Cells. hsa-mir-125b hepatocellular carcinoma down Histone lysine methyltransferase, SUV39H1, promotes HCC progression and is negatively regulated by microRNA-125b. hsa-mir-125b malignant melanoma down miR-125b induces cellular senescence in malignant melanoma. hsa-mir-125b malignant melanoma down MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression. hsa-mir-125b neuroblastoma up MicroRNA-125b is a novel negative regulator of p53. hsa-mir-125b oral squamous cell carcinoma down Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. hsa-mir-125b oral squamous cell carcinoma up [Expression and clinical significance of plasma microRNA-125b level in patients with oral squamous cell carcinoma]. hsa-mir-125b osteosarcoma down miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3. hsa-mir-125b osteosarcoma down Upregulation of miR-300 and downregulation of miR-125b act as potential predictor biomarkers in progression, metastasis, and poor prognosis of osteosarcoma. hsa-mir-125b ovarian cancer down Roles and Mechanism of miR-199a and miR-125b in Tumor Angiogenesis. hsa-mir-125b ovarian cancer down Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research. hsa-mir-125b ovarian cancer down PPAR? inhibits ovarian cancer cells proliferation through upregulation of miR-125b. hsa-mir-125b prostate cancer up Widespread deregulation of microRNA expression in human prostate cancer. hsa-mir-125b prostate cancer up Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer. hsa-mir-125b-1-3p mesenchymal cancer up miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR. hsa-mir-125b-2* colorectal cancer up MicroRNA expression profiles in human colorectal cancers with liver metastases. hsa-mir-126 bladder cancer down MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9. hsa-mir-126 breast cancer down Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2. hsa-mir-126 breast cancer down miR-126 regulated breast cancer cell invasion by targeting ADAM9. hsa-mir-126 colon cancer down MiR-126 suppresses colon cancer cell proliferation and invasion via inhibiting RhoA/ROCK signaling pathway. hsa-mir-126 colon cancer down Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4. hsa-mir-126 colon cancer down [miR-126 inhibits colon cancer proliferation and invasion through targeting IRS1, SLC7A5 and TOM1 gene]. hsa-mir-126 colorectal cancer down Down-regulation of miR-126 expression in colorectal cancer and its clinical significance. hsa-mir-126 colorectal cancer down Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer. hsa-mir-126 colorectal cancer down MicroRNA-126 functions as a tumor suppressor in colorectal cancer cells by targeting CXCR4 via the AKT and ERK1/2 signaling pathways. hsa-mir-126 colorectal cancer down Low expression of MicroRNA-126 is associated with poor prognosis in colorectal cancer. hsa-mir-126 esophageal cancer down Differential expression of miRNAs in esophageal cancer tissue. hsa-mir-126 esophageal squamous cell carcinoma down Insulin receptor substrate-1 and Golgi phosphoprotein 3 are downstream targets of miR?126 in esophageal squamous cell carcinoma. hsa-mir-126 esophageal squamous cell carcinoma down MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway. hsa-mir-126 gastric cancer down miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-mir-126 gastric cancer down Mir-126 inhibits growth of SGC-7901 cells by synergistically targeting the oncogenes PI3KR2 and Crk, and the tumor suppressor PLK2. hsa-mir-126 gastric cancer down Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A. hsa-mir-126 gastric cancer down MicroRNA-126 inhibits cell proliferation in gastric cancer by targeting LAT-1. hsa-mir-126 gastric cancer down miR-126 functions as a tumour suppressor in human gastric cancer. hsa-mir-126 gastric cancer up MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis. hsa-mir-126 hepatocellular carcinoma down Decreased expression of miR-126 correlates with metastatic recurrence of hepatocellular carcinoma. hsa-mir-126 hepatocellular carcinoma down miR-126 inhibits cell proliferation and induces cell apoptosis of hepatocellular carcinoma cells partially by targeting Sox2. hsa-mir-126 malignant melanoma up Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models. hsa-mir-126 malignant mesothelioma down MicroRNA-126 Suppresses Mesothelioma Malignancy by Targeting IRS1 and Interfering with Mitochondrial Function. hsa-mir-126 non-small cell lung cancer down Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application. hsa-mir-126 non-small cell lung cancer down Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer. hsa-mir-126 non-small cell lung cancer down miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7. hsa-mir-126 non-small cell lung cancer down miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A. hsa-mir-126 non-small cell lung cancer down MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients. hsa-mir-126 oral squamous cell carcinoma up Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer. hsa-mir-126 oral squamous cell carcinoma down Suppressive effect of microRNA-126 on oral squamous cell carcinoma in vitro. hsa-mir-126 osteosarcoma down MicroRNA-126 inhibits osteosarcoma cells proliferation by targeting Sirt1. hsa-mir-126 osteosarcoma down miR-126 functions as a tumor suppressor in osteosarcoma by targeting Sox2. hsa-mir-126 osteosarcoma down Tissue microRNA-126 expression level predicts outcome in human osteosarcoma. hsa-mir-126 osteosarcoma down MicroRNA-126 Overexpression Inhibits Proliferation and Invasion in Osteosarcoma Cells. hsa-mir-126 ovarian cancer down microRNA-126 suppresses PAK4 expression in ovarian cancer SKOV3 cells. hsa-mir-126 pancreatic ductal adenocarcinoma down MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors. hsa-mir-126 papillary thyroid carcinoma down miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6. hsa-mir-126 renal cell carcinoma down Low Expression of miR-126 Is a Prognostic Marker for Metastatic Clear Cell Renal Cell Carcinoma. hsa-mir-126 small cell lung cancer down miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5. hsa-mir-126* non-small cell lung cancer down Clinical evaluation of microRNA expression profiling in non small cell lung cancer. hsa-mir-126-3p thyroid cancer down miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer. hsa-mir-126-5p acute myeloid leukemia up Upregulation of microRNA-126-5p is associated with drug resistance to cytarabine and poor prognosis in AML patients. hsa-mir-1260b renal cell carcinoma up Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells. hsa-mir-1266 gastric cancer down miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase. hsa-mir-1269 hepatocellular carcinoma up MicroRNA-1269 promotes proliferation in human hepatocellular carcinoma via downregulation of FOXO1. hsa-mir-1269 hepatocellular carcinoma up Upregulated MiR-1269 in hepatocellular carcinoma and its clinical significance. hsa-mir-1269a colorectal cancer up miR-1269 promotes metastasis and forms a positive feedback loop with TGF-?. hsa-mir-127 breast cancer down MicroRNA-127 is Downregulated by Tudor-SN Protein and Contributes to Metastasis and Proliferation in Breast Cancer Cell Line MDA-MB-231. hsa-mir-127 breast cancer down miR-127 Regulates Cell Proliferation and Senescence by Targeting BCL6. hsa-mir-127 gastric cancer down The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer. hsa-mir-127 hepatocellular carcinoma down MicroRNA-127 Post-Transcriptionally Downregulates Sept7 and Suppresses Cell Growth in Hepatocellular Carcinoma Cells. hsa-mir-127 hepatocellular carcinoma down A Feedback Inhibition between miRNA-127 and TGF?/c-Jun Cascade in HCC Cell Migration via MMP13. hsa-mir-127-3p glioblastoma up MicroRNA-127-3p promotes glioblastoma cell migration and invasion by targeting the tumor-suppressor gene SEPT7. hsa-mir-127-3p glioblastoma down Next Generation Sequencing Analysis of miRNAs: MiR-127-3p Inhibits Glioblastoma Proliferation and Activates TGF-? Signaling by Targeting SKI. hsa-mir-127-3p osteosarcoma down MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. hsa-mir-1271 gastric cancer down miR-1271 Regulates Cisplatin Resistance of Human Gastric Cancer Cell Lines by Targeting IGF1R, IRS1, mTOR, and BCL2. hsa-mir-1271 gastric cancer down MiR-1271 Inhibits Cell Proliferation, Invasion and EMT in Gastric Cancer by Targeting FOXQ1. hsa-mir-1271 hepatocellular carcinoma down A functional screening identifies five miRNAs controlling glypican-3: Role of miR-1271 down-regulation in hepatocellular carcinoma. hsa-mir-1271 oral squamous cell carcinoma down miR-1271 inhibits OSCC cell growth and metastasis by targeting ALK. hsa-mir-1274a gastric cancer up The role of microRNA-1274a in the tumorigenesis of gastric cancer: accelerating cancer cell proliferation and migration via directly targeting FOXO4. hsa-mir-128 acute lymphoblastic leukemia up Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia. hsa-mir-128 acute myeloid leukemia up Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia. hsa-mir-128 glioblastoma down Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation. hsa-mir-128 glioblastoma down PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma. hsa-mir-128 glioblastoma down miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma. hsa-mir-128 glioma down Proteomic screening and identification of microRNA-128 targets in glioma cells. hsa-mir-128 glioma down Serum microRNA-128 as a biomarker for diagnosis of glioma. hsa-mir-128 glioma down MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. hsa-mir-128 glioma down Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. hsa-mir-128 glioma down MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells. hsa-mir-128 glioma down MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1. hsa-mir-128 head and neck squamous cell carcinoma down Functions of MiRNA-128 on the regulation of head and neck squamous cell carcinoma growth and apoptosis. hsa-mir-128 meningioma down Serum microRNA-128 as a biomarker for diagnosis of glioma. hsa-mir-128 osteosarcoma up MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN. hsa-mir-128 prostate cancer down MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells. hsa-mir-128 prostate cancer down miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells. hsa-mir-128-3p hepatocellular carcinoma down miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients. hsa-mir-1280 bladder cancer down MicroRNA-1280 Inhibits Invasion and Metastasis by Targeting ROCK1 in Bladder Cancer. hsa-mir-1280 malignant melanoma down Anti-tumor activity of miR-1280 in melanoma by regulation of Src. hsa-mir-1280 non-small cell lung cancer up Upregulation of MiR-1280 Expression in Non-small Cell Lung Cancer Tissues. hsa-mir-1285 renal cell carcinoma down Tumor suppressive microRNA-1285 regulates novel molecular targets: Aberrant expression and functional significance in renal cell carcinoma. hsa-mir-128a hepatocellular carcinoma up [miR-128a is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation by targeting RND3]. hsa-mir-128a medulloblastoma down MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence. hsa-mir-129 breast cancer down [The down-regulation of miR-129 in breast cancer and its effect on breast cancer migration and motility]. hsa-mir-129 colorectal cancer down miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer. hsa-mir-129 glioblastoma down Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation. hsa-mir-129 hepatocellular carcinoma down miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma. hsa-mir-129 non-small cell lung cancer down MiR-129 regulates MMP9 to control metastasis of non-small cell lung cancer. hsa-mir-129-1-3p gastric cancer down Growth inhibitory effects of three miR-129 family members on gastric cancer. hsa-mir-129-2-3p gastric cancer down Growth inhibitory effects of three miR-129 family members on gastric cancer. hsa-mir-129-3p gastric cancer down Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. hsa-mir-129-3p renal cell carcinoma down miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes. hsa-mir-129-5p gastric cancer down Growth inhibitory effects of three miR-129 family members on gastric cancer. hsa-mir-129-5p gastric cancer down lncRNA-AC130710 targeting by miR-129-5p is upregulated in gastric cancer and associates with poor prognosis. hsa-mir-129-5p hepatocellular carcinoma down MicroRNA-129-5p inhibits hepatocellular carcinoma cell metastasis and invasion via targeting ETS1. hsa-mir-129-5p laryngeal squamous cell carcinoma down Down-Regulation of miR-129-5p Inhibits Growth and Induces Apoptosis in Laryngeal Squamous Cell Carcinoma by Targeting APC. hsa-mir-129-5p medullary thyroid carcinoma down MiR-129-5p is down-regulated and involved in the growth, apoptosis and migration of medullary thyroid carcinoma cells through targeting RET. hsa-mir-129-5p ovarian cancer down A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ. hsa-mir-1290 colon cancer up Up-regulation of microRNA-1290 impairs cytokinesis and affects the reprogramming of colon cancer cells. hsa-mir-1290 esophageal squamous cell carcinoma up MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis. hsa-mir-1291 renal cell carcinoma down Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 (GLUT1) in renal cell carcinoma. hsa-mir-1294 esophageal squamous cell carcinoma down Down-Regulation of MiR-1294 is Related to Dismal Prognosis of Patients with Esophageal Squamous Cell Carcinoma through Elevating C-MYC Expression. hsa-mir-1295b-3p colorectal cancer down Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer. hsa-mir-1296 prostate cancer down Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. hsa-mir-1297 lung adenocarcinoma down miR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2. hsa-mir-1301 liver cancer up Identification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform. hsa-mir-1303 gastric cancer up miR-1303 Targets Claudin-18 Gene to Modulate Proliferation and Invasion of Gastric Cancer Cells. hsa-mir-1307 colorectal cancer down The polymorphic terminal-loop of pre-miR-1307 binding with MBNL1 contributes to colorectal carcinogenesis via interference with Dicer1 recruitment. hsa-mir-130a breast cancer down MicroRNA-130a inhibits cell proliferation, invasion and migration in human breast cancer by targeting the RAB5A. hsa-mir-130a endometrial cancer down Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis. hsa-mir-130a esophageal cancer up Differential expression of miRNAs in esophageal cancer tissue. hsa-mir-130a hepatocellular carcinoma up Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell. hsa-mir-130a hepatocellular carcinoma down MicroRNA-130a is down-regulated in hepatocellular carcinoma and associates with poor prognosis. hsa-mir-130b colorectal cancer up MicroRNA-130b Promotes Tumor Development and Is Associated with Poor Prognosis in Colorectal Cancer. hsa-mir-130b colorectal cancer up MicroRNA-130b Promotes Tumor Development and Is Associated with Poor Prognosis in Colorectal Cancer. hsa-mir-130b colorectal cancer down Microrna 130b Suppresses Migration and Invasion of Colorectal Cancer Cells through Downregulation of Integrin ?1. hsa-mir-130b endometrial cancer down Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis. hsa-mir-130b esophageal squamous cell carcinoma up MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells. hsa-mir-130b glioblastoma up Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway. hsa-mir-130b hepatocellular carcinoma up Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers. hsa-mir-130b hepatocellular carcinoma up High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma. hsa-mir-130b hepatocellular carcinoma down Repression of microRNA-130b by thyroid hormone enhances cell motility. hsa-mir-130b ovarian cancer down Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1. hsa-mir-130b papillary thyroid carcinoma down MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma. hsa-mir-130b prostate cancer down MiR-130b suppresses prostate cancer metastasis through down-regulation of MMP2. hsa-mir-130b* gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-132 breast cancer down MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1. hsa-mir-132 colorectal cancer down miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2. hsa-mir-132 gastric cancer up Upregulation of microRNA-132 in gastric cancer promotes cell proliferation via retinoblastoma 1 targeting. hsa-mir-132 gastric cancer up miR-132 upregulation promotes gastric cancer cell growth through suppression of FoxO1 translation. hsa-mir-132 glioma up Upregulation of miR-132 expression in glioma and its clinical significance. hsa-mir-132 liver cancer down Effects of MicroRNA-132 Transfection on the Proliferation and Apoptosis of Human Liver Cancer Cells in vitro and in vivo. hsa-mir-132 osteosarcoma down Loss of microRNA-132 predicts poor prognosis in patients with primary osteosarcoma. hsa-mir-132 osteosarcoma down miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells. hsa-mir-132 pancreatic cancer up miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. hsa-mir-132 pancreatic carcinoma down Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. hsa-mir-133a bladder cancer down The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. hsa-mir-133a bladder cancer down MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer. hsa-mir-133a breast cancer down microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway. hsa-mir-133a cervical cancer down miR-133a inhibits cervical cancer growth by targeting EGFR. hsa-mir-133a colorectal cancer down Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation. hsa-mir-133a colorectal cancer down Tumor suppressor functions of miR-133a in colorectal cancer. hsa-mir-133a colorectal cancer down The clinicopathological significance of miR-133a in colorectal cancer. hsa-mir-133a colorectal cancer down Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients. hsa-mir-133a colorectal cancer down MicroRNA-133a suppresses colorectal cancer cell invasion by targeting Fascin1. hsa-mir-133a esophageal squamous cell carcinoma down CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma. hsa-mir-133a esophageal squamous cell carcinoma down miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. hsa-mir-133a gastric cancer down MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer. hsa-mir-133a gastric cancer down MicroRNA-133a functions as a tumor suppressor in gastric cancer. hsa-mir-133a gastric cancer down Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R. hsa-mir-133a gastric cancer down MicroRNA-133a inhibits proliferation and invasion, and induces apoptosis in gastric carcinoma cells via targeting fascin actin-bundling protein 1. hsa-mir-133a head and neck squamous cell carcinoma down Tumor suppressive microRNA-133a regulates novel targets: Moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma. hsa-mir-133a head and neck squamous cell carcinoma down Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. hsa-mir-133a hepatocellular carcinoma down MicroRNA-133a inhibits cell proliferation, colony formation ability, migration and invasion by targeting matrix metallopeptidase 9 in hepatocellular carcinoma. hsa-mir-133a hepatocellular carcinoma down MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma. hsa-mir-133a hepatocellular carcinoma down MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1. hsa-mir-133a lung squamous cell carcinoma down Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma. hsa-mir-133a non-small cell lung cancer down MiR-133a is downregulated in non-small cell lung cancer: a study of clinical significance. hsa-mir-133a osteosarcoma down MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1. hsa-mir-133a ovarian cancer down miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor. hsa-mir-133a pancreatic cancer down miR-133a Functions as a Tumor Suppressor and Directly Targets FSCN1 in Pancreatic Cancer. hsa-mir-133a renal cell carcinoma down The functional significance of miR-1 and miR-133a in renal cell carcinoma. hsa-mir-133a-1 prostate cancer down microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor. hsa-mir-133a-2 prostate cancer down microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor. hsa-mir-133b bladder cancer down MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer. hsa-mir-133b cervical carcinoma up MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways. hsa-mir-133b colorectal cancer up Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. hsa-mir-133b colorectal cancer down miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression. hsa-mir-133b esophageal squamous cell carcinoma down miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. hsa-mir-133b gastric cancer down MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells. hsa-mir-133b gastric cancer down MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer. hsa-mir-133b gastric cancer down The role of microRNA-133b and its target gene FSCN1 in gastric cancer. hsa-mir-133b gastric cancer down Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer. hsa-mir-133b gastric cancer down miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer. hsa-mir-133b lung cancer down MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. hsa-mir-133b osteosarcoma down Downregulation of miR-133b/miR-503 acts as efficient prognostic and diagnostic factors in patients with osteosarcoma and these predictor biomarkers are correlated with overall survival. hsa-mir-133b prostate cancer down microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor. hsa-mir-133b renal cell carcinoma down cell lines; microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma. hsa-mir-134 endometrial cancer down MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins. hsa-mir-134 head and neck squamous cell carcinoma up miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene. hsa-mir-134 hepatocellular carcinoma down Genome-Wide Screening Identified That miR-134 Acts as a Metastasis Suppressor by Targeting Integrin ?1 in Hepatocellular Carcinoma. hsa-mir-135a bladder cancer up Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer. hsa-mir-135a breast cancer up miRNA-135a promotes breast cancer cell migration and invasion by targeting HOXA10. hsa-mir-135a colorectal cancer up Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. hsa-mir-135a colorectal cancer up MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro. hsa-mir-135a lung cancer down MiR-135a inhibits migration and invasion and regulates EMT-related marker genes by targeting KLF8 in lung cancer cells. hsa-mir-135a malignant melanoma up MiR-135 post-transcriptionally regulates FOXO1 expression and promotes cell proliferation in human malignant melanoma cells. hsa-mir-135a pancreatic ductal adenocarcinoma down MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma. hsa-mir-135a prostate cancer down Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2. hsa-mir-135a renal cell carcinoma down Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma. hsa-mir-135a-1 colorectal cancer up MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. hsa-mir-135a-2 colorectal cancer up MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. hsa-mir-135a-5p clear cell renal cell cancer down Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles. hsa-mir-135a-5p gastric cancer up Regulation of BGC-823 cell sensitivity to adriamycin via miRNA-135a-5p. hsa-mir-135b colorectal cancer up MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer. hsa-mir-135b colorectal cancer up MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. hsa-mir-135b colorectal cancer up miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer. hsa-mir-135b colorectal cancer up Identification and functional screening of microRNAs highly deregulated in colorectal cancer. hsa-mir-135b colorectal cancer up Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer. hsa-mir-135b colorectal cancer up MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer. hsa-mir-135b colorectal cancer up Identification of microRNA-135b in Stool as a Potential Noninvasive Biomarker for Colorectal Cancer and Adenoma. hsa-mir-135b gastric cancer up [Clinicopathological significance and function of miR-135b in the occurrence and development of gastric cancer]. hsa-mir-135b glioblastoma up MicroRNA-135b exerts oncogenic activity in glioblastoma via the inhibition of glycerol kinase 5 expression. hsa-mir-135b lung cancer up MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. hsa-mir-136 chondrosarcoma down Analysis of microRNAs expressions in chondrosarcoma. hsa-mir-136 glioblastoma down Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation. hsa-mir-136 glioma down MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2. hsa-mir-136 non-small cell lung cancer up Upregulation of miR-136 in human non-small cell lung cancer cells promotes Erk1/2 activation by targeting PPP2R2A. hsa-mir-136 oral squamous cell carcinoma down Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer. hsa-mir-137 anaplastic astrocytoma down miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. hsa-mir-137 bladder cancer up MicroRNA-137 Upregulation Increases Bladder Cancer Cell Proliferation and Invasion by Targeting PAQR3. hsa-mir-137 colorectal cancer down MicroRNA-137, an HMGA1 Target, Suppresses Colorectal Cancer Cell Invasion and Metastasis in Mice by Directly Targeting FMNL2. hsa-mir-137 colorectal cancer down Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer. hsa-mir-137 gastric cancer down miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42. hsa-mir-137 glioblastoma down MiR-137 inhibits proliferation and angiogenesis of human glioblastoma cells by targeting EZH2. hsa-mir-137 glioblastoma down Direct transfection of miR-137 mimics is more effective than DNA demethylation of miR-137 promoter to augment anti-tumor mechanisms of delphinidin in human glioblastoma U87MG and LN18 cells. hsa-mir-137 glioblastoma down miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. hsa-mir-137 glioblastoma down miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2. hsa-mir-137 glioblastoma down MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. hsa-mir-137 glioblastoma down Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III. hsa-mir-137 glioma down Overexpressed miRNA-137 inhibits human glioma cells growth by targeting Rac1. hsa-mir-137 hepatocellular carcinoma down FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2. hsa-mir-137 hepatocellular carcinoma down EDIL3 is a novel regulator of epithelial mesenchymal transition controlling early recurrence of hepatocellular carcinoma. hsa-mir-137 lung cancer down Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer. hsa-mir-137 multiple myeloma down miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma. hsa-mir-137 neuroblastoma down MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A. hsa-mir-137 non-small cell lung cancer down microRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18. hsa-mir-137 osteosarcoma down MicroRNA-137 is downregulated in human osteosarcoma and regulates cell proliferation and migration through targeting FXYD6. hsa-mir-137 ovarian cancer down miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1. hsa-mir-137 ovarian cancer down MicroRNA-137 suppresses tumor growth in epithelial ovarian cancer in vitro and in vivo. hsa-mir-137 ovarian cancer down MicroRNA-29a inhibits cell migration and invasion by targeting Roundabout 1 in breast cancer cells. hsa-mir-137 squamous carcinoma up MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck. hsa-mir-137 uveal melanoma down Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma. hsa-mir-138 anaplastic thyroid carcinoma down Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. hsa-mir-138 chronic lymphocytic leukemia down miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in chronic lymphocytic leukemia. hsa-mir-138 chronic myelogenous leukemia down BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia. hsa-mir-138 colorectal cancer down Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2. hsa-mir-138 esophageal squamous cell carcinoma down Downregulation of miR-138 Sustains NF-?B Activation and Promotes Lipid Raft Formation in Esophageal Squamous Cell Carcinoma. hsa-mir-138 gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-138 head and neck squamous cell carcinoma down MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. hsa-mir-138 head and neck squamous cell carcinoma down Role of microRNA-138 as a potential tumor suppressor in head and neck squamous cell carcinoma. hsa-mir-138 head and neck squamous cell carcinoma down Down regulation of RhoC by microRNA-138 results in de-activation of FAK, Src and Erk(1/2) signaling pathway in head and neck squamous cell carcinoma. hsa-mir-138 hepatocellular carcinoma down MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma. hsa-mir-138 lung cancer down Up-regulation of microRNA-138 induce radiosensitization in lung cancer cells. hsa-mir-138 nasopharyngeal carcinoma down MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene. hsa-mir-138 non-small cell lung cancer up MicroRNA-138 negatively regulates non-small cell lung cancer cells through the interaction with cyclin D3. hsa-mir-138 non-small cell lung cancer down MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C. hsa-mir-138 non-small cell lung cancer down MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung Cancer. hsa-mir-138 non-small cell lung cancer down miR-138 inhibits proliferation by targeting 3-phosphoinositide-dependent protein kinase-1 in non-small cell lung cancer cells. hsa-mir-138 non-small cell lung cancer down Prognostic potential of microRNA-138 and its target mRNA PDK1 in sera for patients with non-small cell lung cancer. hsa-mir-138 oral squamous cell carcinoma down Altered levels of miR-21, miR-125b-2*, miR-134, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics. hsa-mir-138 oral squamous cell carcinoma down miR-138 suppresses the proliferation of oral squamous cell carcinoma cells by targeting Yes-associated protein 1. hsa-mir-138 ovarian cancer down MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1? hsa-mir-138 papillary thyroid carcinoma down Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. hsa-mir-138 renal cell carcinoma down MiR-138 induces renal carcinoma cell senescence by targeting EZH2 and is downregulated in human clear cell renal cell carcinoma. hsa-mir-138 renal clear cell carcinoma down MiR-138 suppresses expression of hypoxia-inducible factor 1? (HIF-1?) in clear cell renal cell carcinoma 786-O cells. hsa-mir-138 small cell lung cancer down MicroRNA-138 Regulates DNA Damage Response in Small Cell Lung Cancer Cells by Directly Targeting H2AX. hsa-mir-139 colorectal cancer down Gene module based regulator inference identifying miR-139 as a tumor suppressor in colorectal cancer. hsa-mir-139 colorectal cancer down Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation. hsa-mir-139 colorectal carcinoma down Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation. hsa-mir-139 glioma down MiR-139 Inhibits Mcl-1 Expression and Potentiates TMZ-Induced Apoptosis in Glioma. hsa-mir-139 hepatocellular carcinoma down The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. hsa-mir-139 hepatocellular carcinoma down Derepression of c-Fos caused by MicroRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma. hsa-mir-139 hepatocellular carcinoma down miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway. hsa-mir-139 non-small cell lung cancer down Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer. hsa-mir-139-3p colorectal cancer up MicroRNA expression profiles in human colorectal cancers with liver metastases. hsa-mir-139-5p breast cancer down MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel. hsa-mir-139-5p colorectal cancer down MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1. hsa-mir-139-5p glioblastoma down miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM. hsa-mir-139-5p hepatocellular carcinoma down miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2. hsa-mir-139-5p non-small cell lung cancer down MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer. hsa-mir-140 breast cancer up Examining estrogen regulation of cancer stem cells through multicolor lineage tracing. hsa-mir-140 esophageal cancer down Down-Regulation of miR-140 Induces EMT and Promotes Invasion by Targeting Slug in Esophageal Cancer. hsa-mir-140 non-small cell lung cancer up Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC. hsa-mir-140 non-small cell lung cancer down miR-140 Suppresses Tumor Growth and Metastasis of Non-Small Cell Lung Cancer by Targeting Insulin-Like Growth Factor 1 Receptor. hsa-mir-140-3p chordoma up MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas. hsa-mir-140-3p chordoma up Identification of miR-140-3p as a marker associated with poor prognosis in spinal chordoma. hsa-mir-140-5p colorectal cancer down Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy. hsa-mir-140-5p hepatocellular carcinoma down miR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRA. hsa-mir-140-5p hepatocellular carcinoma down MicroRNA-140-5p suppresses tumor growth and metastasis by targeting TGFBR1 and FGF9 in hepatocellular carcinoma. hsa-mir-140-5p liver cancer down MicroRNA-140-5p suppresses tumor growth and metastasis by targeting TGFBR1 and FGF9 in hepatocellular carcinoma. hsa-mir-140-5p ovarian cancer down miR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRA. hsa-mir-141 bladder cancer down Expression of microRNAs in the Urine of Patients With Bladder Cancer. hsa-mir-141 bladder cancer up Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer? hsa-mir-141 breast cancer up Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. hsa-mir-141 colorectal cancer down MiR-200 suppresses metastases of colorectal cancer through ZEB1. hsa-mir-141 colorectal cancer up MicroRNA-141 regulates the tumour suppressor DLC-1 in colorectal cancer. hsa-mir-141 esophageal cancer up miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas. hsa-mir-141 gastric cancer down MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression. hsa-mir-141 gastric cancer down Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. hsa-mir-141 gastric cancer down miR-141 suppresses proliferation and motility of gastric cancer cells by targeting HDGF. hsa-mir-141 gastric cancer down The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression. hsa-mir-141 gastric cancer down MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif, TAZ. hsa-mir-141 hepatocellular carcinoma down Expression Profile of MicroRNA-200 Family in Hepatocellular Carcinoma With Bile Duct Tumor Thrombus. hsa-mir-141 hepatocellular carcinoma down miR-141 suppresses the growth and metastasis of HCC cells by targeting E2F3. hsa-mir-141 hepatocellular carcinoma down microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3beta in hepatocellular carcinoma cells. hsa-mir-141 lung adenocarcinoma down miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. hsa-mir-141 lung cancer up MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation. hsa-mir-141 malignant melanoma up MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion. hsa-mir-141 mesenchymal cancer down MicroRNA Expression Profiles in Kaposi's Sarcoma. hsa-mir-141 non-small cell lung cancer up High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. hsa-mir-141 non-small cell lung cancer up MicroRNA-141 promotes the proliferation of non-small cell lung cancer cells by regulating expression of PHLPP1 and PHLPP2. hsa-mir-141 non-small cell lung cancer up MicroRNA-141 is a biomarker for progression of squamous cell carcinoma and adenocarcinoma of the lung: clinical analysis of 125 patients. hsa-mir-141 osteosarcoma down Tumor-Suppressing Effects of miR-141 in Human Osteosarcoma. hsa-mir-141 ovarian cancer down A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. hsa-mir-141 ovarian cancer up Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells. hsa-mir-141 pancreatic cancer down MicroRNA-141, downregulated in pancreatic cancer, inhibited the cell proliferation and invasion by directly targeting MAP4K4. hsa-mir-141 prostate cancer up A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia. hsa-mir-141 renal cell carcinoma down MicroRNA-141 is downregulated in human renal cell carcinoma and regulates cell survival by targeting CDC25B. hsa-mir-141 renal clear cell carcinoma down Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. hsa-mir-142 breast cancer up miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway. hsa-mir-142-3p acute lymphoblastic leukemia down MicroRNA-142-3p inhibits cell proliferation in human acute lymphoblastic leukemia by targeting the MLL-AF4 oncogene. hsa-mir-142-3p colon cancer down MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells. hsa-mir-142-3p glioblastoma down Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma. hsa-mir-142-3p hepatocellular carcinoma down MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells. hsa-mir-142-3p hepatocellular carcinoma down MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility. hsa-mir-142-3p mantle cell lymphoma down microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. hsa-mir-142-3p non-small cell lung cancer up MiR-142-3p represses TGF-?-induced growth inhibition through repression of TGF?R1 in non-small cell lung cancer. hsa-mir-142-3p osteosarcoma down MiR-142-3p Functions as a Potential Tumor Suppressor in Human Osteosarcoma by Targeting HMGA1. hsa-mir-142-5p clear cell renal cell cancer up Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles. hsa-mir-142-5p hepatocellular carcinoma down MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility. hsa-mir-142-5p lung cancer down Uncovering growth-suppressive MicroRNAs in lung cancer. hsa-mir-142-5p malt lymphoma up Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication. hsa-mir-142-5p mantle cell lymphoma down microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. hsa-mir-142-5p osteosarcoma down MicroRNA signatures associate with pathogenesis and progression of osteosarcoma. hsa-mir-143 bladder cancer down MicroRNA-143 as a tumor suppressor for bladder cancer. hsa-mir-143 bladder cancer down MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells. hsa-mir-143 bladder cancer down Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways. hsa-mir-143 breast cancer down MicroRNA-143 is downregulated in breast cancer and regulates DNA methyltransferases 3A in breast cancer cells. hsa-mir-143 cervical cancer down A Functional Polymorphism in the Promoter of MiR-143/145 Is Associated With the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case-Control Study. hsa-mir-143 cervical cancer down miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2. hsa-mir-143 colon cancer down Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon. hsa-mir-143 colon cancer down MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells. hsa-mir-143 colon cancer down The Evi1, microRNA-143, K-Ras axis in colon cancer. hsa-mir-143 colon cancer down miR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation. hsa-mir-143 colon cancer down Forced expression of miR-143 represses ERK5/c-Myc and p68/p72 signaling in concert with miR-145 in gut tumors of Apc(Min) mice. hsa-mir-143 colorectal cancer down The regulation of Toll-like receptor 2 by miR-143 suppresses the invasion and migration of a subset of human colorectal carcinoma cells. hsa-mir-143 colorectal cancer down Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. hsa-mir-143 colorectal cancer down MicroRNA signatures: novel biomarker for colorectal cancer? hsa-mir-143 colorectal cancer down Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer. hsa-mir-143 colorectal cancer down RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets. hsa-mir-143 colorectal cancer down MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers. hsa-mir-143 colorectal carcinoma down Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy. hsa-mir-143 colorectal carcinoma down [Effect of microRNA143 expression on cell proliferation in colonic carcinoma]. hsa-mir-143 colorectal carcinoma down MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. hsa-mir-143 endometrial cancer down Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas. hsa-mir-143 esophageal cancer up Differential expression of miRNAs in esophageal cancer tissue. hsa-mir-143 esophageal cancer up Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma. hsa-mir-143 esophageal squamous cell carcinoma down MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma. hsa-mir-143 gastric cancer up Evaluation of MicroRNA Expression Pattern of Gastric Adenocarcinoma Associated with Socioeconomic, Environmental and Lifestyle Factors in Northwestern Hungary. hsa-mir-143 gastric cancer down MicroRNA-143 suppresses gastric cancer cell growth and induces apoptosis by targeting COX-2. hsa-mir-143 gastric cancer down Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2. hsa-mir-143 gastric cancer down [Expression of miR-143 and miR-145 and their functional study in gastric carcinoma]. hsa-mir-143 glioblastoma down miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells. hsa-mir-143 glioma down miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells. hsa-mir-143 hepatocellular carcinoma down [miR-143 inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of TLR2 expression]. hsa-mir-143 malignant melanoma down MicroRNA-143 targets Syndecan-1 to repress cell growth in melanoma. hsa-mir-143 nasopharyngeal carcinoma down MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. hsa-mir-143 nasopharyngeal carcinoma down Identification of miR-143 as a tumour suppressor in nasopharyngeal carcinoma based on microRNA expression profiling. hsa-mir-143 non-small cell lung cancer down miR-143 inhibits NSCLC cell growth and metastasis by targeting Limk1. hsa-mir-143 non-small cell lung cancer down miR-143 inhibits cell proliferation by targeting autophagy-related 2B in non-small cell lung cancer H1299 cells. hsa-mir-143 oral squamous cell carcinoma down Decreased microRNA-143 expression and its tumor suppressive function in human oral squamous cell carcinoma. hsa-mir-143 oral squamous cell carcinoma down Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis. hsa-mir-143 osteosarcoma down microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2. hsa-mir-143 osteosarcoma down A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma. hsa-mir-143 pancreatic ductal adenocarcinoma down XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism. hsa-mir-143 prostate cancer down MicroRNA-143 inhibits cell migration and invasion by targeting matrix metalloproteinase 13 in prostate cancer. hsa-mir-143 prostate cancer down The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer. hsa-mir-143 prostate cancer down miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. hsa-mir-143 prostate cancer down miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS. hsa-mir-143 renal cell carcinoma down The tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma. hsa-mir-144 bladder cancer down miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling. hsa-mir-144 cholangiocarcinoma down MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b. hsa-mir-144 cholangiocarcinoma down MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b. hsa-mir-144 gastric cancer down MicroRNA-144 inhibits the metastasis of gastric cancer by targeting MET expression. hsa-mir-144 hepatocellular carcinoma down miR-144 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting E2F3. hsa-mir-144 lung cancer down MiR-144 Inhibits Proliferation and Induces Apoptosis and Autophagy in Lung Cancer Cells by Targeting TIGAR. hsa-mir-144 nasopharyngeal carcinoma up MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. hsa-mir-144 osteosarcoma down The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression. hsa-mir-144 osteosarcoma down MicroRNA-144 suppresses osteosarcoma growth and metastasis by targeting ROCK1 and ROCK2. hsa-mir-144 pancreatic ductal adenocarcinoma down XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism. hsa-mir-144 thyroid cancer down Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2. hsa-mir-144 uveal melanoma down MiR-144 Inhibits Uveal Melanoma Cell Proliferation and Invasion by Regulating c-Met Expression. hsa-mir-144-3p glioma down miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met. hsa-mir-145 bladder cancer down miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors. hsa-mir-145 bladder cancer down Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells. hsa-mir-145 bladder cancer down MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells. hsa-mir-145 bladder cancer down Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways. hsa-mir-145 bladder cancer down socs7, a target gene of microRNA-145, regulates interferon-? induction through STAT3 nuclear translocation in bladder cancer cells. hsa-mir-145 bladder cancer down Aberrant expression of microRNAs in bladder cancer. hsa-mir-145 bladder cancer down miR-145 inhibits invasion of bladder cancer cells by targeting PAK1. hsa-mir-145 breast cancer down miR-145 inhibits breast cancer cell growth through RTKN. hsa-mir-145 breast cancer down miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. hsa-mir-145 breast cancer down MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF. hsa-mir-145 breast cancer down Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. hsa-mir-145 cervical cancer down Glucocorticoid regulation of a novel HPV E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells. hsa-mir-145 cervical cancer down Downregulation of microRNA-145 is associated with aggressive progression and poor prognosis in human cervical cancer. hsa-mir-145 cervical cancer down A Functional Polymorphism in the Promoter of MiR-143/145 Is Associated With the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case-Control Study. hsa-mir-145 chondrosarcoma down The Epigenetic Regulation of SOX9 by miR-145 in Human Chondrosarcoma. hsa-mir-145 colon cancer down Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene. hsa-mir-145 colon cancer down MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. hsa-mir-145 colon cancer down Forced expression of miR-143 represses ERK5/c-Myc and p68/p72 signaling in concert with miR-145 in gut tumors of Apc(Min) mice. hsa-mir-145 colon cancer down Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon. hsa-mir-145 colon cancer up miR-21 and miR-145 cooperation in regulation of colon cancer stem cells. hsa-mir-145 colorectal cancer up Up-regulation of microRNA-145 associates with lymph node metastasis in colorectal cancer. hsa-mir-145 colorectal cancer down Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. hsa-mir-145 colorectal cancer down Evaluation of microRNAs-29a, 92a and 145 in colorectal carcinoma as candidate diagnostic markers: An Egyptian pilot study. hsa-mir-145 colorectal cancer down MicroRNA signatures: novel biomarker for colorectal cancer? hsa-mir-145 colorectal cancer down MicroRNA-145 suppresses cell migration and invasion by targeting paxillin in human colorectal cancer cells. hsa-mir-145 colorectal cancer down Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation. hsa-mir-145 colorectal cancer down RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets. hsa-mir-145 colorectal cancer down MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1. hsa-mir-145 colorectal carcinoma down Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy. hsa-mir-145 endometrial cancer down Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas. hsa-mir-145 endometrial cancer up Up-regulation of microRNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells. hsa-mir-145 esophageal squamous cell carcinoma down MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma. hsa-mir-145 esophageal squamous cell carcinoma down miR-145 inhibits proliferation and invasion of esophageal squamous cell carcinoma in part by targeting c-Myc. hsa-mir-145 esophageal squamous cell carcinoma down Evaluating the miR-302b and miR-145 expression in formalin-fixed paraffin-embedded samples of esophageal squamous cell carcinoma. hsa-mir-145 esophageal squamous cell carcinoma down miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. hsa-mir-145 esophageal squamous cell carcinoma up Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma. hsa-mir-145 gastric cancer down MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer. hsa-mir-145 gastric cancer down [Expression of miR-143 and miR-145 and their functional study in gastric carcinoma]. hsa-mir-145 glioblastoma down Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation. hsa-mir-145 glioblastoma down NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma. hsa-mir-145 glioma down NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma. hsa-mir-145 glioma down MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells. hsa-mir-145 glioma down ROCK1, a novel target of miR-145, promotes glioma cell invasion. hsa-mir-145 glioma down miR-145 Inhibits Migration and Invasion of Glioma Stem Cells by Targeting ABCG2. hsa-mir-145 hepatocellular carcinoma down MicroRNA-145: a promising biomarker for hepatocellular carcinoma (HCC). hsa-mir-145 hepatocellular carcinoma down MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling. hsa-mir-145 hepatocellular carcinoma down MicroRNA-145 inhibits cell proliferation by directly targeting ADAM17 in hepatocellular carcinoma. hsa-mir-145 hepatocellular carcinoma down Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno hsa-mir-145 hepatocellular carcinoma down MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1. hsa-mir-145 hepatocellular carcinoma down MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma. hsa-mir-145 hepatocellular carcinoma down miR-145 suppresses cell invasion in hepatocellular carcinoma cells: miR-145 targets ADAM17. hsa-mir-145 intrahepatic cholangiocarcinoma down MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma. hsa-mir-145 kidney cancer down MicroRNA-145 Targets the Metalloprotease ADAM17 and Is Suppressed in Renal Cell Carcinoma Patients. hsa-mir-145 liver cancer down MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer. hsa-mir-145 lung adenocarcinoma down Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. hsa-mir-145 lung adenocarcinoma down MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1. hsa-mir-145 lung adenocarcinoma down microRNA-145 suppresses lung adenocarcinoma-initiating cell proliferation by targeting OCT4. hsa-mir-145 lung adenocarcinoma down [miR-145 inhibits lung adenocarcinoma stem cells proliferation by targeting OCT4 gene]. hsa-mir-145 lung adenocarcinoma down MiR-145 regulates cancer stem-like properties and epithelial-to-mesenchymal transition in lung adenocarcinoma-initiating cells. hsa-mir-145 lung cancer down Uncovering growth-suppressive MicroRNAs in lung cancer. hsa-mir-145 lung cancer down MicroRNA-145 inhibits lung cancer cell metastasis. hsa-mir-145 lung cancer down MicroRNA-145 inhibits migration and invasion by down-regulating FSCN1 in lung cancer. hsa-mir-145 nasopharyngeal carcinoma down MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. hsa-mir-145 nasopharyngeal carcinoma down miR-145 inhibits invasion and metastasis by directly targeting Smad3 in nasopharyngeal cancer. hsa-mir-145 nasopharyngeal carcinoma down MiR-145 inhibits metastasis by targeting fascin actin-bundling protein 1 in nasopharyngeal carcinoma. hsa-mir-145 neuroblastoma down NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma. hsa-mir-145 non-small cell lung cancer down miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc. hsa-mir-145 non-small cell lung cancer down MicroRNA-145 inhibits migration and invasion via inhibition of fascin 1 protein expression in non-small-cell lung cancer cells. hsa-mir-145 non-small cell lung cancer down Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application. hsa-mir-145 non-small cell lung cancer down MiR-145 acts as a metastasis suppressor by targeting metadherin in lung cancer. hsa-mir-145 non-small cell lung cancer down Low miR-145 expression level is associated with poor pathological differentiation and poor prognosis in non-small cell lung cancer. hsa-mir-145 non-small cell lung cancer up Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer. hsa-mir-145 non-small cell lung cancer down Low miR-145 silenced by DNA methylation promotes NSCLC cell proliferation, migration and invasion by targeting mucin 1. hsa-mir-145 oral squamous cell carcinoma down Downregulation of miR-145 expression in oral squamous cell carcinomas and its clinical significance. hsa-mir-145 oral squamous cell carcinoma down MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6. hsa-mir-145 oral squamous cell carcinoma down Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis. hsa-mir-145 osteosarcoma down MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells. hsa-mir-145 osteosarcoma down microRNA-145 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1. hsa-mir-145 osteosarcoma down miR-145 inhibits osteosarcoma cells proliferation and invasion by targeting ROCK1. hsa-mir-145 ovarian cancer down miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma. hsa-mir-145 ovarian cancer down miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma. hsa-mir-145 ovarian cancer down Quercetin induces the apoptosis of human ovarian carcinoma cells by upregulating the expression of microRNA-145. hsa-mir-145 ovarian cancer down MicroRNA-145 Function as a Cell Growth Repressor by Directly Targeting c-Myc in Human Ovarian Cancer. hsa-mir-145 ovarian cancer down MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1. hsa-mir-145 ovarian cancer down Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research. hsa-mir-145 pancreatic cancer down MicroRNA-145 suppresses cell proliferation, invasion and migration in pancreatic cancer cells by targeting NEDD9. hsa-mir-145 pancreatic ductal adenocarcinoma down XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism. hsa-mir-145 primary cns lymphomas down Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas. hsa-mir-145 prostate cancer down miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis. hsa-mir-145 prostate cancer down The functional significance of microRNA-145 in prostate cancer. hsa-mir-145 prostate cancer down Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1. hsa-mir-145 prostate cancer down MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer. hsa-mir-145 prostate cancer down The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer. hsa-mir-145 renal cell carcinoma down The tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma. hsa-mir-145 renal cell carcinoma down miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma. hsa-mir-145 uveal melanoma down MicroRNA 145 may play an important role in uveal melanoma cell growth by potentially targeting insulin receptor substrate-1. hsa-mir-145-5p hepatocellular carcinoma down Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. hsa-mir-1469 lung cancer down MiRNA-1469 promotes lung cancer cells apoptosis through targeting STAT5a. hsa-mir-146a breast cancer down Clinical significance of miR-146a in gastric cancer cases. hsa-mir-146a breast cancer down Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. hsa-mir-146a chronic myelogenous leukemia down ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance. hsa-mir-146a gastric cancer up microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-kappaB by targeting CARD10 and COPS8 in gastric cancer. hsa-mir-146a gastric cancer down MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis. hsa-mir-146a gastric cancer up miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-mir-146a gastric cancer down Clinical significance of miR-146a in gastric cancer cases. hsa-mir-146a gastric cancer down microRNA-146a targets the L1 cell adhesion molecule and suppresses the metastatic potential of gastric cancer. hsa-mir-146a glioma down MicroRNA-146a inhibits glioma development by targeting Notch1. hsa-mir-146a hepatocellular carcinoma up Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. hsa-mir-146a hepatocellular carcinoma down Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno hsa-mir-146a hepatocellular carcinoma down Synergistic effect of MiR-146a mimic and cetuximab on hepatocellular carcinoma cells. hsa-mir-146a hepatocellular carcinoma down microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma. hsa-mir-146a lung cancer down Regulation of COX-2 expression by miR-146a in lung cancer cells. hsa-mir-146a malignant melanoma down Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. hsa-mir-146a non-small cell lung cancer down miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells. hsa-mir-146a non-small cell lung cancer down MicroRNA-146a rs2910164 polymorphism is associated with susceptibility to non-small cell lung cancer in the Chinese population. hsa-mir-146a non-small cell lung cancer up Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer. hsa-mir-146a non-small cell lung cancer down MicroRNA-146a inhibits epithelial mesenchymal transition in non-small cell lung cancer by targeting insulin receptor substrate 2. hsa-mir-146a oral squamous cell carcinoma up miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes. hsa-mir-146a pancreatic cancer down miR-146a suppresses invasion of pancreatic cancer cells. hsa-mir-146a pancreatic cancer down Clinical significance of miR-146a in gastric cancer cases. hsa-mir-146a papillary thyroid carcinoma down MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development. hsa-mir-146a prostate cancer down Clinical significance of miR-146a in gastric cancer cases. hsa-mir-146a prostate cancer down miR-146a functions as a tumor suppressor in prostate cancer by targeting Rac1. hsa-mir-146a renal cell carcinoma up Carbamylated albumin stimulates microRNA-146, which is increased in human renal cell carcinoma. hsa-mir-146a-5p gastric cancer down The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis. hsa-mir-146b anaplastic thyroid carcinoma up A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears. hsa-mir-146b breast cancer down Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. hsa-mir-146b breast cancer down STAT3 Induction of miR-146b Forms a Feedback Loop to Inhibit the NF-?B to IL-6 Signaling Axis and STAT3-Driven Cancer Phenotypes. hsa-mir-146b esophageal cancer up Transcriptional regulation of miR-146b by C/EBP? LAP2 in esophageal cancer cells. hsa-mir-146b follicular thyroid carcinoma up Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas. hsa-mir-146b glioma down microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. hsa-mir-146b malignant melanoma down Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. hsa-mir-146b non-small cell lung cancer down Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. hsa-mir-146b oral squamous cell carcinoma up miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes. hsa-mir-146b papillary thyroid carcinoma up MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. hsa-mir-146b papillary thyroid carcinoma up MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma. hsa-mir-146b papillary thyroid carcinoma up Prognostic Implications of miR-146b Expression and Its Functional Role in Papillary Thyroid Carcinoma. hsa-mir-146b papillary thyroid carcinoma up Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients. hsa-mir-146b primary thyroid lymphoma up A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears. hsa-mir-146b renal cell carcinoma up Carbamylated albumin stimulates microRNA-146, which is increased in human renal cell carcinoma. hsa-mir-146b-5p gallbladder carcinoma down MicroRNA-146b-5p inhibits the growth of gallbladder carcinoma by targeting epidermal growth factor receptor. hsa-mir-146b-5p glioblastoma down MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma. hsa-mir-146b-5p glioma down miR-146b-5p inhibits glioma migration and invasion by targeting MMP16. hsa-mir-146b-5p papillary thyroid carcinoma up Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma. hsa-mir-146b-5p papillary thyroid carcinoma up MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3. hsa-mir-146b-5p papillary thyroid carcinoma up In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications. hsa-mir-146b-5p papillary thyroid carcinoma up MicroRNA miR-146b-5p regulates signal transduction of TGF-? by repressing SMAD4 in thyroid cancer. hsa-mir-147 breast cancer down Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer. hsa-mir-147 gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-147 oral squamous cell carcinoma down Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer. hsa-mir-148a breast cancer down A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. hsa-mir-148a cervical squamous cell carcinoma down MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma. hsa-mir-148a chordoma up MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas. hsa-mir-148a colorectal cancer down MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer. hsa-mir-148a gastric cancer down MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer. hsa-mir-148a gastric cancer down microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition. hsa-mir-148a gastric cancer down MiR-148a is down-regulated in gastric cancer, targets MMP7 and indicates tumor invasiveness and poor prognosis. hsa-mir-148a gastric cancer down The role of miR-148a in gastric cancer. hsa-mir-148a gastric cancer up miR-148a promoted cell proliferation by targeting p27 in gastric cancer cells. hsa-mir-148a gastric cancer down [Impact of miR-148a on the proliferation of gastric carcinoma MKN45 cells and its mechanism]. hsa-mir-148a gastric cancer down MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. hsa-mir-148a gastrointestinal cancer down MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. hsa-mir-148a glioblastoma up microRNA-148a Is a Prognostic oncomiR That Targets MIG6 and BIM to Regulate EGFR and Apoptosis in Glioblastoma. hsa-mir-148a hepatocellular carcinoma down MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling. hsa-mir-148a hepatocellular carcinoma down microRNA-148a inhibits hepatocellular carcinoma cell invasion by targeting sphingosine-1-phosphate receptor 1. hsa-mir-148a nasopharyngeal carcinoma down Silencing of miRNA-148a by hypermethylation activates the integrin-mediated signaling pathway in nasopharyngeal carcinoma. hsa-mir-148a non-small cell lung cancer down MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells. hsa-mir-148a non-small cell lung cancer down Decreased miRNA-148a is associated with lymph node metastasis and poor clinical outcomes and functions as a suppressor of tumor metastasis in non-small cell lung cancer. hsa-mir-148a non-small cell lung cancer down Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening. hsa-mir-148a non-small cell lung cancer down MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC. hsa-mir-148a oral squamous cell carcinoma down Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer. hsa-mir-148a ovarian cancer down Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation. hsa-mir-148a ovarian cancer down MicroRNA-148a inhibits migration and invasion of ovarian cancer cells via targeting sphingosine-1-phosphate receptor 1. hsa-mir-148a pancreatic cancer down MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2. hsa-mir-148a pancreatic ductal adenocarcinoma down Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma. hsa-mir-148a pancreatic ductal adenocarcinoma down MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B. hsa-mir-148a pancreatic ductal adenocarcinoma down MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm. hsa-mir-148b colorectal cancer down MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer. hsa-mir-148b gastric cancer down MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. hsa-mir-148b hepatocellular carcinoma down MicroRNA-148b expression is decreased in hepatocellular carcinoma and associated with prognosis. hsa-mir-148b hepatocellular carcinoma down MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/?-catenin pathway. hsa-mir-148b hepatocellular carcinoma down Downregulation of miR-148b as biomarker for early detection of hepatocellular carcinoma and may serve as a prognostic marker. hsa-mir-148b hepatocellular carcinoma down Profiles of tissue microRNAs; miR-148b and miR-25 serve as potential prognostic biomarkers for hepatocellular carcinoma. hsa-mir-148b liver cancer down microRNA-148b suppresses hepatic cancer stem cell by targeting neuropilin-1. hsa-mir-148b non-small cell lung cancer down Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening. hsa-mir-148b non-small cell lung cancer down MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival. hsa-mir-148b non-small cell lung cancer down miR-148b functions as a tumor suppressor in non-small cell lung cancer by targeting carcinoembryonic antigen (CEA). hsa-mir-148b ovarian cancer up Increased expression of miR-148b in ovarian carcinoma and its clinical significance. hsa-mir-148b ovarian carcinoma up Increased expression of miR-148b in ovarian carcinoma and its clinical significance. hsa-mir-148b pancreatic cancer down miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPK?1. hsa-mir-148b pancreatic cancer down MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines. hsa-mir-148b-3p breast cancer down Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR. hsa-mir-149 breast cancer down MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis. hsa-mir-149 colorectal cancer down MicroRNA-149 Suppresses Colorectal Cancer Cell Migration and Invasion by Directly Targeting Forkhead Box Transcription Factor FOXM1. hsa-mir-149 gastric cancer down MicroRNA-149 inhibits proliferation and cell cycle progression through the targeting of ZBTB2 in human gastric cancer. hsa-mir-149 glioblastoma down miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma. hsa-mir-149 head and neck squamous cell carcinoma down The association between genetic polymorphism and the processing efficiency of miR-149 affects the prognosis of patients with head and neck squamous cell carcinoma. hsa-mir-149 nasopharyngeal carcinoma up miR-149 promotes epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma cells. hsa-mir-149 non-small cell lung cancer down miR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by Targeting FOXM1. hsa-mir-150 adult t-cell leukemia up STAT1: A Novel Target of miR-150 and miR-223 Is Involved in the Proliferation of HTLV-I-Transformed and ATL Cells. hsa-mir-150 breast cancer up miR-150 promotes human breast cancer growth and malignant behavior by targeting the pro-apoptotic purinergic P2X7 receptor. hsa-mir-150 breast cancer up miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway. hsa-mir-150 chronic lymphocytic leukemia up Opposite prognostic significance of cellular and serum circulating microRNA-150 in Chronic Lymphocytic Leukemia patients. hsa-mir-150 chronic myelogenous leukemia down Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. hsa-mir-150 colorectal cancer up Circulating Exosomal microRNAs as Biomarkers of Colon Cancer. hsa-mir-150 esophageal squamous cell carcinoma down MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducers ZEB1. hsa-mir-150 gastric cancer up MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. hsa-mir-150 hepatocellular carcinoma down microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma. hsa-mir-150 lung adenocarcinoma up Altered miR-143 and miR-150 expressions in peripheral blood mononuclear cells for diagnosis of non-small cell lung cancer. hsa-mir-150 lung cancer up miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1. hsa-mir-150 mantle cell lymphoma down microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. hsa-mir-150 non-small cell lung cancer up Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer. hsa-mir-150 pancreatic ductal adenocarcinoma down A Decrease in miR-150 Regulates the Malignancy of Pancreatic Cancer by Targeting c-Myb and MUC4. hsa-mir-150* colorectal cancer up MicroRNA expression profiles in human colorectal cancers with liver metastases. hsa-mir-150* pancreatic cancer down Upregulation of miR-150* and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R. hsa-mir-150-5p colorectal cancer down MiR-150-5p Suppresses Colorectal Cancer Cell Migration and Invasion through Targeting MUC4. hsa-mir-150-5p hepatocellular carcinoma down Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. hsa-mir-150-5p hepatocellular carcinoma down miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14. hsa-mir-150-5p pancreatic cancer down [MiR-150-5p inhibits the proliferation and promoted apoptosis of pancreatic cancer cells]. hsa-mir-151 chronic myelogenous leukemia down Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. hsa-mir-151-3p osteosarcoma up MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. hsa-mir-151-5p papillary thyroid carcinoma up Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma. hsa-mir-152 breast cancer down A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. hsa-mir-152 endometrial cancer down miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer. hsa-mir-152 gastric cancer down miR-152 suppresses gastric cancer cell proliferation and motility by targeting CD151. hsa-mir-152 gastrointestinal cancer down MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. hsa-mir-152 glioblastoma down MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Kr?ppel-like factor 4. hsa-mir-152 glioma down MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3. hsa-mir-152 non-small cell lung cancer down MicroRNA-152 targets ADAM17 to suppress NSCLC progression. hsa-mir-152 non-small cell lung cancer down Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening. hsa-mir-152 ovarian cancer down Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation. hsa-mir-152 pancreatic cancer down MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines. hsa-mir-153 breast cancer down MiR-153 inhibits epithelial-mesenchymal transition by targeting metadherin in human breast cancer. hsa-mir-153 gastric cancer down MiR-153 regulates metastases of gastric cancer through Snail. hsa-mir-153 glioblastoma down MicroRNA-153 is tumor suppressive in glioblastoma stem cells. hsa-mir-153 hepatocellular carcinoma up MicroRNA-153 promotes Wnt/?-catenin activation in hepatocellular carcinoma through suppression of WWOX. hsa-mir-153 hepatocellular carcinoma up MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells. hsa-mir-153 lung cancer down Suppression of AKT expression by miR-153 produced anti-tumor activity in lung cancer. hsa-mir-153 non-small cell lung cancer down MiR-153 inhibits migration and invasion of human non-small-cell lung cancer by targeting ADAM19. hsa-mir-153 osteosarcoma down MicroRNA-153 inhibits osteosarcoma cells proliferation and invasion by targeting TGF-?2. hsa-mir-153 ovarian cancer down MicroRNA-153 functions as a tumor suppressor by targeting SET7 and ZEB2 in ovarian cancer cells. hsa-mir-153 prostate cancer up Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer. hsa-mir-154 colorectal cancer down miR-154 suppresses colorectal cancer cell growth and motility by targeting TLR2. hsa-mir-154 non-small cell lung cancer down miR-154 suppresses non-small cell lung cancer growth in vitro and in vivo. hsa-mir-154 prostate cancer down miR-154 inhibits prostate cancer cell proliferation by targeting CCND2. hsa-mir-155 acute myeloid leukemia up Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia. hsa-mir-155 anaplastic large-cell lymphoma up Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation. hsa-mir-155 bladder cancer down Expression of microRNAs in the Urine of Patients With Bladder Cancer. hsa-mir-155 bladder cancer up Correlation of Increased Expression of MicroRNA-155 in Bladder Cancer and Prognosis. hsa-mir-155 bladder cancer up MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1. hsa-mir-155 breast cancer up MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. hsa-mir-155 breast cancer up Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females. hsa-mir-155 breast cancer up [Expression and its clinical significance of miR-155 in human primary breast cancer]. hsa-mir-155 breast cancer up Clinical significance of MicoRNA-155 expression in human breast cancer. hsa-mir-155 breast cancer up Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. hsa-mir-155 breast cancer up 17?-Estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells. hsa-mir-155 breast cancer up MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. hsa-mir-155 breast cancer up miR-155 drives telomere fragility in human breast cancer by targeting TRF1. hsa-mir-155 cervical cancer up Mir-155 promotes cervical cancer cell proliferation through suppression of its target gene LKB1. hsa-mir-155 chronic lymphocytic leukemia up Signal Transducer and Activator of Transcription-3 Induces MicroRNA-155 Expression in Chronic Lymphocytic Leukemia. hsa-mir-155 chronic myelogenous leukemia down Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells. hsa-mir-155 clear cell renal cell cancer up microRNA-155 silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in renal cancer cells. hsa-mir-155 colon cancer up Correlation between expression of miR-155 in colon cancer and serum carcinoembryonic antigen level and its contribution to recurrence and metastasis forecast. hsa-mir-155 colorectal cancer up Upregulation of microRNA-155 promotes the migration and invasion of colorectal cancer cells through the regulation of claudin-1 expression. hsa-mir-155 cutaneous t-cell lymphoma up STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma. hsa-mir-155 diffuse large B-cell lymphoma up Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. hsa-mir-155 endometrial cancer up Angiotensin II type I receptor and miR-155 in endometrial cancers: synergistic antiproliferative effects of anti-miR-155 and losartan on endometrial cancer cells. hsa-mir-155 gallbladder carcinoma up High expression of microRNA-155 is associated with the aggressive malignant behavior of gallbladder carcinoma. hsa-mir-155 gastric cancer down microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis. hsa-mir-155 gastric cancer down Downregulation of microRNA-155 accelerates cell growth and invasion by targeting c-myc in human gastric carcinoma cells. hsa-mir-155 glioma up MicroRNA-155 Promotes Glioma Cell Proliferation via the Regulation of MXI1. hsa-mir-155 glioma up Overexpression of microRNA-155 predicts poor prognosis in glioma patients. hsa-mir-155 hepatocellular carcinoma up Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. hsa-mir-155 hepatocellular carcinoma up [Expression and survival prediction of microRNA-155 in hepatocellular carcinoma after liver transplantation]. hsa-mir-155 liver cancer up TGF-?1 acts through miR-155 to down-regulate TP53INP1 in promoting epithelial-mesenchymal transition and cancer stem cell phenotypes. hsa-mir-155 lung adenocarcinoma up Potential diagnostic value of miR-155 in serum from lung adenocarcinoma patients. hsa-mir-155 lung cancer up Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia. hsa-mir-155 lung cancer up Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells. hsa-mir-155 lung cancer up MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression. hsa-mir-155 malignant melanoma down Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. hsa-mir-155 malignant melanoma down MicroRNA-155 targets the SKI gene in human melanoma cell lines. hsa-mir-155 malt lymphoma up Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication. hsa-mir-155 mantle cell lymphoma up microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. hsa-mir-155 nasopharyngeal carcinoma up Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A. hsa-mir-155 nasopharyngeal carcinoma up MiR-155 up-regulation by LMP1 DNA contributes to increased nasopharyngeal carcinoma cell proliferation and migration. hsa-mir-155 nasopharyngeal carcinoma up Inhibition of MiR-155 suppresses cell migration in nasopharyngeal carcinoma through targeting ZDHHC2. hsa-mir-155 non-small cell lung cancer down Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. hsa-mir-155 oral squamous cell carcinoma up Upregulation of a potential prognostic biomarker, miR-155, enhances cell proliferation in patients with oral squamous cell carcinoma. hsa-mir-155 oral squamous cell carcinoma up MicroRNA-155 in oral squamous cell carcinoma: Overexpression, localization, and prognostic potential. hsa-mir-155 ovarian cancer down MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1. hsa-mir-155 papillary thyroid carcinoma up Upregulated miR-155 in Papillary Thyroid Carcinoma Promotes Tumor Growth by Targeting APC and Activating Wnt/?-Catenin Signaling. hsa-mir-155 prostate cancer up A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia. hsa-mir-155 rectal cancer up The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer. hsa-mir-155 renal clear cell carcinoma up miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. hsa-mir-155 squamous carcinoma up Unique MicroRNA Expression Profiles in Cervical Cancer. hsa-mir-155-5p colorectal carcinoma up Up-regulated miR-155-5p promotes cell proliferation, invasion and metastasis in colorectal carcinoma. hsa-mir-155-5p gastric cancer down The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis. hsa-mir-15a breast cancer down MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer. hsa-mir-15a cervical carcinoma down MiR-15a and miR-16 induce autophagy and enhance chemosensitivity of Camptothecin. hsa-mir-15a chronic lymphocytic leukemia down Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. hsa-mir-15a chronic lymphocytic leukemia down miR-15 and miR-16 induce apoptosis by targeting BCL2. hsa-mir-15a chronic lymphocytic leukemia down Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia. hsa-mir-15a chronic lymphocytic leukemia down Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia. hsa-mir-15a colorectal cancer down Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. hsa-mir-15a esophageal cancer up Differential expression of miRNAs in esophageal cancer tissue. hsa-mir-15a lung cancer down Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer. hsa-mir-15a neuroblastoma up miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid. hsa-mir-15a neuroblastoma up MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression. hsa-mir-15a non-small cell lung cancer down MicroRNA-15a induces cell apoptosis and inhibits metastasis by targeting BCL2L2 in non-small cell lung cancer. hsa-mir-15a osteosarcoma down MiRNA-15a inhibits proliferation, migration and invasion by targeting TNFAIP1 in human osteosarcoma cells. hsa-mir-15a pancreatic cancer down Dysregulation of miR-15a and miR-214 in human pancreatic cancer. hsa-mir-15a pancreatic cancer up Dysregulation of miR-15a and miR-214 in human pancreatic cancer. hsa-mir-15a pancreatic ductal adenocarcinoma down miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression. hsa-mir-15a prostate cancer down Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1. hsa-mir-15a prostate cancer down A microRNA code for prostate cancer metastasis. hsa-mir-15a squamous carcinoma down miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. hsa-mir-15a-3p colorectal cancer up Oncogenic Role of miR-15a-3p in 13q Amplicon-Driven Colorectal Adenoma-to-Carcinoma Progression. hsa-mir-15b chronic lymphocytic leukemia down Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia. hsa-mir-15b chronic lymphocytic leukemia down miR-15 and miR-16 induce apoptosis by targeting BCL2. hsa-mir-15b colorectal cancer down Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. hsa-mir-15b glioma down MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3. hsa-mir-15b hepatocellular carcinoma down Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression. hsa-mir-15b lung cancer down Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer. hsa-mir-15b malignant melanoma up MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. hsa-mir-15b neuroblastoma up miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid. hsa-mir-15b pancreatic cancer up miR-15b promotes epithelial-mesenchymal transition by inhibiting SMURF2 in pancreatic cancer. hsa-mir-15b prostate cancer down A microRNA code for prostate cancer metastasis. hsa-mir-15b tongue cancer down MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. hsa-mir-16 bladder cancer down MicroRNA-16 Inhibits Bladder Cancer Proliferation by Targeting Cyclin D1. hsa-mir-16 breast cancer down Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. hsa-mir-16 breast cancer down Overexpression of microRNA-16 declines cellular growth, proliferation and induces apoptosis in human breast cancer cells. hsa-mir-16 cervical carcinoma down MiR-15a and miR-16 induce autophagy and enhance chemosensitivity of Camptothecin. hsa-mir-16 chronic lymphocytic leukemia down Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia. hsa-mir-16 chronic myelogenous leukemia down ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance. hsa-mir-16 colorectal cancer down Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. hsa-mir-16 colorectal cancer down Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. hsa-mir-16 colorectal cancer down microRNA-16 represses colorectal cancer cell growth in vitro by regulating the p53/survivin signaling pathway. hsa-mir-16 colorectal cancer down Prognostic Significance of MicroRNA-16 Expression in Human Colorectal Cancer. hsa-mir-16 esophageal squamous cell carcinoma up Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. hsa-mir-16 glioma down MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-?B1/MMP9 signaling pathway. hsa-mir-16 head and neck squamous cell carcinoma up Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. hsa-mir-16 hepatocellular carcinoma down Circulating microRNAs as biomarkers for hepatocellular carcinoma. hsa-mir-16 hepatocellular carcinoma down Expression of serum miR-16, let-7f, and miR-21 in patients with hepatocellular carcinoma and their clinical significances. hsa-mir-16 hepatocellular carcinoma down Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection. hsa-mir-16 laryngeal carcinoma up MicroRNA-16 targets zyxin and promotes cell motility in human laryngeal carcinoma cell line HEp-2. hsa-mir-16 lung adenocarcinoma down Quercetin Decreases Claudin-2 Expression Mediated by Up-Regulation of microRNA miR-16 in Lung Adenocarcinoma A549 Cells. hsa-mir-16 non-small cell lung cancer down Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells. hsa-mir-16 osteosarcoma down MicroRNA signatures associate with pathogenesis and progression of osteosarcoma. hsa-mir-16 osteosarcoma down miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma. hsa-mir-16 pancreatic ductal adenocarcinoma down MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors. hsa-mir-16 papillary thyroid carcinoma down Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma. hsa-mir-16 prostate cancer down A microRNA code for prostate cancer metastasis. hsa-mir-16 renal cell carcinoma up Upregulated microRNA-16 as an oncogene in renal cell carcinoma. hsa-mir-16 squamous carcinoma down miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. hsa-mir-16-1 chronic lymphocytic leukemia down miR-15 and miR-16 induce apoptosis by targeting BCL2. hsa-mir-16-1 chronic lymphocytic leukemia down Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia. hsa-mir-16-1 lung cancer down Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer. hsa-mir-16-1 neuroblastoma up miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid. hsa-mir-16-1 prostate cancer down A microRNA code for prostate cancer metastasis. hsa-mir-16-1-3p chronic lymphocytic leukemia down Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia. hsa-mir-16-2 chronic lymphocytic leukemia down Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia. hsa-mir-16-2 chronic lymphocytic leukemia down miR-15 and miR-16 induce apoptosis by targeting BCL2. hsa-mir-16-2 lung cancer down Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer. hsa-mir-16-2 neuroblastoma up miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid. hsa-mir-16-2 prostate cancer down A microRNA code for prostate cancer metastasis. hsa-mir-17 acute myeloid leukemia down HIF-1? downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation. hsa-mir-17 b-cell lymphoma up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. hsa-mir-17 breast cancer up MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment. hsa-mir-17 breast carcinoma up MiR-93 enhances angiogenesis and metastasis by targeting LATS2. hsa-mir-17 cholangiocarcinoma up miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator. hsa-mir-17 cholangiocarcinoma up miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator. hsa-mir-17 colorectal cancer up Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. hsa-mir-17 colorectal cancer up MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. hsa-mir-17 colorectal carcinoma up Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma. hsa-mir-17 esophageal squamous cell carcinoma up TNF-? is a novel target of miR-19a. hsa-mir-17 gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-17 gastric cancer up Overexpression of miR-17 in gastric cancer is correlated with proliferation-associated oncogene amplification. hsa-mir-17 gastric cancer up Inhibition of microRNA-17/20a suppresses cell proliferation in gastric cancer by modulating UBE2C expression. hsa-mir-17 glioma up Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. hsa-mir-17 glioma up Increased expression of microRNA-17 predicts poor prognosis in human glioma. hsa-mir-17 hepatocellular carcinoma up MiR-17-92 cluster promotes hepatocarcinogenesis. hsa-mir-17 lung cancer up Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. hsa-mir-17 lung cancer up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. hsa-mir-17 lung cancer up A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. hsa-mir-17 malignant melanoma down MicroRNA-17 inhibits tumor growth by stimulating T-cell mediated host immune response. hsa-mir-17 malignant melanoma up Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models. hsa-mir-17 mantle cell lymphoma up The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. hsa-mir-17 medulloblastoma up The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. hsa-mir-17 nasopharyngeal cancer up Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma. hsa-mir-17 osteosarcoma up Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma. hsa-mir-17 t-cell lymphoblastic lymphoma up Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma. hsa-mir-17-5p bladder cancer up Micro-RNA profiling in kidney and bladder cancers. hsa-mir-17-5p breast cancer up miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1. hsa-mir-17-5p breast cancer down Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. hsa-mir-17-5p cervical cancer down MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells. hsa-mir-17-5p gastric cancer up miR-17-5p promotes proliferation by targeting SOCS6 in gastric cancer cells. hsa-mir-17-5p gastric cancer up Circulating microRNAs in plasma of patients with gastric cancers. hsa-mir-17-5p gastric cancer up Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma. hsa-mir-17-5p hepatocellular carcinoma up miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway. hsa-mir-17-5p hepatocellular carcinoma up miR-17-5p as a novel prognostic marker for hepatocellular carcinoma. hsa-mir-17-5p malignant melanoma up Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. hsa-mir-17-5p malignant melanoma up Regulation of cancer aggressive features in melanoma cells by microRNAs. hsa-mir-17-5p non-small cell lung cancer down Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. hsa-mir-17-5p pancreatic cancer up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. hsa-mir-17-5p pancreatic cancer up MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene. hsa-mir-17-5p pancreatic cancer up miR-17-5p Inhibitor Enhances Chemosensitivity to Gemcitabine Via Upregulating Bim Expression in Pancreatic Cancer Cells. hsa-mir-17-5p pituitary carcinoma up MicroRNA involvement in a metastatic non-functioning pituitary carcinoma. hsa-mir-181a acute myeloid leukemia down MicroRNA 181a Influences the Expression of HMGB1 and CD4 in Acute Leukemias. hsa-mir-181a acute promyelocytic leukemia up PML/RAR? -regulated miR-181a/b cluster targets the tumor suppressor RASSF1A in Acute Promyelocytic Leukemia. hsa-mir-181a breast cancer up Transforming growth factor-? regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM. hsa-mir-181a breast cancer down Decreased serum miR-181a is a potential new tool for breast cancer screening. hsa-mir-181a cervical cancer up MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD. hsa-mir-181a chondrosarcoma up The expression of miR-181a-5p and miR-371b-5p in chondrosarcoma. hsa-mir-181a chronic lymphocytic leukemia down Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia. hsa-mir-181a chronic lymphocytic leukemia down miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes. hsa-mir-181a colon cancer up miR-181a mediates metabolic shift in colon cancer cells via the PTEN/AKT pathway. hsa-mir-181a colorectal cancer up MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1. hsa-mir-181a gastric cancer up MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6. hsa-mir-181a gastric cancer up Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility. hsa-mir-181a gastric cancer down MicroRNA-181a Inhibits Tumor Proliferation, Invasiveness, and Metastasis and Is Downregulated in Gastric Cancer. hsa-mir-181a glioma down hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. hsa-mir-181a glioma up MiR-181a regulates blood-tumor barrier permeability by targeting Kr?ppel-like factor 6. hsa-mir-181a hepatocellular carcinoma up Polycyclic aromatic hydrocarbon (PAH)-mediated upregulation of hepatic microRNA-181 family promotes cancer cell migration by targeting MAPK phosphatase-5, regulating the activation of p38 MAPK. hsa-mir-181a hepatocellular carcinoma up Up-regulated MicroRNA-181a induces carcinogenesis in Hepatitis B virus-related hepatocellular carcinoma by targeting E2F5. hsa-mir-181a oral squamous cell carcinoma down miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras. hsa-mir-181a osteosarcoma up MicroRNA signatures associate with pathogenesis and progression of osteosarcoma. hsa-mir-181a osteosarcoma up MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell. hsa-mir-181a pancreatic cancer up LPS Induced miR-181a Promotes Pancreatic Cancer Cell Migration via Targeting PTEN and MAP2K4. hsa-mir-181a-1 glioma down MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1. hsa-mir-181a-1 hepatocellular carcinoma up Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. hsa-mir-181a-1 non-small cell lung cancer down MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2. hsa-mir-181a-1 papillary thyroid carcinoma up Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients. hsa-mir-181a-1 prostate cancer up microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression. hsa-mir-181a-2 glioma down MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1. hsa-mir-181a-2 hepatocellular carcinoma up Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. hsa-mir-181a-2 non-small cell lung cancer down MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2. hsa-mir-181a-2 papillary thyroid carcinoma up Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients. hsa-mir-181a-2 prostate cancer up microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression. hsa-mir-181a-2* gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-181a-5p gastric cancer up Hsa-miR-181a-5p Expression and Effects on Cell Proliferation in Gastric Cancer. hsa-mir-181a-5p hepatocellular carcinoma down miR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met. hsa-mir-181a-5p non-small cell lung cancer down MiR-181a-5p inhibits cell proliferation and migration by targeting Kras in non-small cell lung cancer A549 cells. hsa-mir-181b acute promyelocytic leukemia up PML/RAR? -regulated miR-181a/b cluster targets the tumor suppressor RASSF1A in Acute Promyelocytic Leukemia. hsa-mir-181b breast cancer up Transforming growth factor-? regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM. hsa-mir-181b cervical cancer up miR-181b promotes cell proliferation and reduces apoptosis by repressing the expression of adenylyl cyclase 9 (AC9) in cervical cancer cells. hsa-mir-181b chronic lymphocytic leukemia down Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia. hsa-mir-181b chronic lymphocytic leukemia down miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes. hsa-mir-181b gastric adenocarcinoma down MicroRNA-181b targets cAMP responsive element binding protein 1 in gastric adenocarcinomas. hsa-mir-181b gastric cancer down miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-mir-181b glioblastoma down Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma. hsa-mir-181b glioma down hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. hsa-mir-181b glioma down MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas. hsa-mir-181b glioma down MiR-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells. hsa-mir-181b hepatocellular carcinoma up Polycyclic aromatic hydrocarbon (PAH)-mediated upregulation of hepatic microRNA-181 family promotes cancer cell migration by targeting MAPK phosphatase-5, regulating the activation of p38 MAPK. hsa-mir-181b non-small cell lung cancer down Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer. hsa-mir-181b oral squamous cell carcinoma up Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia. hsa-mir-181b osteosarcoma up MicroRNA signatures associate with pathogenesis and progression of osteosarcoma. hsa-mir-181b ovarian cancer up MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2. hsa-mir-181b prostate cancer up MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3. hsa-mir-181b retinoblastoma up Hypoxia-induced miR-181b enhances angiogenesis of retinoblastoma cells by targeting PDCD10 and GATA6. hsa-mir-181b-1 glioma down MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1. hsa-mir-181b-1 hepatocellular carcinoma up Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. hsa-mir-181b-1 non-small cell lung cancer down MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2. hsa-mir-181b-1 papillary thyroid carcinoma up Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients. hsa-mir-181b-1 prostate cancer up microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression. hsa-mir-181b-2 glioma down MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1. hsa-mir-181b-2 hepatocellular carcinoma up Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. hsa-mir-181b-2 non-small cell lung cancer down MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2. hsa-mir-181b-2 papillary thyroid carcinoma up Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients. hsa-mir-181b-2 prostate cancer up microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression. hsa-mir-181b-5p astrocytoma down MiR-181b-5p downregulates NOVA1 to suppress proliferation, migration and invasion and promote apoptosis in astrocytoma. hsa-mir-181c gastric cancer up Upregulation of MicroRNA 181c Expression in Gastric Cancer Tissues and Plasma. hsa-mir-181c glioma down MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1. hsa-mir-181c hepatocellular carcinoma up Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. hsa-mir-181c neuroblastoma down MiR-181c modulates the proliferation, migration, and invasion of neuroblastoma cells by targeting Smad7. hsa-mir-181c non-small cell lung cancer down MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2. hsa-mir-181c osteosarcoma up MicroRNA signatures associate with pathogenesis and progression of osteosarcoma. hsa-mir-181c papillary thyroid carcinoma up Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients. hsa-mir-181c prostate cancer up microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression. hsa-mir-181d glioma down MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2. hsa-mir-181d glioma down MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1. hsa-mir-181d hepatocellular carcinoma up Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. hsa-mir-181d hepatocellular carcinoma up Polycyclic aromatic hydrocarbon (PAH)-mediated upregulation of hepatic microRNA-181 family promotes cancer cell migration by targeting MAPK phosphatase-5, regulating the activation of p38 MAPK. hsa-mir-181d non-small cell lung cancer down MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2. hsa-mir-181d papillary thyroid carcinoma up Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients. hsa-mir-181d prostate cancer up microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression. hsa-mir-182 bladder cancer up Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells. hsa-mir-182 breast cancer up Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis. hsa-mir-182 breast cancer up Higher expression of circulating miR-182 as a novel biomarker for breast cancer. hsa-mir-182 breast cancer up Up-regulation of miR-182 by ?-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK. hsa-mir-182 colorectal adenocarcinoma up Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients. hsa-mir-182 colorectal cancer up SATB1 and 2 in colorectal cancer. hsa-mir-182 colorectal cancer up miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer. hsa-mir-182 colorectal cancer up Up-regulation of miR-182 expression in colorectal cancer tissues and its prognostic value. hsa-mir-182 colorectal cancer up microRNA-182 targets special AT-rich sequence-binding protein 2 to promote colorectal cancer proliferation and metastasis. hsa-mir-182 colorectal cancer up Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression. hsa-mir-182 colorectal carcinoma up Increased expression of miRNA-182 in colorectal carcinoma: an independent and tissue-specific prognostic factor. hsa-mir-182 endometrial cancer up MicroRNA-182 Promotes Tumor Cell Growth by Targeting Transcription Elongation Factor A-like 7 in Endometrial Carcinoma. hsa-mir-182 gallbladder carcinoma up TGF-? upregulates miR-182 expression to promote gallbladder cancer metastasis by targeting CADM1. hsa-mir-182 gastric adenocarcinoma down MicroRNA-182 targets cAMP-responsive element-binding protein?1 and suppresses cell growth in human gastric adenocarcinoma. hsa-mir-182 gastric cancer down MicroRNA-182 inhibits proliferation through targeting oncogenic ANUBL1 in gastric cancer. hsa-mir-182 glioma up The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas. hsa-mir-182 glioma up miR-182 as a prognostic marker for glioma progression and patient survival. hsa-mir-182 hepatocellular carcinoma up MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma. hsa-mir-182 hepatocellular carcinoma up MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma. hsa-mir-182 hepatocellular carcinoma up OncomiR miR-96 and miR-182 promote cell proliferation and invasion through targeting ephrinA5 in hepatocellular carcinoma. hsa-mir-182 hepatocellular carcinoma up Wnt/?-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion. hsa-mir-182 hepatocellular carcinoma up Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma. hsa-mir-182 hepatocellular carcinoma up Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma. hsa-mir-182 lung cancer up Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia. hsa-mir-182 lung cancer up Downregulation of microRNA-182 inhibits cell growth and invasion by targeting programmed cell death 4 in human lung adenocarcinoma cells. hsa-mir-182 lung cancer down [Methylation Status of miR-182 Promoter in Lung Cancer Cell Lines]. hsa-mir-182 malignant melanoma up Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. hsa-mir-182 malignant melanoma up Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models. hsa-mir-182 mesenchymal cancer up MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes. hsa-mir-182 ovarian cancer up Anti-MiR-182 reduces ovarian cancer burden, invasion and metastasis: An in vivo study in orthotopic xenografts of nude mice. hsa-mir-182 ovarian cancer up The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimul hsa-mir-182 ovarian cancer up Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research. hsa-mir-182 ovarian carcinoma up MicroRNA-182 promotes cell growth, invasion and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas. hsa-mir-182 papillary thyroid carcinoma up miR-182 targets CHL1 and controls tumor growth and invasion in papillary thyroid carcinoma. hsa-mir-182 prostate cancer up miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells. hsa-mir-182 prostate cancer up Overexpressed microRNA-182 promotes proliferation and invasion in prostate cancer PC-3 cells by down-regulating N-myc downstream regulated gene 1 (NDRG1). hsa-mir-182 prostate cancer up Hypoxia-inducible miR-182 enhances HIF1? signaling via targeting PHD2 and FIH1 in prostate cancer. hsa-mir-182 uveal melanoma down Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2. hsa-mir-182-5p bladder cancer up Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer. hsa-mir-182-5p prostate cancer up MicroRNA-182-5p Promotes Cell Invasion and Proliferation by Down Regulating FOXF2, RECK and MTSS1 Genes in Human Prostate Cancer. hsa-mir-182-5p renal cell carcinoma down Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway. hsa-mir-1826 breast cancer down MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer. hsa-mir-1826 kidney cancer down MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer. hsa-mir-183 bladder cancer up MicroRNA expression signatures of bladder cancer revealed by deep sequencing. hsa-mir-183 bladder cancer up Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells. hsa-mir-183 breast cancer down Dysregulated miR-183 inhibits migration in breast cancer cells. hsa-mir-183 colorectal cancer up Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. hsa-mir-183 colorectal cancer up Overexpression of microRNA-183 in human colorectal cancer and its clinical significance. hsa-mir-183 colorectal cancer up Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer. hsa-mir-183 esophageal cancer up miRNA-183 suppresses apoptosis and promotes proliferation in esophageal cancer by targeting PDCD4. hsa-mir-183 esophageal squamous cell carcinoma up MicroRNA-183 promotes proliferation and invasion in oesophageal squamous cell carcinoma by targeting programmed cell death 4. hsa-mir-183 follicular thyroid carcinoma up Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas. hsa-mir-183 gastric cancer up MicroRNA-183 inhibits apoptosis and promotes proliferation and invasion of gastric cancer cells by targeting PDCD4. hsa-mir-183 gastric cancer down MicroRNA-183 inhibits gastric cancer proliferation and invasion via directly targeting Bmi-1. hsa-mir-183 gastric cancer down miR-183 inhibits invasion of gastric cancer by targeting Ezrin. hsa-mir-183 glioma up The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas. hsa-mir-183 hepatocellular carcinoma up miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells. hsa-mir-183 hepatocellular carcinoma up Expression and Significance of MicroRNA-183 in Hepatocellular Carcinoma. hsa-mir-183 hepatocellular carcinoma up Wnt/?-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion. hsa-mir-183 kidney cancer up microRNA-183 plays as oncogenes by increasing cell proliferation, migration and invasion via targeting protein phosphatase 2A in renal cancer cells. hsa-mir-183 medullary thyroid carcinoma up MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets. hsa-mir-183 osteosarcoma down Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin. hsa-mir-183 papillary thyroid carcinoma up miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4. hsa-mir-183 prostate cancer up miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells. hsa-mir-183 prostate cancer up microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer. hsa-mir-183 renal cell carcinoma up High serum miR-183 level is associated with poor responsiveness of renal cancer to natural killer cells. hsa-mir-183 retinoblastoma down MicroRNA-183 suppresses retinoblastoma cell growth, invasion and migration by targeting LRP6. hsa-mir-183-3p lung cancer up Up-regulation of microRNA-183-3p is a potent prognostic marker for lung adenocarcinoma of female non-smokers. hsa-mir-184 glioma down Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. hsa-mir-184 glioma down MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma. hsa-mir-184 head and neck squamous cell carcinoma up Co-targeting of multiple microRNAs on factor-inhibiting hypoxia-inducible factor (FIH) gene for the pathogenesis of head and neck carcinomas. hsa-mir-184 hepatocellular carcinoma up Mir-184 Post-Transcriptionally Regulates SOX7 Expression and Promotes Cell Proliferation in Human Hepatocellular Carcinoma. hsa-mir-184 hepatocellular carcinoma up MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma. hsa-mir-184 malignant melanoma down Regulation of cancer aggressive features in melanoma cells by microRNAs. hsa-mir-184 neuroblastoma down MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2. hsa-mir-184 neuroblastoma down MicroRNA-184-mediated inhibition of tumour growth in an orthotopic murine model of neuroblastoma. hsa-mir-184 non-small cell lung cancer down MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc. hsa-mir-184 squamous carcinoma up MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma. hsa-mir-185 bladder cancer up Micro-RNA profiling in kidney and bladder cancers. hsa-mir-185 breast cancer down MicroRNA-185 inhibits proliferation by targeting c-Met in human breast cancer cells. hsa-mir-185 breast cancer down MiR-185 is involved in human breast carcinogenesis by targeting Vegfa. hsa-mir-185 esophageal squamous cell carcinoma down [Molecular mechanism and effect of microRNA185 on proliferation, migration and invasion of esophageal squamous cell carcinoma]. hsa-mir-185 esophageal squamous cell carcinoma down Plasma miR-185 is decreased in esophageal squamous cell carcinoma patients and might suppress tumor migration and invasion by targeting RAGE. hsa-mir-185 gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-185 gastric cancer down miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer. hsa-mir-185 glioma down LRRC4 inhibits glioma cell growth and invasion through a miR-185-dependent pathway. hsa-mir-185 hepatocellular carcinoma down miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway. hsa-mir-185 malignant melanoma down Regulation of cancer aggressive features in melanoma cells by microRNAs. hsa-mir-186 bladder cancer down MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1. hsa-mir-186 colon carcinoma down [Expression of hsa-miR-186 and its role in human colon carcinoma cells]. hsa-mir-186 non-small cell lung cancer down miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation. hsa-mir-186 non-small cell lung cancer down MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells. hsa-mir-186 pancreatic ductal adenocarcinoma up miR-186 and 326 Predict the Prognosis of Pancreatic Ductal Adenocarcinoma and Affect the Proliferation and Migration of Cancer Cells. hsa-mir-187 prostate cancer down MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer. hsa-mir-188-5p hepatocellular carcinoma down MicroRNA-188-5p Suppresses Tumor Cell Proliferation and Metastasis by Directly Targeting FGF5 in Hepatocellular Carcinoma. hsa-mir-188-5p prostate cancer down miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression. hsa-mir-18a b-cell lymphoma up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. hsa-mir-18a bladder cancer down microRNA-18a, a member of the oncogenic miR-17-92 cluster, targets Dicer and suppresses cell proliferation in bladder cancer T24 cells. hsa-mir-18a breast cancer up MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment. hsa-mir-18a breast carcinoma up MiR-93 enhances angiogenesis and metastasis by targeting LATS2. hsa-mir-18a cholangiocarcinoma up miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator. hsa-mir-18a cholangiocarcinoma up miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator. hsa-mir-18a colon cancer up MicroRNA-18a Attenuates DNA Damage Repair through Suppressing the Expression of Ataxia Telangiectasia Mutated in Colorectal Cancer. hsa-mir-18a colorectal cancer up MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. hsa-mir-18a colorectal cancer up microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers. hsa-mir-18a colorectal cancer up Plasma miR-200c and miR-18a as potential biomarkers for the detection of colorectal carcinoma. hsa-mir-18a colorectal cancer down miR-18a Inhibits CDC42 and Plays a Tumour Suppressor Role in Colorectal Cancer Cells. hsa-mir-18a esophageal squamous cell carcinoma up TNF-? is a novel target of miR-19a. hsa-mir-18a esophageal squamous cell carcinoma up Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma. hsa-mir-18a gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-18a gastric cancer up Diagnostic and prognostic value of circulating miR-18a in the plasma of patients with gastric cancer. hsa-mir-18a gastric cancer up MicroRNA-18a modulates P53 expression by targeting IRF2 in gastric cancer patients. hsa-mir-18a glioblastoma up MiR-18a regulates the proliferation, migration and invasion of human glioblastoma cell by targeting neogenin. hsa-mir-18a hepatocellular carcinoma up MiR-17-92 cluster promotes hepatocarcinogenesis. hsa-mir-18a lung cancer up A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. hsa-mir-18a lung cancer up Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. hsa-mir-18a lung cancer up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. hsa-mir-18a malignant melanoma up Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. hsa-mir-18a malignant melanoma up Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models. hsa-mir-18a mantle cell lymphoma up The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. hsa-mir-18a medulloblastoma up The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. hsa-mir-18a nasopharyngeal carcinoma up miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma. hsa-mir-18a neuroblastoma up MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma. hsa-mir-18a non-small cell lung cancer up Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC. hsa-mir-18a osteosarcoma up Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma. hsa-mir-18a pancreatic cancer up Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer. hsa-mir-18a pancreatic ductal adenocarcinoma up Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas. hsa-mir-18a prostate cancer up MicroRNA-18a is elevated in prostate cancer and promotes tumorigenesis through suppressing STK4 in vitro and in vivo. hsa-mir-18b breast cancer up microRNA-18b is upregulated in breast cancer and modulates genes involved in cell migration. hsa-mir-18b malignant melanoma down The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma Progression. hsa-mir-1908 glioblastoma up MicroRNA-1908 functions as a glioblastoma oncogene by suppressing PTEN tumor suppressor pathway. hsa-mir-1908 osteosarcoma up MicroRNA-1908 is upregulated in human osteosarcoma and regulates cell proliferation and migration by repressing PTEN expression. hsa-mir-190b hepatocellular carcinoma up Up-Regulation of MicroRNA-190b Plays a Role for Decreased IGF-1 That Induces Insulin Resistance in Human Hepatocellular Carcinoma. hsa-mir-191 breast cancer up Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue. hsa-mir-191 breast cancer down Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. hsa-mir-191 breast cancer up HIF-inducible miR-191 promotes migration in breast cancer through complex regulation of TGF?-signaling in hypoxic microenvironment. hsa-mir-191 colorectal cancer down Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. hsa-mir-191 colorectal cancer up miR-191 promotes tumorigenesis of human colorectal cancer through targeting C/EBP?. hsa-mir-191 colorectal carcinoma up MicroRNA-191 correlates with poor prognosis of colorectal carcinoma and plays multiple roles by targeting tissue inhibitor of metalloprotease 3. hsa-mir-191 colorectal carcinoma up MicroRNA-191 correlates with poor prognosis of colorectal carcinoma and plays multiple roles by targeting tissue inhibitor of metalloprotease 3. hsa-mir-191 gastric cancer up miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-mir-191 hepatocellular carcinoma up Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinoma. hsa-mir-191 osteosarcoma up MicroRNA-191 promotes osteosarcoma cells proliferation by targeting checkpoint kinase 2. hsa-mir-191 osteosarcoma up MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. hsa-mir-191 pancreatic cancer up MicroRNA-191 promotes pancreatic cancer progression by targeting USP10. hsa-mir-192 bladder cancer down Expression of microRNAs in the Urine of Patients With Bladder Cancer. hsa-mir-192 bladder cancer down Regulation of growth of human bladder cancer by miR-192. hsa-mir-192 colon cancer down Prognostic significance of miR-215 in colon cancer. hsa-mir-192 colorectal cancer down Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. hsa-mir-192 colorectal cancer down microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer. hsa-mir-192 epithelial ovarian cancer down Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells. hsa-mir-192 esophageal squamous cell carcinoma up Mir-192 suppresses apoptosis and promotes proliferation in esophageal aquamous cell caicinoma by targeting Bim. hsa-mir-192 gastric cancer up MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. hsa-mir-192 gastric cancer up Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer. hsa-mir-192 gastric cancer up MiR-215/192 participates in gastric cancer progression. hsa-mir-192 lung cancer down MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells. hsa-mir-192 pancreatic ductal adenocarcinoma up Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma. hsa-mir-193a epithelial ovarian cancer down Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells. hsa-mir-193a-3p breast cancer down Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer. hsa-mir-193a-3p lung cancer down miR-193a-3p functions as a tumor suppressor in lung cancer by downregulating ERBB4. hsa-mir-193a-3p non-small cell lung cancer down Expression and clinicopathological significance of miR-193a-3p and its potential target astrocyte elevated gene-1 in non-small lung cancer tissues. hsa-mir-193a-3p renal cell carcinoma up A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma. hsa-mir-193a-5p colorectal cancer down Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer. hsa-mir-193b breast cancer down Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer. hsa-mir-193b breast cancer cell lines:MDA-MB-231,MCF-7; Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A. hsa-mir-193b glioma up miR-193b promotes cell proliferation by targeting Smad3 in human glioma. hsa-mir-193b hepatocellular carcinoma down miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy. hsa-mir-193b malignant melanoma down Stathmin 1 is a potential novel oncogene in melanoma. hsa-mir-193b malignant melanoma up miR-193b Regulates Mcl-1 in Melanoma. hsa-mir-193b non-small cell lung cancer down MicroRNA-193b modulates proliferation, migration, and invasion of non-small cell lung cancer cells. hsa-mir-193b primary cns lymphomas down Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas. hsa-mir-194 colorectal cancer down microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer. hsa-mir-194 colorectal cancer down MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway. hsa-mir-194 gastric cancer down MicroRNA-194 Inhibits the Epithelial-Mesenchymal Transition in Gastric Cancer Cells by Targeting FoxM1. hsa-mir-194 gastric cancer down miR-194 targets RBX1 gene to modulate proliferation and migration of gastric cancer cells. hsa-mir-194 hepatocellular carcinoma down NF-?B signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1?. hsa-mir-194 lung cancer down miR-194 suppresses metastasis of non-small cell lung cancer through regulating expression of BMP1 and p27(kip1.) hsa-mir-194 osteosarcoma down microRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R. hsa-mir-194 pancreatic ductal adenocarcinoma up Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma. hsa-mir-195 adrenal cortical carcinoma down The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. hsa-mir-195 adrenal cortical carcinoma down miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer. hsa-mir-195 bladder cancer down Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells. hsa-mir-195 breast cancer down Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. hsa-mir-195 breast cancer down Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1. hsa-mir-195 breast cancer down Serum microRNA-195 is down-regulated in breast cancer: a potential marker for the diagnosis of breast cancer. hsa-mir-195 chronic lymphocytic leukemia down Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia. hsa-mir-195 chronic lymphocytic leukemia down miR-15 and miR-16 induce apoptosis by targeting BCL2. hsa-mir-195 colorectal cancer down Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. hsa-mir-195 colorectal cancer down MicroRNA-195 inhibits colorectal cancer cell proliferation, colony-formation and invasion through targeting CARMA3. hsa-mir-195 colorectal cancer down microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. hsa-mir-195 esophageal squamous cell carcinoma down Differential expression of miR-195 in esophageal squamous cell carcinoma and miR-195 expression inhibits tumor cell proliferation and invasion by targeting of Cdc42. hsa-mir-195 gastric cancer down MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer. hsa-mir-195 glioblastoma down MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion. hsa-mir-195 glioma down MicroRNA-195 Inhibits the Proliferation of Human Glioma Cells by Directly Targeting Cyclin D1 and Cyclin E1. hsa-mir-195 hepatocellular carcinoma down MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2 and CDC42. hsa-mir-195 hepatocellular carcinoma down MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells. hsa-mir-195 hepatocellular carcinoma down microRNA-195 functions as a tumor suppressor by inhibiting CBX4 in hepatocellular carcinoma. hsa-mir-195 lung cancer down Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer. hsa-mir-195 lung cancer down MiR-195 suppresses non-small cell lung cancer by targeting CHEK1. hsa-mir-195 neuroblastoma up miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid. hsa-mir-195 non-small cell lung cancer down MicroRNA-195 inhibits non-small cell lung cancer cell proliferation, migration and invasion by targeting MYB. hsa-mir-195 non-small cell lung cancer down miR-195 inhibits the growth and metastasis of NSCLC cells by targeting IGF1R. hsa-mir-195 non-small cell lung cancer down MiR-195 suppresses non-small cell lung cancer by targeting CHEK1. hsa-mir-195 osteosarcoma down microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN. hsa-mir-195 osteosarcoma down MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1. hsa-mir-195 papillary thyroid carcinoma down microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake. hsa-mir-195 prostate cancer down miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer. hsa-mir-195 prostate cancer down A microRNA code for prostate cancer metastasis. hsa-mir-195 prostate carcinoma down MicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma. hsa-mir-195-5p hepatocellular carcinoma down MicroRNA-195-5p acts as an anti-oncogene by targeting PHF19 in hepatocellular carcinoma. hsa-mir-195-5p hepatocellular carcinoma down Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. hsa-mir-195-5p osteosarcoma up Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma. hsa-mir-196a breast cancer up MicroRNA-196a post-transcriptionally upregulates the UBE2C proto-oncogene and promotes cell proliferation in breast cancer. hsa-mir-196a cervical cancer up MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27(Kip1.). hsa-mir-196a colorectal cancer down Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. hsa-mir-196a colorectal cancer up Upregulation of microRNA-196a and microRNA-196b cooperatively correlate with aggressive progression and unfavorable prognosis in patients with colorectal cancer. hsa-mir-196a esophageal adenocarcinoma up MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma. hsa-mir-196a gastric cancer up MiR-196a Is Up-regulated in Gastric cancer and Promotes Cell proliferation by Down-regulating p27kip1. hsa-mir-196a gastrointestinal stromal tumor up Upregulation of miR-196a and HOTAIR Drive Malignant Character in Gastrointestinal Stromal Tumors. hsa-mir-196a glioblastoma up MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of I?B? both in vitro and in vivo. hsa-mir-196a head and neck squamous cell carcinoma up MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance. hsa-mir-196a non-small cell lung cancer up MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5. hsa-mir-196a ovarian carcinoma up Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma. hsa-mir-196a pancreatic cancer up MiR-196a Promotes Pancreatic Cancer Progression by Targeting Nuclear Factor Kappa-B-Inhibitor Alpha. hsa-mir-196a pancreatic ductal adenocarcinoma up MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm. hsa-mir-196a squamous carcinoma up Unique MicroRNA Expression Profiles in Cervical Cancer. hsa-mir-196a* gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-196a-1 glioblastoma up MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance. hsa-mir-196a-1 oral cancer up OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway. hsa-mir-196a-1 oral squamous cell carcinoma up miR-196a Overexpression and miR-196a2 Gene Polymorphism Are Prognostic Predictors of Oral Carcinomas. hsa-mir-196a-2 glioblastoma up MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance. hsa-mir-196a-2 oral cancer up OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway. hsa-mir-196a-2 oral squamous cell carcinoma up miR-196a Overexpression and miR-196a2 Gene Polymorphism Are Prognostic Predictors of Oral Carcinomas. hsa-mir-196a-5p gastric cancer up Clinical significance of upregulation of mir-196a-5p in gastric cancer and enriched KEGG pathway analysis of target genes. hsa-mir-196b colorectal cancer up Upregulation of microRNA-196a and microRNA-196b cooperatively correlate with aggressive progression and unfavorable prognosis in patients with colorectal cancer. hsa-mir-196b esophageal cancer up Differential expression of miRNAs in esophageal cancer tissue. hsa-mir-196b gastric cancer up Epigenetic regulation of miR-196b expression in gastric cancer. hsa-mir-196b gastric cancer up Transcriptional regulation of miR-196b by ETS2 in gastric cancer cells. hsa-mir-196b glioblastoma up MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance. hsa-mir-196b glioblastoma up Upregulation of miR-196b confers a poor prognosis in glioblastoma patients via inducing a proliferative phenotype. hsa-mir-196b oral cancer up OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway. hsa-mir-196b oral squamous cell carcinoma up miR-196a Overexpression and miR-196a2 Gene Polymorphism Are Prognostic Predictors of Oral Carcinomas. hsa-mir-197 breast cancer up Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females. hsa-mir-197 esophageal cancer down Implications of microRNA-197 downregulated expression in esophageal cancer with poor prognosis. hsa-mir-197 follicular thyroid carcinoma up A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. hsa-mir-197 gastric cancer down miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-mir-197 hepatocellular carcinoma down Anti-miR-197 inhibits migration in HCC cells by targeting KAI 1/CD82. hsa-mir-197 lung cancer up Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia. hsa-mir-197 multiple myeloma down miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma. hsa-mir-197 uterine leiomyoma down Upregulation of miR-197 inhibits cell proliferation by directly targeting IGFBP5 in human uterine leiomyoma cells. hsa-mir-1974 adrenal cortical carcinoma down The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. hsa-mir-198 colorectal cancer down MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8. hsa-mir-198 hepatocellular carcinoma down miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway. hsa-mir-198 lung cancer down MicroRNA-198 Inhibits Proliferation and Induces Apoptosis of Lung Cancer Cells Via Targeting FGFR1. hsa-mir-198 pancreatic cancer down A Tumorigenic Factor Interactome Connected Through Tumor Suppressor MicroRNA-198 in Human Pancreatic Cancer. hsa-mir-198 pancreatic ductal adenocarcinoma up MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma. hsa-mir-199a chondrosarcoma down CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells. hsa-mir-199a gastric cancer up miR-199a regulates the tumor suppressor mitogen-activated protein kinase kinase kinase 11 in gastric cancer. hsa-mir-199a hepatocellular carcinoma down [MicroRNA profiling in patients with hepatocellular carcinoma]. hsa-mir-199a hepatocellular carcinoma down Circulating microRNAs as biomarkers for hepatocellular carcinoma. hsa-mir-199a hepatocellular carcinoma down Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma. hsa-mir-199a hepatocellular carcinoma down MiR-199a regulates cell proliferation and survival by targeting FZD7. hsa-mir-199a kidney cancer down Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3?. hsa-mir-199a non-small cell lung cancer down MiR-199a suppresses the hypoxia-induced proliferation of non-small cell lung cancer cells through targeting HIF1? hsa-mir-199a ovarian cancer down Roles and Mechanism of miR-199a and miR-125b in Tumor Angiogenesis. hsa-mir-199a ovarian cancer down Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research. hsa-mir-199a primary cns lymphomas down Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas. hsa-mir-199a-3p esophageal adenocarcinoma up MicroRNA 223 is Up-regulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1. hsa-mir-199a-3p gastric cancer down MicroRNA-199a-3p is downregulated in gastric carcinomas and modulates cell proliferation. hsa-mir-199a-3p gastric cancer up MiR-199a-3p promotes gastric cancer progression by targeting ZHX1. hsa-mir-199a-3p glioma down MicroRNA-199a-3p suppresses glioma cell proliferation by regulating the AKT/mTOR signaling pathway. hsa-mir-199a-3p hepatocellular carcinoma down Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. hsa-mir-199a-3p kidney cancer down miR-199a-3p inhibits hepatocyte growth factor/c-Met signaling in renal cancer carcinoma. hsa-mir-199a-3p osteosarcoma down A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma. hsa-mir-199a-3p osteosarcoma up Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma. hsa-mir-199a-3p osteosarcoma down Polymeric nanoparticle-based delivery of microRNA-199a-3p inhibits proliferation and growth of osteosarcoma cells. hsa-mir-199a-3p osteosarcoma down CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma. hsa-mir-199a-3p osteosarcoma down MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. hsa-mir-199a-3p papillary thyroid carcinoma down miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma. hsa-mir-199a-3p renal cell carcinoma down miR-199a-3p inhibits hepatocyte growth factor/c-Met signaling in renal cancer carcinoma. hsa-mir-199a-5p colorectal cancer down The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer. hsa-mir-199a-5p esophageal adenocarcinoma up MicroRNA 223 is Up-regulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1. hsa-mir-199a-5p gastric cancer up Up-regulated miR-199a-5p in gastric cancer functions as an oncogene and targets klotho. hsa-mir-199a-5p hepatocellular carcinoma down Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. hsa-mir-199a-5p hepatocellular carcinoma down Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers. hsa-mir-199a-5p hepatocellular carcinoma down Increase of miR-199a-5p by protoporphyrin IX, a photocatalyzer, directly inhibits E2F3, sensitizing mesenchymal tumor cells to anti-cancer agents. hsa-mir-199b choriocarcinoma down Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma. hsa-mir-199b follicular thyroid carcinoma down Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas. hsa-mir-199b hepatocellular carcinoma down [MicroRNA profiling in patients with hepatocellular carcinoma]. hsa-mir-199b hepatocellular carcinoma down Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1? in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients. hsa-mir-199b prostate cancer down MiR199b Suppresses Expression of Hypoxia-Inducible Factor 1? (HIF-1?) in Prostate Cancer Cells. hsa-mir-199b-3p esophageal adenocarcinoma up MicroRNA 223 is Up-regulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1. hsa-mir-199b-5p breast cancer down MiR-199b-5p targets HER2 in breast cancer cells. hsa-mir-199b-5p hepatocellular carcinoma down Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers. hsa-mir-199b-5p medulloblastoma down The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma. hsa-mir-199b-5p mesenchymal cancer down MicroRNA Expression Profiles in Kaposi's Sarcoma. hsa-mir-199b-5p osteosarcoma up Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma. hsa-mir-199b-5p papillary thyroid carcinoma up Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma. hsa-mir-19a b-cell lymphoma up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. hsa-mir-19a bladder cancer up miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer. hsa-mir-19a breast cancer up MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment. hsa-mir-19a breast carcinoma up MiR-93 enhances angiogenesis and metastasis by targeting LATS2. hsa-mir-19a cervical cancer up MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5. hsa-mir-19a cholangiocarcinoma up miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator. hsa-mir-19a cholangiocarcinoma up miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator. hsa-mir-19a colorectal cancer up MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. hsa-mir-19a colorectal cancer up Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-? induced epithelial-to-mesenchymal transition in colorectal cancer. hsa-mir-19a esophageal squamous cell carcinoma up TNF-? is a novel target of miR-19a. hsa-mir-19a gastric cancer up MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1. hsa-mir-19a gastric cancer up MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer. hsa-mir-19a gastric cancer up MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer. hsa-mir-19a gastric cancer up MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN. hsa-mir-19a gastric cancer up miR-19a Promotes Cell Growth and Tumorigenesis through Targeting SOCS1 in Gastric Cancer. hsa-mir-19a glioma up miR-19a and miR-19b Overexpression in Gliomas. hsa-mir-19a glioma up MicroRNA-19a promotes glioma cell growth by repressing LRIG1. hsa-mir-19a hepatocellular carcinoma up MiR-17-92 cluster promotes hepatocarcinogenesis. hsa-mir-19a lung cancer up Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. hsa-mir-19a lung cancer up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. hsa-mir-19a lung cancer up A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. hsa-mir-19a mantle cell lymphoma up The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. hsa-mir-19a medulloblastoma up The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. hsa-mir-19a neuroblastoma up MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma. hsa-mir-19a non-small cell lung cancer up Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer. hsa-mir-19a osteosarcoma up Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma. hsa-mir-19a t-cell lymphoblastic lymphoma up Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma. hsa-mir-19a-3p breast cancer down MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene. hsa-mir-19b b-cell lymphoma up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. hsa-mir-19b breast cancer up MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment. hsa-mir-19b breast carcinoma up MiR-93 enhances angiogenesis and metastasis by targeting LATS2. hsa-mir-19b cervical cancer up MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5. hsa-mir-19b cholangiocarcinoma up miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator. hsa-mir-19b cholangiocarcinoma up miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator. hsa-mir-19b colorectal cancer up MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. hsa-mir-19b esophageal squamous cell carcinoma up TNF-? is a novel target of miR-19a. hsa-mir-19b gastric cancer up MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN. hsa-mir-19b gastric cancer up MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1. hsa-mir-19b glioma up miR-19a and miR-19b Overexpression in Gliomas. hsa-mir-19b hepatocellular carcinoma up MiR-17-92 cluster promotes hepatocarcinogenesis. hsa-mir-19b lung cancer up A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. hsa-mir-19b lung cancer up Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. hsa-mir-19b lung cancer up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. hsa-mir-19b mantle cell lymphoma up The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. hsa-mir-19b medulloblastoma up The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. hsa-mir-19b osteosarcoma up Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma. hsa-mir-19b-1 t-cell lymphoblastic lymphoma up Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma. hsa-mir-19b-2 t-cell lymphoblastic lymphoma up Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma. hsa-mir-200a bladder cancer down Expression of microRNAs in the Urine of Patients With Bladder Cancer. hsa-mir-200a breast cancer up MicroRNA-200a Promotes Anoikis Resistance and Metastasis by Targeting YAP1 in Human Breast Cancer. hsa-mir-200a breast cancer down microRNA-200a Inhibits Cell Proliferation by Targeting Mitochondrial Transcription Factor A in Breast Cancer. hsa-mir-200a breast cancer up Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. hsa-mir-200a colorectal cancer down MiR-200 suppresses metastases of colorectal cancer through ZEB1. hsa-mir-200a esophageal adenocarcinoma up Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma. hsa-mir-200a esophageal cancer up Differential expression of miRNAs in esophageal cancer tissue. hsa-mir-200a esophageal cancer up miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas. hsa-mir-200a gastric adenocarcinoma down Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/?-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. hsa-mir-200a gastric adenocarcinoma down Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma. hsa-mir-200a glioma down MiR-200a impairs glioma cell growth, migration, and invasion by targeting SIM2-s. hsa-mir-200a hepatocellular carcinoma down MicroRNA-200a suppresses metastatic potential of side population cells in human hepatocellular carcinoma by decreasing ZEB2. hsa-mir-200a hepatocellular carcinoma down The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma. hsa-mir-200a hepatocellular carcinoma down The microRNA-200 family-A potential diagnostic marker in hepatocellular carcinoma? hsa-mir-200a hepatocellular carcinoma down miR-200a suppresses cell growth and migration by targeting MACC1 and predicts prognosis in hepatocellular carcinoma. hsa-mir-200a lung adenocarcinoma down miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. hsa-mir-200a lung cancer up MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation. hsa-mir-200a malignant melanoma up MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion. hsa-mir-200a meningioma down Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. hsa-mir-200a mesenchymal cancer down MicroRNA Expression Profiles in Kaposi's Sarcoma. hsa-mir-200a neuroblastoma down miR-200a inhibits tumor proliferation by targeting AP-2? in neuroblastoma cells. hsa-mir-200a non-small cell lung cancer up MiR-200a enhances the migrations of A549 and SK-MES-1 cells by regulating the expression of TSPAN1. hsa-mir-200a ovarian cancer down A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. hsa-mir-200a ovarian cancer up Upregulation of microRNA-200a associates with tumor proliferation, CSCs phenotype and chemosensitivity in ovarian cancer. hsa-mir-200a pancreatic ductal adenocarcinoma down XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism. hsa-mir-200a renal cell carcinoma down Tumor suppressive microRNA-200a inhibits renal cell carcinoma development by directly targeting TGFB2. hsa-mir-200a-3p gastric cancer up Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer. hsa-mir-200b astrocytoma down Prognostic value of coexistence of abnormal expression of micro-RNA-200b and cyclic adenosine monophosphate-responsive element-binding protein 1 in human astrocytoma. hsa-mir-200b bladder cancer down Expression of microRNAs in the Urine of Patients With Bladder Cancer. hsa-mir-200b breast cancer up Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. hsa-mir-200b breast cancer down Regulation of the MicroRNA 200b (miRNA-200b) by Transcriptional Regulators PEA3 and ELK-1 Protein Affects Expression of Pin1 Protein to Control Anoikis. hsa-mir-200b breast cancer down miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family. hsa-mir-200b cholangiocarcinoma down Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis. hsa-mir-200b cholangiocarcinoma down Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis. hsa-mir-200b colorectal cancer down MiR-200 suppresses metastases of colorectal cancer through ZEB1. hsa-mir-200b colorectal cancer up microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs. hsa-mir-200b endometrial cancer up MicroRNA-200b is overexpressed in endometrial adenocarcinomas and enhances MMP2 activity by downregulating TIMP2 in human endometrial cancer cell line HEC-1A cells. hsa-mir-200b esophageal squamous cell carcinoma down miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2. hsa-mir-200b esophageal squamous cell carcinoma down Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin ?1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism. hsa-mir-200b gastric cancer up MicroRNA-200b Regulates Cell Proliferation, Invasion, and Migration by Directly Targeting ZEB2 in Gastric Carcinoma. hsa-mir-200b gastric cancer down miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression. hsa-mir-200b glioma down miR-200b as a prognostic factor targets multiple members of RAB family in glioma. hsa-mir-200b glioma down Decreased expression of microRNA-200b is an independent unfavorable prognostic factor for glioma patients. hsa-mir-200b glioma down [miR-200b suppresses glioma cell invasion by targeting PROM1]. hsa-mir-200b hepatocellular carcinoma down The microRNA-200 family-A potential diagnostic marker in hepatocellular carcinoma? hsa-mir-200b lung adenocarcinoma down miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. hsa-mir-200b lung cancer up MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation. hsa-mir-200b malignant melanoma up MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion. hsa-mir-200b mesenchymal cancer down MicroRNA Expression Profiles in Kaposi's Sarcoma. hsa-mir-200b nasopharyngeal carcinoma down miR-200b Suppresses Cell Growth, Migration and Invasion by Targeting Notch1 in Nasopharyngeal Carcinoma. hsa-mir-200b ovarian cancer down A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. hsa-mir-200b pancreatic ductal adenocarcinoma down XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism. hsa-mir-200b prostate cancer down miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1. hsa-mir-200b prostate cancer down miR-200b inhibits prostate cancer EMT, growth and metastasis. hsa-mir-200b tongue cancer down MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. hsa-mir-200c bladder cancer down Expression of microRNAs in the Urine of Patients With Bladder Cancer. hsa-mir-200c breast cancer up Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. hsa-mir-200c breast cancer down MiR-200c suppresses TGF-? signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer. hsa-mir-200c cholangiocarcinoma down Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis. hsa-mir-200c cholangiocarcinoma down Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis. hsa-mir-200c colon cancer down miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1. hsa-mir-200c colon cancer up The roles of miR-200c in colon cancer and associated molecular mechanisms. hsa-mir-200c colorectal cancer down MiR-200 suppresses metastases of colorectal cancer through ZEB1. hsa-mir-200c colorectal cancer down miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1. hsa-mir-200c colorectal cancer up MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. hsa-mir-200c colorectal cancer up Plasma miR-200c and miR-18a as potential biomarkers for the detection of colorectal carcinoma. hsa-mir-200c colorectal cancer up microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs. hsa-mir-200c endometrial cancer up The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma. hsa-mir-200c gastric cancer down miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression. hsa-mir-200c gastric cancer down The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression. hsa-mir-200c head and neck squamous cell carcinoma down MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. hsa-mir-200c hepatocellular carcinoma down Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno hsa-mir-200c hepatocellular carcinoma down Expression Profile of MicroRNA-200 Family in Hepatocellular Carcinoma With Bile Duct Tumor Thrombus. hsa-mir-200c lung adenocarcinoma down miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. hsa-mir-200c lung cancer up MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation. hsa-mir-200c malignant melanoma down miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment. hsa-mir-200c malignant melanoma up MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion. hsa-mir-200c malignant melanoma down Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors. hsa-mir-200c malignant melanoma down miR-200c Inhibits Melanoma Progression and Drug Resistance through Down-Regulation of Bmi-1. hsa-mir-200c mesenchymal cancer down MicroRNA Expression Profiles in Kaposi's Sarcoma. hsa-mir-200c non-small cell lung cancer up High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. hsa-mir-200c non-small cell lung cancer up Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer. hsa-mir-200c ovarian cancer down A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. hsa-mir-200c ovarian cancer down Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel. hsa-mir-200c ovarian cancer up Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells. hsa-mir-200c ovarian cancer up miR-200c modulates ovarian cancer cell metastasis potential by targeting zinc finger E-box-binding homeobox 2 (ZEB2) expression. hsa-mir-200c pancreatic ductal adenocarcinoma down XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism. hsa-mir-200c rectal cancer up The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer. hsa-mir-200c renal clear cell carcinoma down Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. hsa-mir-200c renal clear cell carcinoma down miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. hsa-mir-202 follicular lymphoma down Targetome profiling, pathway analysis and genetic association study implicate miR-202 in lymphomagenesis. hsa-mir-202 hepatocellular carcinoma down miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally. hsa-mir-202 osteosarcoma up TGF-?1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma. hsa-mir-202-3p colorectal carcinoma down MicroRNA-202-3p Inhibits Cell Proliferation by Targeting ADP-Ribosylation Factor-like 5A in Human Colorectal Carcinoma. hsa-mir-202-3p gastric cancer down Decrease of miR-202-3p Expression, a Novel Tumor Suppressor, in Gastric Cancer. hsa-mir-203 basal cell carcinoma down MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma. hsa-mir-203 bladder cancer up Micro-RNA profiling in kidney and bladder cancers. hsa-mir-203 bladder cancer down microRNA-203 suppresses bladder cancer development by repressing bcl-w expression. hsa-mir-203 bladder cancer down Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. hsa-mir-203 breast cancer up Anti-miR-203 Upregulates SOCS3 Expression in Breast Cancer Cells and Enhances Cisplatin Chemosensitivity. hsa-mir-203 cervical cancer down miR-203 Suppresses Tumor Growth and Angiogenesis by Targeting VEGFA in Cervical Cancer. hsa-mir-203 cervical cancer down BANF1 Is Downregulated by IRF1-Regulated MicroRNA-203 in Cervical Cancer. hsa-mir-203 colorectal cancer up Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. hsa-mir-203 colorectal cancer down MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity. hsa-mir-203 esophageal adenocarcinoma down Deciphering the Unique MicroRNA Signature in Human Esophageal Adenocarcinoma. hsa-mir-203 esophageal cancer down MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer. hsa-mir-203 esophageal cancer down miR-203 inhibits the proliferation and self-renewal of esophageal cancer stem-like cells by suppressing stem renewal factor Bmi-1. hsa-mir-203 esophageal cancer up Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma. hsa-mir-203 esophageal squamous cell carcinoma down miR-203 is a Direct Transcriptional Target of E2F1 and Causes G1 Arrest in Esophageal Cancer Cells. hsa-mir-203 esophageal squamous cell carcinoma down MicroRNA-203 inhibits cell proliferation by repressing ?Np63 expression in human esophageal squamous cell carcinoma. hsa-mir-203 gastric cancer down Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer. hsa-mir-203 glioma down MicroRNA 203 Modulates Glioma Cell Migration via Robo1/ERK/MMP-9 Signaling. hsa-mir-203 hepatocellular carcinoma down Association between underexpression of microrna-203 and clinicopathological significance in hepatocellular carcinoma tissues. hsa-mir-203 hepatocellular carcinoma down miR-203 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting oncogene ADAM9 and oncogenic long non-coding RNA HULC. hsa-mir-203 hepatocellular carcinoma down miR-203 inhibits proliferation of HCC cells by targeting survivin. hsa-mir-203 hypopharyngeal cancer up Effect of microRNA-203 on tumor growth in human hypopharyngeal squamous cell carcinoma. hsa-mir-203 kidney cancer down miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2. hsa-mir-203 laryngeal squamous cell carcinoma down MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours. hsa-mir-203 lung cancer down The expression and function of microRNA-203 in lung cancer. hsa-mir-203 lung cancer down miR-203 Suppresses the Proliferation and Migration and Promotes the Apoptosis of Lung Cancer Cells by Targeting SRC. hsa-mir-203 lung carcinoma down miR-203 Inhibits Frizzled-2 Expression via CD82/KAI1 Expression in Human Lung Carcinoma Cells. hsa-mir-203 malignant melanoma down Anti-oncogenic MicroRNA-203 Induces Senescence by Targeting E2F3 in Human Melanoma Cells. hsa-mir-203 malignant melanoma down MicroRNA-203 inhibits malignant melanoma cell migration by targeting versican. hsa-mir-203 malignant melanoma down Analysis of microRNA-203 function in CREB/MITF/RAB27a pathway: comparison between canine and human melanoma cells. hsa-mir-203 malignant melanoma down MiR-203 inhibits melanoma invasive and proliferative abilities by targeting the polycomb group gene BMI1. hsa-mir-203 malignant melanoma down DNA methylation contributes toward silencing of antioncogenic microRNA-203 in human and canine melanoma cells. hsa-mir-203 non-small cell lung cancer down MicroRNA-203 inhibits cellular proliferation and invasion by targeting Bmi1 in non-small cell lung cancer. hsa-mir-203 pancreatic adenocarcinoma up MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma. hsa-mir-203 pancreatic cancer down miR-203 inhibits tumor cell migration and invasion via caveolin-1 in pancreatic cancer cells. hsa-mir-203 pancreatic ductal adenocarcinoma up Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas. hsa-mir-203 prostate cancer down Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance. hsa-mir-203 prostate cancer down MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer. hsa-mir-203 rhabdomyosarcoma down miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in Rhabdomyosarcoma. hsa-mir-203 squamous carcinoma up Unique MicroRNA Expression Profiles in Cervical Cancer. hsa-mir-203 squamous carcinoma down MicroRNA expression profiles of esophageal cancer. hsa-mir-203a renal cell carcinoma up miR-203a regulates proliferation, migration, and apoptosis by targeting glycogen synthase kinase-3? in human renal cell carcinoma. hsa-mir-204 breast cancer down MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway. hsa-mir-204 gastric cancer down MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells. hsa-mir-204 glioma down Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype. hsa-mir-204 intrahepatic cholangiocarcinoma down miR-204 inhibits epithelial to mesenchymal transition by targeting slug in intrahepatic cholangiocarcinoma cells. hsa-mir-204 malignant melanoma down Regulation of cancer aggressive features in melanoma cells by microRNAs. hsa-mir-204 nasopharyngeal carcinoma down Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells. hsa-mir-204 non-small cell lung cancer down miR-204 functions as a tumor suppressor by regulating SIX1 in NSCLC. hsa-mir-204 non-small cell lung cancer down MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1. hsa-mir-204 osteosarcoma down MicroRNA-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting Sirtuin 1. hsa-mir-204 prostate cancer up Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression. hsa-mir-204 renal cell carcinoma down Upregulation of microRNA-204 inhibits cell proliferation, migration and invasion in human renal cell carcinoma cells by downregulating SOX4. hsa-mir-204 renal clear cell carcinoma down VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. hsa-mir-204 retinoblastoma down MiR-204, down-regulated in retinoblastoma, regulates proliferation and invasion of human retinoblastoma cells by targeting CyclinD2 and MMP-9. hsa-mir-204-3p hepatocellular carcinoma down Growth inhibition of hepatocellular carcinoma tumor endothelial cells by miR-204-3p and underlying mechanism. hsa-mir-204-5p colorectal cancer up miR-204-5p expression in colorectal cancer: an autophagy-associated gene. hsa-mir-204-5p colorectal cancer down miR-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A. hsa-mir-204-5p gastric cancer down MicroRNA-204-5p inhibits gastric cancer cell proliferation by downregulating USP47 and RAB22A. hsa-mir-204-5p papillary thyroid carcinoma down miR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma. hsa-mir-205 bladder cancer up Micro-RNA profiling in kidney and bladder cancers. hsa-mir-205 bladder cancer down Expression of microRNAs in the Urine of Patients With Bladder Cancer. hsa-mir-205 breast cancer down miRNA-205 affects infiltration and metastasis of breast cancer. hsa-mir-205 breast cancer up Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females. hsa-mir-205 breast cancer down MicroRNA-205 inhibits the proliferation and invasion of breast cancer by regulating AMOT expression. hsa-mir-205 breast cancer down Suppression of cell growth and invasion by miR-205 in breast cancer. hsa-mir-205 breast cancer down Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. hsa-mir-205 cervical cancer up miR-205 Expression Promotes Cell Proliferation and Migration of Human Cervical Cancer Cells. hsa-mir-205 cervical cancer up Serum microRNA-205 as a novel biomarker for cervical cancer patients. hsa-mir-205 cervical squamous cell carcinoma up miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes. hsa-mir-205 endometrial cancer up miR-205 promotes tumor proliferation and invasion through targeting ESRRG in endometrial carcinoma. hsa-mir-205 endometrial cancer down MiR-205 inhibits cell apoptosis by targeting phosphatase and tensin homolog deleted on chromosome ten in endometrial cancer Ishikawa cells. hsa-mir-205 esophageal cancer up Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma. hsa-mir-205 esophageal cancer up miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas. hsa-mir-205 gastric cancer down Down-regulation of MicroRNA-205 promotes gastric cancer cell proliferation. hsa-mir-205 glioma down Identification of microRNA-205 as a potential prognostic indicator for human glioma. hsa-mir-205 glioma down Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma. hsa-mir-205 glioma down MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A. hsa-mir-205 head and neck squamous cell carcinoma down Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. hsa-mir-205 hepatocellular carcinoma down Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis. hsa-mir-205 hepatocellular carcinoma down MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA. hsa-mir-205 kidney cancer down MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. hsa-mir-205 laryngeal carcinoma up [Effect of microRNA-205 on proliferation of laryngeal carcinoma cell line Hep-2]. hsa-mir-205 laryngeal squamous cell carcinoma down MicroRNA-205 suppresses proliferation and promotes apoptosis in laryngeal squamous cell carcinoma. hsa-mir-205 lung cancer up Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients. hsa-mir-205 lung cancer up miR-205 regulates A549 cells proliferation by targeting PTEN. hsa-mir-205 malignant melanoma down miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. hsa-mir-205 malignant melanoma down Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors. hsa-mir-205 malignant melanoma down Chemically Modified Synthetic microRNA-205 Inhibits the Growth of Melanoma Cells In Vitro and In Vivo. hsa-mir-205 non-small cell lung cancer up Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. hsa-mir-205 non-small cell lung cancer up miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN. hsa-mir-205 ovarian cancer up The role of miR-205 in the VEGF-mediated promotion of human ovarian cancer cell invasion. hsa-mir-205 prostate cancer down MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer. hsa-mir-205 prostate cancer down Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells. hsa-mir-205 prostate cancer down Editorial Comment to MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer. hsa-mir-205 prostate cancer down Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer. hsa-mir-205 prostate cancer down MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer. hsa-mir-205 prostate cancer down miR-205 is frequently downregulated in prostate cancer and acts as a tumor suppressor by inhibiting tumor growth. hsa-mir-205 prostate cancer down Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31. hsa-mir-205 renal cell carcinoma down miRNA-205 Is a Candidate Tumor Suppressor that Targets ZEB2 in Renal Cell Carcinoma. hsa-mir-205 squamous carcinoma down MicroRNA expression profiles of esophageal cancer. hsa-mir-205 thyroid cancer down Modulatory role of miR-205 in angiogenesis and progression of thyroid cancer. hsa-mir-205-3p non-small cell lung cancer up Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients. hsa-mir-205-5p non-small cell lung cancer up Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients. hsa-mir-206 breast cancer down miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2. hsa-mir-206 breast cancer down Overexpression of miR-206 suppresses glycolysis, proliferation and migration in breast cancer cells via PFKFB3 targeting. hsa-mir-206 clear cell renal cell cancer down Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles. hsa-mir-206 colorectal cancer down microRNA-206 attenuates tumor proliferation and migration involving the downregulation of NOTCH3 in colorectal cancer. hsa-mir-206 gastric cancer down MicroRNA-206 suppresses gastric cancer cell growth and metastasis. hsa-mir-206 gastric cancer down Activation of PAX3-MET pathways due to miR-206 loss promotes gastric cancer metastasis. hsa-mir-206 gastric cancer down MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met Pathway. hsa-mir-206 gastric cancer down MiR-206 inhibits gastric cancer proliferation in part by repressing CyclinD2. hsa-mir-206 gastric cancer down Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer. hsa-mir-206 hepatocellular carcinoma down MicroRNA-206, down-regulated in hepatocellular carcinoma, suppresses cell proliferation and promotes apoptosis. hsa-mir-206 hepatocellular carcinoma down MicroRNA-206, down-regulated in hepatocellular carcinoma, suppresses cell proliferation and promotes apoptosis. hsa-mir-206 laryngeal squamous cell carcinoma down Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. hsa-mir-206 laryngeal squamous cell carcinoma down miR-206 inhibits human laryngeal squamous cell carcinoma cell growth by regulation of cyclinD2. hsa-mir-206 lung cancer down Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis. hsa-mir-206 lung cancer down Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation. hsa-mir-206 malignant melanoma down MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D. hsa-mir-206 medulloblastoma down MiR-206, a Cerebellum Enriched miRNA Is Downregulated in All Medulloblastoma Subgroups and Its Overexpression Is Necessary for Growth Inhibition of Medulloblastoma Cells. hsa-mir-206 non-small cell lung cancer down miR-206 inhibits non small cell lung cancer cell proliferation and invasion by targeting SOX9. hsa-mir-206 oral squamous cell carcinoma down MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma. hsa-mir-208 esophageal squamous cell carcinoma up Mir-208 promotes cell proliferation by repressing SOX6 expression in human esophageal squamous cell carcinoma. hsa-mir-20a acute myeloid leukemia down HIF-1? downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation. hsa-mir-20a b-cell lymphoma up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. hsa-mir-20a breast cancer up MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment. hsa-mir-20a breast cancer up Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients. hsa-mir-20a breast carcinoma up MiR-93 enhances angiogenesis and metastasis by targeting LATS2. hsa-mir-20a cervical cancer up MiR-20a promotes cervical cancer proliferation and metastasis in vitro and in vivo. hsa-mir-20a cervical cancer up miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells. hsa-mir-20a cervical cancer up Circulating miRNA-20a and miRNA-203 for Screening Lymph Node Metastasis in Early Stage Cervical Cancer. hsa-mir-20a cholangiocarcinoma up miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator. hsa-mir-20a cholangiocarcinoma up miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator. hsa-mir-20a colorectal cancer up MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. hsa-mir-20a colorectal cancer up MicroRNA signatures: novel biomarker for colorectal cancer? hsa-mir-20a esophageal squamous cell carcinoma up TNF-? is a novel target of miR-19a. hsa-mir-20a esophageal squamous cell carcinoma up Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma. hsa-mir-20a gastric cancer up Involvement of miR-20a in Promoting Gastric Cancer Progression by Targeting Early Growth Response 2 (EGR2). hsa-mir-20a gastric cancer up miR-20a enhances cisplatin resistance of human gastric cancer cell line by targeting NFKBIB. hsa-mir-20a glioma up [Expression of hsa-miR-20a in human glioma tissues and its effect on the proliferation of human glioma cells in vitro]. hsa-mir-20a glioma up DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells. hsa-mir-20a hepatocellular carcinoma down Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma. hsa-mir-20a hepatocellular carcinoma up MiR-20a Induces Cell Radioresistance by Activating the PTEN/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma. hsa-mir-20a hepatocellular carcinoma up MiR-17-92 cluster promotes hepatocarcinogenesis. hsa-mir-20a lung cancer up A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. hsa-mir-20a lung cancer up Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. hsa-mir-20a lung cancer up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. hsa-mir-20a malignant melanoma down Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex. hsa-mir-20a malignant melanoma up Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. hsa-mir-20a mantle cell lymphoma up The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. hsa-mir-20a medulloblastoma up The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. hsa-mir-20a nasopharyngeal cancer up Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma. hsa-mir-20a osteosarcoma up Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma. hsa-mir-20a ovarian cancer up miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells. hsa-mir-20a ovarian cancer up Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression. hsa-mir-20a pituitary carcinoma up MicroRNA involvement in a metastatic non-functioning pituitary carcinoma. hsa-mir-20a prostate cancer up miR-20a promotes Prostate cancer invasion and migration through targeting ABL2. hsa-mir-20a-5p colorectal cancer up Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. hsa-mir-20b bladder cancer down MicroRNA-20b inhibits the proliferation, migration and invasion of bladder cancer EJ cells via the targeting of cell cycle regulation and Sp-1-mediated MMP-2 expression. hsa-mir-20b breast cancer up MicroRNA-20b promotes cell growth of breast cancer cells partly via targeting phosphatase and tensin homologue (PTEN). hsa-mir-20b gastric cancer up miR-20b overexpression is predictive of poor prognosis in gastric cancer. hsa-mir-20b hepatocellular carcinoma up Crucial Role for Early Growth Response-1 in the Transcriptional Regulation of miR-20b in Breast Cancer. hsa-mir-21 adrenal cortical carcinoma up The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. hsa-mir-21 b-cell lymphoma up Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies. hsa-mir-21 breast cancer up Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients. hsa-mir-21 breast cancer up Tissue specific expression of extracellular microRNA in human breast cancers and normal human breast tissue in vivo. hsa-mir-21 breast cancer up Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue. hsa-mir-21 breast cancer up BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1. hsa-mir-21 breast cancer up Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer. hsa-mir-21 breast cancer up Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion. hsa-mir-21 breast cancer up The Regulation and Function of miR-21-FOXO3a-miR-34b/c Signaling in Breast Cancer. hsa-mir-21 breast cancer up MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. hsa-mir-21 breast cancer up Combination of miR-21 with Circulating Tumor Cells Markers Improve Diagnostic Specificity of Metastatic Breast Cancer. hsa-mir-21 breast cancer up Next-generation sequencing of microRNAs for breast cancer detection. hsa-mir-21 breast cancer up Quantitative Measurement of Serum MicroRNA-21 Expression in Relation to Breast Cancer Metastasis in Chinese Females. hsa-mir-21 cervical cancer up Overexpression of miR-21 promotes the proliferation and migration of cervical cancer cells via the inhibition of PTEN. hsa-mir-21 cervical carcinoma up MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. hsa-mir-21 cholangiocarcinoma up MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. hsa-mir-21 cholangiocarcinoma up PTEN and PDCD4 are bona fide targets of microRNA-21 in human cholangiocarcinoma. hsa-mir-21 cholangiocarcinoma up PTEN and PDCD4 are bona fide targets of microRNA-21 in human cholangiocarcinoma. hsa-mir-21 cholangiocarcinoma up miR-21 Targets 15-PGDH and Promotes Cholangiocarcinoma Growth. hsa-mir-21 cholangiocarcinoma up miR-21 Targets 15-PGDH and Promotes Cholangiocarcinoma Growth. hsa-mir-21 cholangiocarcinoma up miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells. hsa-mir-21 cholangiocarcinoma up miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells. hsa-mir-21 cholangiocarcinoma up MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. hsa-mir-21 colon cancer down miR-21 and miR-145 cooperation in regulation of colon cancer stem cells. hsa-mir-21 colorectal cancer up Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells. hsa-mir-21 colorectal cancer up Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer. hsa-mir-21 colorectal cancer up MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells. hsa-mir-21 colorectal cancer up MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. hsa-mir-21 colorectal cancer up Circulating Exosomal microRNAs as Biomarkers of Colon Cancer. hsa-mir-21 colorectal cancer up Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. hsa-mir-21 colorectal cancer up Correlation of over-expressions of miR-21 and Notch-1 in human colorectal cancer with clinical stages. hsa-mir-21 colorectal cancer up Increased expression of microRNA-21and its association with chemotherapeutic response in human colorectal cancer. hsa-mir-21 colorectal cancer up MicroRNA-21 controls hTERT via PTEN in human colorectal cancer cell proliferation. hsa-mir-21 colorectal carcinoma up Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy. hsa-mir-21 diffuse large B-cell lymphoma up Inhibition of miR-21 Induces Biological and Behavioral Alterations in Diffuse Large B-Cell Lymphoma. hsa-mir-21 endometrial cancer up Highly increased maspin expression corresponds with up-regulation of miR-21 in endometrial cancer: a preliminary report. hsa-mir-21 esophageal cancer up [Diagnostic values of salivary versus and plasma microRNA-21 for early esophageal cancer]. hsa-mir-21 esophageal cancer up Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma. hsa-mir-21 esophageal cancer up The expression of miR-21 and miR-375 predict prognosis of esophageal cancer. hsa-mir-21 esophageal squamous cell carcinoma up Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. hsa-mir-21 esophageal squamous cell carcinoma up Down-Regulation of PTEN Expression Modulated by Dysregulated miR-21 Contributes to the Progression of Esophageal Cancer. hsa-mir-21 esophageal squamous cell carcinoma down Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma. hsa-mir-21 esophageal squamous cell carcinoma up Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma. hsa-mir-21 esophageal squamous cell carcinoma up miR-21 Down-Regulation Suppresses Cell Growth, Invasion and Induces Cell Apoptosis by Targeting FASL, TIMP3, and RECK Genes in Esophageal Carcinoma. hsa-mir-21 esophageal squamous cell carcinoma up Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. hsa-mir-21 esophageal squamous cell carcinoma up MicroRNA-21 promotes the proliferation and inhibits apoptosis in Eca109 via activating ERK1/2/MAPK pathway. hsa-mir-21 esophageal squamous cell carcinoma up Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma. hsa-mir-21 esophageal squamous cell carcinoma up Expression, Tissue Distribution and Function of miR-21 in Esophageal Squamous Cell Carcinoma. hsa-mir-21 gastric cancer up Stromal miR-21 is more important than miR-21 of tumour cells for the progression of gastric cancer. hsa-mir-21 gastric cancer up miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. hsa-mir-21 gastric cancer up Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. hsa-mir-21 gastric cancer up Circulating microRNAs in plasma of patients with gastric cancers. hsa-mir-21 gastric cancer up Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma. hsa-mir-21 gastric cancer up miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-mir-21 gastric cancer up Oxidative Stress Upregulates PDCD4 Expression in Patients with Gastric Cancer via miR-21. hsa-mir-21 gastric cancer up microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. hsa-mir-21 gastric cancer up Evaluation of MicroRNA Expression Pattern of Gastric Adenocarcinoma Associated with Socioeconomic, Environmental and Lifestyle Factors in Northwestern Hungary. hsa-mir-21 gastric cancer up MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer. hsa-mir-21 gastric cancer up MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog. hsa-mir-21 gastric cancer up miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer. hsa-mir-21 glioblastoma up MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme. hsa-mir-21 glioblastoma up PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma. hsa-mir-21 glioblastoma up Targeting strategies on miRNA-21 and PDCD4 for glioblastoma. hsa-mir-21 glioblastoma up Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. hsa-mir-21 glioblastoma up Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III. hsa-mir-21 glioblastoma up Co-delivery of as-miR-21 and 5-FU by poly(amidoamine) dendrimer attenuates human glioma cell growth in vitro. hsa-mir-21 glioblastoma up MicroRNA-21 Promotes Glioblastoma Tumorigenesis by Down-regulating Insulin-like Growth Factor-binding Protein-3 (IGFBP3). hsa-mir-21 glioblastoma up Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo. hsa-mir-21 glioblastoma up MiR-21 up-regulation mediates glioblastoma cancer stem cells apoptosis and proliferation by targeting FASLG. hsa-mir-21 glioblastoma up MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. hsa-mir-21 glioblastoma down MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide. hsa-mir-21 glioblastoma up Delivery of anti-microRNA-21 antisense-oligodeoxynucleotide using amphiphilic peptides for glioblastoma gene therapy. hsa-mir-21 glioblastoma up MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. hsa-mir-21 glioblastoma up Heterogeneous Nuclear Ribonucleoprotein C1/C2 Controls the Metastatic Potential of Glioblastoma by Regulating PDCD4. hsa-mir-21 glioblastoma up Sulforaphane enhances temozolomide-induced apoptosis due to downregulation of miR-21 via Wnt/?-catenin signaling in glioblastoma. hsa-mir-21 head and neck cancer up MicroRNA alterations in head and neck squamous cell carcinoma. hsa-mir-21 head and neck cancer up [Expression of mir-21 and mir-375 in laryngeal squamous cell carcinoma]. hsa-mir-21 head and neck squamous cell carcinoma up Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. hsa-mir-21 head and neck squamous cell carcinoma up Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. hsa-mir-21 head and neck squamous cell carcinoma up Clusterin Is a Gene-Specific Target of microRNA-21 in Head and Neck Squamous Cell Carcinoma. hsa-mir-21 head and neck squamous cell carcinoma up Co-targeting of multiple microRNAs on factor-inhibiting hypoxia-inducible factor (FIH) gene for the pathogenesis of head and neck carcinomas. hsa-mir-21 hepatocellular carcinoma up Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. hsa-mir-21 hepatocellular carcinoma up MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3. hsa-mir-21 hepatocellular carcinoma up MicroRNA-21 promotes cell proliferation in human hepatocellular carcinoma partly by targeting HEPN1. hsa-mir-21 hepatocellular carcinoma up Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. hsa-mir-21 hepatocellular carcinoma down Expression of serum miR-16, let-7f, and miR-21 in patients with hepatocellular carcinoma and their clinical significances. hsa-mir-21 hepatocellular carcinoma up Anti-miR-21 Suppresses Hepatocellular Carcinoma Growth via Broad Transcriptional Network Deregulation. hsa-mir-21 hepatocellular carcinoma up Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno hsa-mir-21 hepatocellular carcinoma up Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor ? and androgen receptor. hsa-mir-21 hepatocellular carcinoma up miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells. hsa-mir-21 hepatocellular carcinoma up miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. hsa-mir-21 hepatocellular carcinoma up Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma. hsa-mir-21 hepatocellular carcinoma up MiR-21 promoted proliferation and migration in hepatocellular carcinoma through negative regulation of Navigator-3. hsa-mir-21 hepatocellular carcinoma up Thyroid hormone regulation of miR-21 enhances migration and invasion of hepatoma. hsa-mir-21 hepatocellular carcinoma up miR-21 expression predicts prognosis in hepatocellular carcinoma. hsa-mir-21 hepatocellular carcinoma up Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma. hsa-mir-21 hepatocellular carcinoma up MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways. hsa-mir-21 hepatocellular carcinoma up Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog. hsa-mir-21 hepatocellular carcinoma up Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies. hsa-mir-21 hypopharyngeal squamous cell carcinoma up Altered Expression of miR-21 and PTEN in Human Laryngeal and Hypopharyngeal Squamous Cell Carcinomas. hsa-mir-21 kidney cancer up miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer. hsa-mir-21 laryngeal carcinoma up Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. hsa-mir-21 laryngeal squamous cell carcinoma up Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma. hsa-mir-21 laryngeal squamous cell carcinoma up Altered Expression of miR-21 and PTEN in Human Laryngeal and Hypopharyngeal Squamous Cell Carcinomas. hsa-mir-21 liver cancer up microRNA 21-mediated suppression of Sprouty1 by Pokemon affects liver cancer cell growth and proliferation. hsa-mir-21 lung cancer up Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia. hsa-mir-21 lung cancer up Expression and significance of miRNA-21 and BTG2 in lung cancer. hsa-mir-21 lung cancer up Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients. hsa-mir-21 malignant melanoma up microRNA-21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells. hsa-mir-21 malignant melanoma up MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of MiR-21 inhibitor. hsa-mir-21 malignant melanoma up Expression and clinicopathological significance of microRNA-21 and programmed cell death 4 in malignant melanoma. hsa-mir-21 multiple myeloma up Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine. hsa-mir-21 multiple myeloma up Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts. hsa-mir-21 nasopharyngeal carcinoma up Activation of miR-21 by STAT3 Induces Proliferation and Suppresses Apoptosis in Nasopharyngeal Carcinoma by Targeting PTEN Gene. hsa-mir-21 nasopharyngeal carcinoma up Downregulation of microRNA-21 enhances radiosensitivity in nasopharyngeal carcinoma. hsa-mir-21 non-small cell lung cancer up [Overexpression of miR-21 promotes proliferation and reduces apoptosis in non-small cell lung cancer]. hsa-mir-21 non-small cell lung cancer up MiR-21 suppresses the anticancer activities of curcumin by targeting PTEN gene in human non-small cell lung cancer A549 cells. hsa-mir-21 non-small cell lung cancer up Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application. hsa-mir-21 non-small cell lung cancer up Alteration in Mir-21/PTEN expression modulates gefitinib resistance in non-small cell lung cancer. hsa-mir-21 non-small cell lung cancer up Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. hsa-mir-21 non-small cell lung cancer up Reduction of Plasma MicroRNA-21 is Associated with Chemotherapeutic Response in Patients with Non-small Cell Lung Cancer. hsa-mir-21 non-small cell lung cancer up MicroRNA-21 (miR-21) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China. hsa-mir-21 non-small cell lung cancer up High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. hsa-mir-21 non-small cell lung cancer up Clinical evaluation of microRNA expression profiling in non small cell lung cancer. hsa-mir-21 non-small cell lung cancer up Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4. hsa-mir-21 non-small cell lung cancer up Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. hsa-mir-21 non-small cell lung cancer up Overexpression of miRNA-21 promotes radiation-resistance of non-small cell lung cancer. hsa-mir-21 non-small cell lung cancer up Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer. hsa-mir-21 non-small cell lung cancer up Let-7g and miR-21 expression in non-small cell lung cancer: Correlation with clinicopathological and molecular features. hsa-mir-21 oral cancer up MicroRNA-21 Promotes Oral Cancer Invasion via the Wnt/?-Catenin Pathway by Targeting DKK2. hsa-mir-21 oral squamous cell carcinoma up Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia. hsa-mir-21 oral squamous cell carcinoma up Altered levels of miR-21, miR-125b-2*, miR-134, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics. hsa-mir-21 osteosarcoma up A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma. hsa-mir-21 osteosarcoma up Identification of Serum MicroRNA-21 as a Biomarker for Chemosensitivity and Prognosis in Human Osteosarcoma. hsa-mir-21 osteosarcoma up MicroRNA-21 is involved in osteosarcoma cell invasion and migration. hsa-mir-21 ovarian cancer up The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer. hsa-mir-21 pancreatic adenocarcinoma up Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma. hsa-mir-21 pancreatic cancer up MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. hsa-mir-21 pancreatic cancer up MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. hsa-mir-21 pancreatic ductal adenocarcinoma up MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. hsa-mir-21 pancreatic ductal adenocarcinoma up Modulation of FoxO1 expression by miR-21 to promote growth of pancreatic ductal adenocarcinoma. hsa-mir-21 pancreatic ductal adenocarcinoma up Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma. hsa-mir-21 pancreatic ductal adenocarcinoma up Interplay of miR-21 and FoxO1 modulates growth of pancreatic ductal adenocarcinoma. hsa-mir-21 pancreatic ductal adenocarcinoma up Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma. hsa-mir-21 pancreatic ductal adenocarcinoma up MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma. hsa-mir-21 pancreatic ductal adenocarcinoma up MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm. hsa-mir-21 pancreatic ductal adenocarcinoma up MicroRNA-21 in Pancreatic Ductal Adenocarcinoma Tumor-Associated Fibroblasts Promotes Metastasis. hsa-mir-21 pancreatic ductal adenocarcinoma up MiR-21 upregulation induced by promoter zone histone acetylation is associated with chemoresistance to gemcitabine and enhanced malignancy of pancreatic cancer cells. hsa-mir-21 papillary thyroid carcinoma up Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients. hsa-mir-21 papillary thyroid carcinoma up MicroRNA-21 regulates biological behaviors in papillary thyroid carcinoma by targeting programmed cell death 4. hsa-mir-21 papillary thyroid carcinoma up In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications. hsa-mir-21 prostate cancer up A microRNA code for prostate cancer metastasis. hsa-mir-21 prostate cancer up MicroRNA-21 inhibits p57Kip2 expression in prostate cancer. hsa-mir-21 prostate cancer up A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia. hsa-mir-21 renal cell carcinoma up The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma. hsa-mir-21 renal cell carcinoma up miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer. hsa-mir-21 renal cell carcinoma up MicroRNA-21 is overexpressed in renal cell carcinoma. hsa-mir-21 renal cell carcinoma up MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma. hsa-mir-21 retinoblastoma up Seed-targeting anti-miR-21 inhibiting malignant progression of retinoblastoma and analysis of their phosphorylation signaling pathways. hsa-mir-21 squamous carcinoma up Unique MicroRNA Expression Profiles in Cervical Cancer. hsa-mir-21-3p hepatocellular carcinoma down MicroRNA-21-3p, a berberine-induced miRNA, directly down-regulates human methionine adenosyltransferases 2A and 2B and inhibits hepatoma cell growth. hsa-mir-21-5p clear cell renal cell cancer up Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles. hsa-mir-21-5p hepatocellular carcinoma up Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. hsa-mir-21-5p rectal cancer up Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients. hsa-mir-210 adrenal cortical carcinoma up The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. hsa-mir-210 bladder cancer up Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells. hsa-mir-210 colorectal cancer up Hypoxia-inducible MiR-210 is an independent prognostic factor and contributes to metastasis in colorectal cancer. hsa-mir-210 esophageal cancer up Differential expression of miRNAs in esophageal cancer tissue. hsa-mir-210 esophageal squamous cell carcinoma down MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). hsa-mir-210 esophageal squamous cell carcinoma down The Role of MicroRNA-210 in Esophageal Squamous Cell Carcinoma. hsa-mir-210 esophageal squamous cell carcinoma down MiR-210 expression reverses radioresistance of stem-like cells of oesophageal squamous cell carcinoma. hsa-mir-210 gastric cancer down miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-mir-210 glioblastoma up Acute hypoxia induces upregulation of microRNA-210 expression in glioblastoma spheroids. hsa-mir-210 glioma up MicroRNA-210 overexpression predicts poorer prognosis in glioma patients. hsa-mir-210 glioma up MiR-210 up-regulation inhibits proliferation and induces apoptosis in glioma cells by targeting SIN3A. hsa-mir-210 hepatocellular carcinoma up Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma. hsa-mir-210 hepatocellular carcinoma up Effects of knockdown of miR-210 in combination with ionizing radiation on human hepatoma xenograft in nude mice. hsa-mir-210 kidney cancer up miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis. hsa-mir-210 lung cancer up MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines. hsa-mir-210 malignant melanoma up A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients. hsa-mir-210 malignant melanoma up MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. hsa-mir-210 malignant melanoma up Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models. hsa-mir-210 osteosarcoma up Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma. hsa-mir-210 ovarian cancer up miR-210, a modulator of hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cell. hsa-mir-210 renal cell carcinoma up MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma. hsa-mir-210 renal clear cell carcinoma up Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma. hsa-mir-210 renal clear cell carcinoma up Overexpression of miR-210, a downstream target of HIF1?, causes centrosome amplification in renal carcinoma cells. hsa-mir-210 renal clear cell carcinoma up miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. hsa-mir-210-3p glioblastoma up Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing. hsa-mir-211 breast cancer down MicroRNA-211, a direct negative regulator of CDC25B expression, inhibits triple-negative breast cancer cells' growth and migration. hsa-mir-211 colorectal cancer up MicroRNA-211 expression promotes colorectal cancer cell growth in vitro and in vivo by targeting tumor suppressor CHD5. hsa-mir-211 hepatocellular carcinoma down miR-211 suppresses hepatocellular carcinoma by downregulating SATB2. hsa-mir-211 malignant melanoma down The regulation of miRNA-211 expression and its role in melanoma cell invasiveness. hsa-mir-211 malignant melanoma down Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. hsa-mir-211 malignant melanoma down Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor. hsa-mir-211 malignant melanoma down Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors. hsa-mir-211 non-small cell lung cancer up miR-211 promotes non-small cell lung cancer proliferation by targeting SRCIN1. hsa-mir-212 colorectal cancer down Genetic and Epigenetic Down-regulation of MicroRNA-212 Promotes Colorectal Tumor Metastasis via Dysregulation of MnSOD. hsa-mir-212 gastric cancer down miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer. hsa-mir-212 gastric cancer down Down-regulation of miR-212 expression by DNA hypermethylation in human gastric cancer cells. hsa-mir-212 hepatocellular carcinoma down Histone Demethylase Retinoblastoma Binding Protein 2 is Overexpressed in Hepatocellular Carcinoma and Negatively Regulated by hsa-miR-212. hsa-mir-212 non-small cell lung cancer down miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. hsa-mir-212 non-small cell lung cancer up MiR-212 displays Tumor Promoting properties in NSCLC Cells and targets the Hedgehog Pathway Receptor PTCH1. hsa-mir-212 non-small cell lung cancer up Synaptic acetylcholinesterase targeted by microRNA-212 functions as a tumor suppressor in non-small cell lung cancer. hsa-mir-212 osteosarcoma down MicroRNA-212 inhibits osteosarcoma cells proliferation and invasion by down-regulation of Sox4. hsa-mir-212 ovarian cancer down MiR-212 exerts suppressive effect on SKOV3 ovarian cancer cells through targeting HBEGF. hsa-mir-212 pancreatic cancer up miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. hsa-mir-212 pancreatic ductal adenocarcinoma up miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1. hsa-mir-212 prostate cancer down A potential regulatory loop between Lin28B:miR?212 in androgen-independent prostate cancer. hsa-mir-212-3p glioblastoma down MiR-212-3p inhibits glioblastoma cell proliferation by targeting SGK3. hsa-mir-214 bladder cancer down MicroRNA-214 Suppresses Oncogenesis and Exerts Impact on Prognosis by Targeting PDRG1 in Bladder Cancer. hsa-mir-214 cervical cancer down MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-?-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7. hsa-mir-214 cervical cancer down MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells. hsa-mir-214 cervical squamous cell carcinoma down Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK. hsa-mir-214 colon cancer down microRNA-214 functions as a tumor suppressor in human colon cancer via the suppression of ADP-ribosylation factor-like protein 2. hsa-mir-214 esophageal squamous cell carcinoma down MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma. hsa-mir-214 gastric cancer up Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer. hsa-mir-214 gastric cancer up Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasis. hsa-mir-214 gastric cancer up miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-mir-214 gastric cancer up Down-regulated miRNA-214 induces a cell cycle G1 arrest in gastric cancer cells by up-regulating the PTEN protein. hsa-mir-214 glioma up Associations between the Expression of micro-RNA 214 and clinicopathologic parameters of glioma. hsa-mir-214 hepatocellular carcinoma up MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines. hsa-mir-214 hepatocellular carcinoma down MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of ?-catenin. hsa-mir-214 hepatocellular carcinoma down Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis. hsa-mir-214 hepatocellular carcinoma down Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers. hsa-mir-214 malignant melanoma up Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models. hsa-mir-214 multiple myeloma down Restoration of miR-214 expression reduces growth of myeloma cells through a positive regulation of P53 and inhibition of DNA replication. hsa-mir-214 nasopharyngeal carcinoma up miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma. hsa-mir-214 nasopharyngeal carcinoma up Knockdown of miR-214 Promotes Apoptosis and Inhibits Cell Proliferation in Nasopharyngeal Carcinoma. hsa-mir-214 osteosarcoma up Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma. hsa-mir-214 ovarian cancer up Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research. hsa-mir-214 pancreatic cancer down Dysregulation of miR-15a and miR-214 in human pancreatic cancer. hsa-mir-214 pancreatic cancer up Dysregulation of miR-15a and miR-214 in human pancreatic cancer. hsa-mir-214 primary cns lymphomas down Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas. hsa-mir-214-3p esophageal cancer down Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1. hsa-mir-214-3p hepatocellular carcinoma down Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. hsa-mir-215 cervical cancer up MicroRNA-215 is a potential prognostic marker for cervical cancer. hsa-mir-215 colon cancer down Prognostic significance of miR-215 in colon cancer. hsa-mir-215 colorectal cancer down Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. hsa-mir-215 colorectal cancer down Identification and functional screening of microRNAs highly deregulated in colorectal cancer. hsa-mir-215 colorectal cancer down microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer. hsa-mir-215 gastric cancer up MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. hsa-mir-215 gastric cancer up MiR-215 modulates gastric cancer cell proliferation by targeting RB1. hsa-mir-215 gastric cancer up MiR-215/192 participates in gastric cancer progression. hsa-mir-215 gastric cancer up Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer. hsa-mir-215 glioma up MiR-215, an activator of the CTNNBIP1/?-catenin pathway, is a marker of poor prognosis in human glioma. hsa-mir-215 hepatocellular carcinoma up Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. hsa-mir-216a hepatocellular carcinoma up Androgen pathway stimulates microRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis. hsa-mir-216a hepatocellular carcinoma up MiR-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer. hsa-mir-216a oral squamous cell carcinoma down MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B. hsa-mir-216a pancreatic cancer down MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2. hsa-mir-216a pancreatic cancer down miR-216a may inhibit pancreatic tumor growth by targeting JAK2. hsa-mir-216a pancreatic cancer down [Expression of miR-216a in pancreatic cancer and its clinical significance]. hsa-mir-216b breast cancer down Regulation of the P2X7R by microRNA-216b in human breast cancer. hsa-mir-216b nasopharyngeal carcinoma down miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma. hsa-mir-216b nasopharyngeal carcinoma down [miR-216b suppresses cell proliferation and invasion by targeting PKC? in nasopharyngeal carcinoma cells]. hsa-mir-217 breast cancer up MiR-217 Promotes Tumor Proliferation in Breast Cancer via Targeting DACH1. hsa-mir-217 gastric cancer down microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer. hsa-mir-217 gastric cancer down The MicroRNA-217 Functions as a Potential Tumor Suppressor in Gastric Cancer by Targeting GPC5. hsa-mir-217 hepatocellular carcinoma up MiR-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer. hsa-mir-217 hepatocellular carcinoma down miR-217 inhibits invasion of hepatocellular carcinoma cells through direct suppression of E2F3. hsa-mir-217 lung cancer down MicroRNA-217 functions as a tumour suppressor gene and correlates with cell resistance to cisplatin in lung cancer. hsa-mir-217 osteosarcoma down The microRNA-217 functions as a tumor suppressor and is frequently downregulated in human osteosarcoma. hsa-mir-217 osteosarcoma down MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in osteosarcoma. hsa-mir-217 pancreatic ductal adenocarcinoma down MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm. hsa-mir-217 pancreatic ductal adenocarcinoma down MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma. hsa-mir-217 pancreatic ductal adenocarcinoma down The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS. hsa-mir-218 bladder cancer down MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1. hsa-mir-218 breast cancer down Silencing of miRNA-218 promotes migration and invasion of breast cancer via Slit2-Robo1 pathway. hsa-mir-218 cervical cancer down MicroRNA-218 increases cellular sensitivity to Rapamycin via targeting Rictor in cervical cancer. hsa-mir-218 cervical cancer down Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion. hsa-mir-218 cervical squamous cell carcinoma down Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma. hsa-mir-218 choriocarcinoma down MicroRNA-218 inhibits the proliferation of human choriocarcinoma JEG-3 cell line by targeting Fbxw8. hsa-mir-218 colorectal cancer down MicroRNA-218 Inhibits Cell Cycle Progression and Promotes Apoptosis in Colon Cancer by Downregulating BMI1 Polycomb Ring Finger Oncogene. hsa-mir-218 colorectal cancer down Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer. hsa-mir-218 esophageal cancer down Serum microRNA-218 is a potential biomarker for esophageal cancer. hsa-mir-218 esophageal squamous cell carcinoma up miR-218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin. hsa-mir-218 esophageal squamous cell carcinoma down MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1. hsa-mir-218 gastric cancer down MicroRNA-218 is upregulated in gastric cancer after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and increases chemosensitivity to cisplatin. hsa-mir-218 gastric cancer down Thermo-chemotherapy Induced miR-218 upregulation inhibits the invasion of gastric cancer via targeting Gli2 and E-cadherin. hsa-mir-218 gastric cancer down Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. hsa-mir-218 gastric cancer down [Reduced expression of miR-218 and its significance in gastric cancer]. hsa-mir-218 gastric cancer down Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. hsa-mir-218 gastric cancer down Reduced expression of circulating microRNA-218 in gastric cancer and correlation with tumor invasion and prognosis. hsa-mir-218 gastrointestinal stromal tumor down MicroRNA-218 inhibits gastrointestinal stromal tumor cell and invasion by targeting KIT. hsa-mir-218 glioma down MicroRNA-218 Inhibits Glioma Invasion, Migration, Proliferation and Cancer Stem-like Cell Self-renewal by Targeting the Polycomb Group Gene Bmi1. hsa-mir-218 glioma down Expression of microRNA-218 and its clinicopathological and prognostic significance in human glioma cases. hsa-mir-218 glioma down miR-218 inhibits the proliferation of glioma U87 cells through the inactivation of the CDK6/cyclin D1/p21(Cip1/Waf1) pathway. hsa-mir-218 head and neck squamous cell carcinoma down Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma. hsa-mir-218 hepatocellular carcinoma down Overexpression of miR-218 inhibits hepatocellular carcinoma cell growth through RET hsa-mir-218 hepatocellular carcinoma down MicroRNA-218 and microRNA-520a inhibit cell proliferation by downregulating E2F2 in hepatocellular carcinoma. hsa-mir-218 hepatocellular carcinoma down miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10. hsa-mir-218 lung cancer down MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma. hsa-mir-218 lung cancer down MiRNA-218, a new regulator of HMGB1, suppresses cell migration and invasion in non-small cell lung cancer. hsa-mir-218 lung squamous cell carcinoma down MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma. hsa-mir-218 malignant melanoma down Expression patterns of microRNA-218 and its potential functions by targeting CIP2A and BMI1 genes in melanoma. hsa-mir-218 nasopharyngeal cancer down MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. hsa-mir-218 oral cancer down The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. hsa-mir-218 osteosarcoma down miRNA-218 Inhibits Osteosarcoma Cell Migration and Invasion by Down-regulating of TIAM1, MMP2 and MMP9. hsa-mir-218 pancreatic ductal adenocarcinoma down Enhancer of Zeste Homolog 2 Silences miR-218 in Human Pancreatic Ductal Adenocarcinoma Cells by Inducing Formation of Heterochromatin. hsa-mir-218 prostate cancer down Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer. hsa-mir-218 prostate cancer down microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression. hsa-mir-218 renal cell carcinoma down MicroRNA-218 Inhibits Cell Migration and Invasion in Renal Cell Carcinoma Through Targeting Caveolin-2 Involved in Focal Adhesion Pathway. hsa-mir-218 renal clear cell carcinoma down miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. hsa-mir-219-5p glioblastoma down miR-219-5p Inhibits Receptor Tyrosine Kinase Pathway by Targeting EGFR in Glioblastoma. hsa-mir-219-5p glioma down miR-219-5p Inhibits Receptor Tyrosine Kinase Pathway by Targeting EGFR in Glioblastoma. hsa-mir-219-5p hepatocellular carcinoma down MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3. hsa-mir-219-5p papillary thyroid carcinoma down miR-219-5p Modulates Cell Growth of Papillary Thyroid Carcinoma by Targeting Estrogen Receptor ? hsa-mir-22 breast cancer down miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer. hsa-mir-22 breast cancer down A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis. hsa-mir-22 colon cancer down MicroRNA-22 regulates hypoxia signaling in colon cancer cells. hsa-mir-22 colon cancer down MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells. hsa-mir-22 colon cancer down miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9. hsa-mir-22 colorectal cancer down Clinical significance of miR-22 expression in patients with colorectal cancer. hsa-mir-22 esophageal squamous cell carcinoma down Increased miRNA-22 expression sensitizes esophageal squamous cell carcinoma to irradiation. hsa-mir-22 esophageal squamous cell carcinoma down miR-22 is down-regulated in esophageal squamous cell carcinoma and inhibits cell migration and invasion. hsa-mir-22 gastric cancer down miR-22 is down-regulated in gastric cancer, and its overexpression inhibits cell migration and invasion via targeting transcription factor Sp1. hsa-mir-22 gastric cancer down Reduced expression of miR-22 in gastric cancer is related to clinicopathologic characteristics or patient prognosis. hsa-mir-22 gastric cancer down miR-22 suppresses the proliferation and invasion of gastric cancer cells by inhibiting CD151. hsa-mir-22 gastric cancer down microRNA-22 acts as a metastasis suppressor by targeting metadherin in gastric cancer. hsa-mir-22 hepatocellular carcinoma down microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. hsa-mir-22 hepatocellular carcinoma down MicroRNA-22 expression in hepatocellular carcinoma and its correlation with ezrin protein. hsa-mir-22 liver cancer down microRNA-22 downregulation of galectin-9 influences lymphocyte apoptosis and tumor cell proliferation in liver cancer. hsa-mir-22 lung cancer down Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3. hsa-mir-22 medulloblastoma down MiR-22 is Frequently Down-regulated in Medulloblastomas, and Inhibits Cell Proliferation via the Novel Target PAPST1. hsa-mir-22 non-small cell lung cancer up Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer. hsa-mir-22 osteosarcoma down miR-22 inhibits osteosarcoma cell proliferation and migration by targeting HMGB1 and inhibiting HMGB1-mediated autophagy. hsa-mir-22 osteosarcoma down Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma. hsa-mir-22 t-cell lymphoma down miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9. hsa-mir-220a oral squamous cell carcinoma down Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer. hsa-mir-221 anaplastic thyroid carcinoma up A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears. hsa-mir-221 bladder cancer up Micro-RNA profiling in kidney and bladder cancers. hsa-mir-221 bladder cancer up MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL. hsa-mir-221 breast cancer up TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer. hsa-mir-221 breast cancer up From microRNA functions to microRNA therapeutics: Novel targets and novel drugs in breast cancer research and treatment (Review). hsa-mir-221 breast cancer up miR-221/222 promotes S-phase entry and cellular migration in control of basal-like breast cancer. hsa-mir-221 colon carcinoma up [MicroRNA-221 promotes colon carcinoma cell proliferation in vitro by inhibiting CDKN1C/p57 expression]. hsa-mir-221 colorectal cancer up MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma. hsa-mir-221 colorectal cancer up [MicroRNA-221 controls CDKN1C/P57 expression in human colorectal carcinoma]. hsa-mir-221 colorectal cancer up MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK. hsa-mir-221 esophageal cancer up Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma. hsa-mir-221 follicular thyroid carcinoma up Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas. hsa-mir-221 gastric cancer up miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-mir-221 gastric cancer up Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance. hsa-mir-221 gastric cancer up Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer. hsa-mir-221 gastrointestinal stromal tumor down Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors. hsa-mir-221 gastrointestinal stromal tumor down Multiple sporadic gastrointestinal stromal tumors concomitant with ampullary adenocarcinoma: a case report with KIT and PDGFRA mutational analysis and miR-221/222 expression profile. hsa-mir-221 glioma up Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo. hsa-mir-221 glioma up MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. hsa-mir-221 glioma up Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221. hsa-mir-221 glioma up MicroRNA-221 targeting PI3-K/Akt signaling axis induces cell proliferation and BCNU resistance in human glioblastoma. hsa-mir-221 glioma up MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2. hsa-mir-221 hepatocellular carcinoma up Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. hsa-mir-221 hepatocellular carcinoma up miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. hsa-mir-221 hepatocellular carcinoma up Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno hsa-mir-221 hepatocellular carcinoma up MicroRNAs in Hepatobiliary and Pancreatic Cancers. hsa-mir-221 hepatocellular carcinoma up Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro. hsa-mir-221 hepatocellular carcinoma up MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. hsa-mir-221 liver cancer up Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses tumor properties. hsa-mir-221 malignant melanoma up The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway. hsa-mir-221 non-small cell lung cancer up MicroRNA-221 promotes human non-small cell lung cancer cell H460 growth. hsa-mir-221 non-small cell lung cancer up miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. hsa-mir-221 non-small cell lung cancer down Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. hsa-mir-221 oral squamous cell carcinoma up miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells. hsa-mir-221 osteosarcoma up MicroRNA-221 Induces Cell Survival and Cisplatin Resistance through PI3K/Akt Pathway in Human Osteosarcoma. hsa-mir-221 ovarian cancer up Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research. hsa-mir-221 pancreatic adenocarcinoma up Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma. hsa-mir-221 pancreatic cancer up Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA. hsa-mir-221 pancreatic cancer up miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases. hsa-mir-221 pancreatic cancer up Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells. hsa-mir-221 papillary thyroid carcinoma up In vivo imaging of functional targeting of miR-221 in papillary thyroid carcinoma. hsa-mir-221 papillary thyroid carcinoma up In vivo imaging of miR-221 biogenesis in papillary thyroid carcinoma. hsa-mir-221 papillary thyroid carcinoma up Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients. hsa-mir-221 papillary thyroid carcinoma up Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma. hsa-mir-221 papillary thyroid carcinoma up MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. hsa-mir-221 prostate cancer up Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells. hsa-mir-221 prostate cancer down MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker. hsa-mir-221 prostate cancer up MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A. hsa-mir-221 prostate cancer down Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1. hsa-mir-221 renal cell carcinoma up miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma. hsa-mir-221 squamous carcinoma up Unique MicroRNA Expression Profiles in Cervical Cancer. hsa-mir-221 thyroid carcinoma up MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. hsa-mir-221* gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-221-3p hepatocellular carcinoma up Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. hsa-mir-222 anaplastic thyroid carcinoma up A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears. hsa-mir-222 bladder cancer up Increased expression of miR-222 is associated with poor prognosis in bladder cancer. hsa-mir-222 breast cancer up Analysis of serum genome-wide microRNAs for breast cancer detection. hsa-mir-222 breast cancer up miR-221/222 promotes S-phase entry and cellular migration in control of basal-like breast cancer. hsa-mir-222 breast cancer up TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer. hsa-mir-222 chondrosarcoma down Analysis of microRNAs expressions in chondrosarcoma. hsa-mir-222 chordoma down MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas. hsa-mir-222 gastric cancer up Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer. hsa-mir-222 gastric cancer up Circulating miR-222 in plasma and its potential diagnostic and prognostic value in gastric cancer. hsa-mir-222 gastric cancer up miR-222/VGLL4/YAP-TEAD1 regulatory loop promotes proliferation and invasion of gastric cancer cells. hsa-mir-222 gastric cancer up miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-mir-222 gastric cancer up Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK. hsa-mir-222 gastrointestinal stromal tumor down Multiple sporadic gastrointestinal stromal tumors concomitant with ampullary adenocarcinoma: a case report with KIT and PDGFRA mutational analysis and miR-221/222 expression profile. hsa-mir-222 gastrointestinal stromal tumor down Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors. hsa-mir-222 glioblastoma down Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III. hsa-mir-222 glioma up Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo. hsa-mir-222 glioma up MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. hsa-mir-222 glioma up MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2. hsa-mir-222 hepatocellular carcinoma up Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. hsa-mir-222 hepatocellular carcinoma up miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. hsa-mir-222 hepatocellular carcinoma up Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno hsa-mir-222 hepatocellular carcinoma up MicroRNAs in Hepatobiliary and Pancreatic Cancers. hsa-mir-222 hepatocellular carcinoma up [Expression of serum microRNAs (miR-222, miR-181, miR-216) in human hepatocellular carcinoma and its clinical significance]. hsa-mir-222 hepatocellular carcinoma up GNAI3 inhibits tumor cell migration and invasion and is post-transcriptionally regulated by miR-222 in hepatocellular carcinoma. hsa-mir-222 malignant melanoma up The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway. hsa-mir-222 non-small cell lung cancer up miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. hsa-mir-222 non-small cell lung cancer up Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application. hsa-mir-222 non-small cell lung cancer up MicroRNA-222 promotes human non-small cell lung cancer H460 growth by targeting p27. hsa-mir-222 oral squamous cell carcinoma up miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells. hsa-mir-222 pancreatic cancer up miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases. hsa-mir-222 papillary thyroid carcinoma up Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma. hsa-mir-222 papillary thyroid carcinoma up Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients. hsa-mir-222 papillary thyroid carcinoma up Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma. hsa-mir-222 papillary thyroid carcinoma up MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. hsa-mir-222 papillary thyroid carcinoma up MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma. hsa-mir-222 prostate cancer up Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells. hsa-mir-222 prostate cancer down MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker. hsa-mir-222 thyroid carcinoma up MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. hsa-mir-222-3p endometrial cancer up Elevated MiR-222-3p Promotes Proliferation and Invasion of Endometrial Carcinoma via Targeting ER?. hsa-mir-223 acute myeloid leukemia down Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. hsa-mir-223 bladder cancer up Micro-RNA profiling in kidney and bladder cancers. hsa-mir-223 chronic lymphocytic leukemia down MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia. hsa-mir-223 chronic lymphocytic leukemia down [Expression of microRNA-223 and its clinical value in B lymphoproliferative disorders]. hsa-mir-223 colorectal cancer up Overexpression of miR-223 correlates with tumor metastasis and poor prognosis in patients with colorectal cancer. hsa-mir-223 colorectal cancer up Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. hsa-mir-223 colorectal cancer up C/EBP-?-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer. hsa-mir-223 colorectal cancer up Circulating Exosomal microRNAs as Biomarkers of Colon Cancer. hsa-mir-223 colorectal cancer up MicroRNA-223 functions as an oncogene in human colorectal cancer cells. hsa-mir-223 endometrial cancer down MiR-223 suppresses endometrial carcinoma cells proliferation by targeting IGF-1R. hsa-mir-223 esophageal adenocarcinoma up MicroRNA 223 is Up-regulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1. hsa-mir-223 esophageal cancer down Differential expression of miRNAs in esophageal cancer tissue. hsa-mir-223 esophageal squamous cell carcinoma up Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma. hsa-mir-223 gastric cancer up MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4. hsa-mir-223 gastric cancer up Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. hsa-mir-223 gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-223 gastric cancer up miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-mir-223 glioblastoma up microRNA-223 promotes the growth and invasion of glioblastoma cells by targeting tumor suppressor PAX6. hsa-mir-223 hepatocellular carcinoma up Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. hsa-mir-223 hepatocellular carcinoma down [Role of microRNA-223 and its target gene oncogene c-myc in hepatocellular carcinoma pathogenesis.] hsa-mir-223 hepatocellular carcinoma down Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno hsa-mir-223 hepatocellular carcinoma down Sulfatide Epigenetically Regulates miR-223 and Promotes the Migration of Human Hepatocellular Carcinoma Cells. hsa-mir-223 kidney cancer up [Expression of miR-223 in clear cell renal cell carcinoma and its significance]. hsa-mir-223 lung cancer down miR-223 functions as a potent tumor suppressor of the Lewis lung carcinoma cell line by targeting insulin-like growth factor-1 receptor and cyclin-dependent kinase 2. hsa-mir-223 mantle cell lymphoma down [Expression of microRNA-223 and its clinical value in B lymphoproliferative disorders]. hsa-mir-223 mantle cell lymphoma down MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia. hsa-mir-223 nasopharyngeal cancer down Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma. hsa-mir-223 nasopharyngeal carcinoma down MiR-223 targeting MAFB suppresses proliferation and migration of nasopharyngeal carcinoma cells. hsa-mir-223 splenic marginal zone lymphoma down MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia. hsa-mir-223 splenic marginal zone lymphoma down [Expression of microRNA-223 and its clinical value in B lymphoproliferative disorders]. hsa-mir-223-3p prostate cancer up MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer. hsa-mir-224 breast cancer up MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells. hsa-mir-224 cervical cancer up Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer. hsa-mir-224 colorectal cancer up The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis. hsa-mir-224 colorectal cancer up microRNA-224 Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer by Repressing PHLPP1 and PHLPP2. hsa-mir-224 colorectal cancer up Up-regulation of miR-224 promotes cancer cell proliferation and invasion and predicts relapse of colorectal cancer. hsa-mir-224 colorectal cancer up Molecular biomarkers and classification models in the evaluation of the prognosis of colorectal cancer. hsa-mir-224 colorectal cancer down MicroRNA-224 suppresses colorectal cancer cell migration by targeting Cdc42. hsa-mir-224 esophageal squamous cell carcinoma tissue; Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma. hsa-mir-224 gastric cancer up [Effect of antisense miR-224 on gastric cancer cell proliferation and apoptosis]. hsa-mir-224 glioma up Upregulation of microRNA-224 confers a poor prognosis in glioma patients. hsa-mir-224 hepatocellular carcinoma up Transcriptional regulation of miR-224 upregulated in human HCCs by NF?B inflammatory pathways. hsa-mir-224 hepatocellular carcinoma up Androgen pathway stimulates microRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis. hsa-mir-224 hepatocellular carcinoma up MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms. hsa-mir-224 hepatocellular carcinoma up miR-224 promotes cell migration and invasion by modulating p-PAK4 and MMP-9 via targeting HOXD10 in human hepatocellular carcinoma. hsa-mir-224 hepatocellular carcinoma up MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma. hsa-mir-224 hepatocellular carcinoma up Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. hsa-mir-224 meningioma up MicroRNA-224 targets ERG2 and contributes to malignant progressions of meningioma. hsa-mir-224 non-small cell lung cancer down Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients. hsa-mir-224 non-small cell lung cancer up MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7. hsa-mir-224 prostate cancer down Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer. hsa-mir-224 prostate cancer down MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer. hsa-mir-224 prostate cancer down MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1. hsa-mir-224-5p hepatocellular carcinoma up Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. hsa-mir-224-5p ovarian cancer up Expression of miR-224-5p is associated with the original cisplatin resistance of ovarian papillary serous carcinoma. hsa-mir-2278 chronic myelogenous leukemia down Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeti hsa-mir-23a bladder cancer up Micro-RNA profiling in kidney and bladder cancers. hsa-mir-23a breast cancer up c-MYC regulated miR-23a~24-2~27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2. hsa-mir-23a colon carcinoma up [Expression and clinical significance of miR-23a and metastasis suppressor 1 in colon carcinoma]. hsa-mir-23a colorectal cancer up Circulating Exosomal microRNAs as Biomarkers of Colon Cancer. hsa-mir-23a gastric adenocarcinoma up miR-23a targets interferon regulatory factor 1 and modulates cellular proliferation and paclitaxel-induced apoptosis in gastric adenocarcinoma cells. hsa-mir-23a gastric adenocarcinoma up MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor. hsa-mir-23a gastric cancer up miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-mir-23a gastric cancer up MiR-23a in Amplified 19p13.13 Loci Targets Metallothionein 2A and Promotes Growth in Gastric Cancer Cells. hsa-mir-23a gastric cancer up Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer. hsa-mir-23a glioma up Targeting microRNA-23a to inhibit glioma cell invasion via HOXD10. hsa-mir-23a hepatocellular carcinoma up Stat3-mediated activation of miR-23a suppresses gluconeogenesis in hepatocellular carcinoma by downregulating G6PC and PGC-1? hsa-mir-23a laryngeal cancer up High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis. hsa-mir-23a laryngeal carcinoma up Upregulation of microRNA-23a regulates proliferation and apoptosis by targeting APAF-1 in laryngeal carcinoma. hsa-mir-23a neuroblastoma up MicroRNA-23a promotes neuroblastoma cell metastasis by targeting CDH1. hsa-mir-23a osteosarcoma down miR-23a suppresses proliferation of osteosarcoma cells by targeting SATB1. hsa-mir-23a osteosarcoma down MiR-23a Functions as a Tumor Suppressor in Osteosarcoma. hsa-mir-23a prostate cancer down Downregulation of microRNA-23a suppresses prostate cancer metastasis by targeting the PAK6-LIMK1 signaling pathway. hsa-mir-23b bladder cancer down MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer. hsa-mir-23b bladder cancer up Micro-RNA profiling in kidney and bladder cancers. hsa-mir-23b gastric cancer up miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-mir-23b gastric cancer up Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer. hsa-mir-23b gastric cancer down The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis. hsa-mir-23b glioma down miRNA expression profiling in migrating glioblastoma cells: regulation of cell migration and invasion by miR-23b via targeting of Pyk2. hsa-mir-23b ovarian cancer up MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance. hsa-mir-23b prostate cancer down miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer. hsa-mir-24 bladder cancer down MicroRNA-24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3. hsa-mir-24 breast cancer up Association between mir-24 and mir-378 in formalin-fixed paraffin-embedded tissues of breast cancer. hsa-mir-24 breast carcinoma up MicroRNA miR-24 Enhances Tumor Invasion and Metastasis by Targeting PTPN9 and PTPRF to Promote EGF Signaling. hsa-mir-24 colorectal cancer down Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma. hsa-mir-24 gastric cancer down Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV. hsa-mir-24 glioma up MiR-24 regulates the proliferation and invasion of glioma by ST7L via ?-catenin/Tcf-4 signaling. hsa-mir-24 hepatocellular carcinoma up MicroRNA-24 Modulates Aflatoxin B1-Related Hepatocellular Carcinoma Prognosis and Tumorigenesis. hsa-mir-24 hepatocellular carcinoma up miR-24 promotes the proliferation and invasion of HCC cells by targeting SOX7. hsa-mir-24 laryngeal squamous cell carcinoma down miR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein. hsa-mir-24 lung cancer up Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients. hsa-mir-24 nasopharyngeal carcinoma up [Clinical significance of plasma miR-24 dysregulation in nasopharyngeal carcinoma]. hsa-mir-24 non-small cell lung cancer up Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer. hsa-mir-24 non-small cell lung cancer up Upregulation of miR-24 promotes cell proliferation by targeting NAIF1 in non-small cell lung cancer. hsa-mir-24 oral squamous cell carcinoma up miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. hsa-mir-24 oral squamous cell carcinoma up Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer. hsa-mir-24 osteosarcoma down MicroRNA-24 inhibits osteosarcoma cell proliferation both in vitro and in vivo by targeting LPAAT?. hsa-mir-24-2-5p breast cancer up c-MYC regulated miR-23a~24-2~27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2. hsa-mir-24-3p breast cancer up miRNA-24-3p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting p27Kip1. hsa-mir-24-3p colorectal cancer down Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior. hsa-mir-24-3p glioma up miR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1. hsa-mir-25 astrocytoma up miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL. hsa-mir-25 cervical carcinoma up [miR-25 promotes cell proliferation by targeting RECK in human cervical carcinoma HeLa cells]. hsa-mir-25 colon cancer down MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7. hsa-mir-25 colorectal cancer up Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. hsa-mir-25 colorectal cancer up The expression of miR-25 is increased in colorectal cancer and is associated with patient prognosis. hsa-mir-25 endometrial cancer up TSA Suppresses miR-106b-93-25 Cluster Expression through Downregulation of MYC and Inhibits Proliferation and Induces Apoptosis in Human EMC. hsa-mir-25 esophageal squamous cell carcinoma up MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma. hsa-mir-25 esophageal squamous cell carcinoma up Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma. hsa-mir-25 gastric cancer up MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival. hsa-mir-25 gastric cancer up miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-mir-25 gastric cancer up miR-25 promotes gastric cancer cells growth and motility by targeting RECK. hsa-mir-25 glioblastoma up miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL. hsa-mir-25 glioma up miR-25 promotes glioma cell proliferation by targeting CDKN1C. hsa-mir-25 head and neck squamous cell carcinoma up Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. hsa-mir-25 hepatocellular carcinoma up Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma. hsa-mir-25 hepatocellular carcinoma up Profiles of tissue microRNAs; miR-148b and miR-25 serve as potential prognostic biomarkers for hepatocellular carcinoma. hsa-mir-25 non-small cell lung cancer up Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42. hsa-mir-25 non-small cell lung cancer up miR-25 targets the modulator of apoptosis 1 gene in lung cancer. hsa-mir-25 ovarian cancer up MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer. hsa-mir-25 ovarian cancer up MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2. hsa-mir-25 prostate cancer down miR-25 Modulates Invasiveness and Dissemination of Human Prostate Cancer Cells via Regulation of ?v- and ?6-Integrin Expression. hsa-mir-25 small cell lung cancer up MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2. hsa-mir-26a acute myeloid leukemia down Critical Role of c-Myc in Acute Myeloid Leukemia Involving Direct Regulation of miR-26a and Histone Methyltransferase EZH2. hsa-mir-26a bladder cancer down miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1. hsa-mir-26a breast cancer down Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. hsa-mir-26a breast cancer down MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1. hsa-mir-26a breast cancer down MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer. hsa-mir-26a cholangiocarcinoma up MicroRNA-26a promotes cholangiocarcinoma growth by activating ?-catenin. hsa-mir-26a cholangiocarcinoma up MicroRNA-26a promotes cholangiocarcinoma growth by activating ?-catenin. hsa-mir-26a chronic myelogenous leukemia down ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance. hsa-mir-26a gastric cancer down miR-26a Suppresses Tumor Growth and Metastasis by Targeting FGF9 in Gastric Cancer. hsa-mir-26a glioma up MicroRNA-26a Promotes Tumor Growth and Angiogenesis in Glioma by Directly Targeting Prohibitin. hsa-mir-26a hepatocellular carcinoma down IL-6 upregulation contributes to the reduction of miR-26a expression in hepatocellular carcinoma cells. hsa-mir-26a hepatocellular carcinoma down MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting IL-6-Stat3 pathway. hsa-mir-26a hepatocellular carcinoma down MicroRNA-26a Inhibits Angiogenesis by Down-Regulating VEGFA through the PIK3C2?/Akt/HIF-1? Pathway in Hepatocellular Carcinoma. hsa-mir-26a hepatocellular carcinoma down MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting HGF-cmet pathway. hsa-mir-26a hepatocellular carcinoma down MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin. hsa-mir-26a hepatocellular carcinoma down Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways. hsa-mir-26a hepatocellular carcinoma down microRNA-26a suppresses recruitment of macrophages by down-regulating macrophage colony-stimulating factor expression through the PI3K/Akt pathway in hepatocellular carcinoma. hsa-mir-26a lung cancer down MicroRNA-26a/b Regulate DNA Replication Licensing, Tumorigenesis and Prognosis by Targeting CDC6 in Lung Cancer. hsa-mir-26a malignant melanoma down MicroRNA-26a Is Strongly Downregulated in Melanoma and Induces Cell Death through Repression of Silencer of Death Domains (SODD). hsa-mir-26a oral squamous cell carcinoma down MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways. hsa-mir-26a osteosarcoma down Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients. hsa-mir-26a ovarian cancer up MiR-26a promotes ovarian cancer proliferation and tumorigenesis. hsa-mir-26a papillary thyroid carcinoma down miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma. hsa-mir-26a primary thyroid lymphoma down A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears. hsa-mir-26a prostate cancer down MiR-26a inhibits prostate cancer progression by repression of Wnt5a. hsa-mir-26a prostate cancer down Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms. hsa-mir-26b b-cell lymphoma down Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies. hsa-mir-26b bladder cancer up Micro-RNA profiling in kidney and bladder cancers. hsa-mir-26b breast cancer down MiRNA-26b inhibits cellular proliferation by targeting CDK8 in breast cancer. hsa-mir-26b breast cancer down MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11. hsa-mir-26b breast cancer down MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer. hsa-mir-26b colorectal cancer down Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. hsa-mir-26b glioma down Role of microRNA-26b in glioma development and its mediated regulation on EphA2. hsa-mir-26b hepatocellular carcinoma down MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X. hsa-mir-26b hepatocellular carcinoma down MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2. hsa-mir-26b hepatocellular carcinoma down Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies. hsa-mir-26b lung cancer down MicroRNA-26a/b Regulate DNA Replication Licensing, Tumorigenesis and Prognosis by Targeting CDC6 in Lung Cancer. hsa-mir-26b non-small cell lung cancer down Down-regulation of microRNA-26b modulates non-small cell lung cancer cells chemoresistance and migration through the association of PTEN. hsa-mir-26b oral squamous cell carcinoma down MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways. hsa-mir-26b osteosarcoma down miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells. hsa-mir-26b osteosarcoma down MicroRNA-26b inhibits metastasis of osteosarcoma via targeting CTGF and Smad1. hsa-mir-26b prostate cancer down Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms. hsa-mir-27a acute leukemia down MiR-27a functions as a tumor suppressor in acute leukemia by regulating 14-3-3?. hsa-mir-27a breast cancer up c-MYC regulated miR-23a~24-2~27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2. hsa-mir-27a colorectal cancer down Tumor Suppressor MicroRNA-27a in Colorectal Carcinogenesis and Progression by Targeting SGPP1 and Smad2. hsa-mir-27a colorectal cancer up Novel evidence for curcumin and boswellic acid induced chemoprevention through regulation of miR-34a and miR-27a in colorectal cancer. hsa-mir-27a esophageal cancer up Differential expression of miRNAs in esophageal cancer tissue. hsa-mir-27a esophageal squamous cell carcinoma down microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS. hsa-mir-27a esophageal squamous cell carcinoma down MicroRNA-27a directly targets KRAS to inhibit cell proliferation in esophageal squamous cell carcinoma. hsa-mir-27a gastric adenocarcinoma up MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. hsa-mir-27a gastric cancer up Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells. hsa-mir-27a gastric cancer up miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition. hsa-mir-27a glioma up MiR-27a regulates Wnt/beta-catenin signaling through targeting SFRP1 in glioma. hsa-mir-27a glioma down Emerging role of microRNA-27a in human malignant glioma cell survival via targeting of prohibitin. hsa-mir-27a hepatocellular carcinoma up MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor ?. hsa-mir-27a laryngeal carcinoma up MicroRNA-27a promotes proliferation and suppresses apoptosis by targeting PLK2 in laryngeal carcinoma. hsa-mir-27a liver cancer up Adipose tissue-secreted miR-27a promotes liver cancer by targeting FOXO1 in obese individuals. hsa-mir-27a non-small cell lung cancer down Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. hsa-mir-27a osteosarcoma up Diagnostic and prognostic potentials of microRNA-27a in osteosarcoma. hsa-mir-27a osteosarcoma up MicroRNA-27a Promotes Proliferation, Migration and Invasion by Targeting MAP2K4 in Human Osteosarcoma Cells. hsa-mir-27a ovarian cancer up Oncogenic MicroRNA-27a is a Target for Genistein in Ovarian Cancer Cells. hsa-mir-27a ovarian cancer up MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance. hsa-mir-27a pancreatic cancer up Genistein Inhibits Cell Growth and Invasion Through Regulation of MiR-27a in Pancreatic Cancer Cells. hsa-mir-27a renal cell carcinoma up miR-27a promotes cell proliferation and metastasis in renal cell carcinoma. hsa-mir-27a small cell lung cancer down miR-27a regulates the self renewal of the H446 small cell lung cancer cell line in vitro. hsa-mir-27a squamous carcinoma up Unique MicroRNA Expression Profiles in Cervical Cancer. hsa-mir-27a* head and neck squamous cell carcinoma down Coordinated Targeting of the EGFR Signaling Axis by MicroRNA-27a* hsa-mir-27a-3p glioma up miR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1. hsa-mir-27b gastric cancer up miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition. hsa-mir-27b glioma up Expression and function of miR-27b in human glioma. hsa-mir-27b glioma up MicroRNA-27b inhibits Spry2 expression and promotes cell invasion in glioma U251 cells. hsa-mir-27b non-small cell lung cancer down MicroRNA-27b suppresses growth and invasion of NSCLC cells by targeting Sp1. hsa-mir-27b oral squamous cell carcinoma up Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer. hsa-mir-27b ovarian cancer up MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance. hsa-mir-28-3p colorectal cancer down Strand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer Cells. hsa-mir-28-3p esophageal cancer up Differential expression of miRNAs in esophageal cancer tissue. hsa-mir-28-5p colorectal cancer down Strand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer Cells. hsa-mir-28-5p renal cell carcinoma down A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma. hsa-mir-296-5p gastric cancer up MicroRNA-296-5p increases proliferation in gastric cancer through repression of Caudal-related homeobox 1. hsa-mir-29a acute myeloid leukemia up microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. hsa-mir-29a acute myeloid leukemia down MicroRNA29a regulates the expression of the nuclear oncogene Ski. hsa-mir-29a breast cancer up Next-generation sequencing of microRNAs for breast cancer detection. hsa-mir-29a breast cancer up microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer. hsa-mir-29a breast cancer down MicroRNA-29a inhibits cell migration and invasion by targeting Roundabout 1 in breast cancer cells. hsa-mir-29a cervical squamous cell carcinoma down Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma. hsa-mir-29a colorectal cancer up MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4. hsa-mir-29a colorectal cancer up Evaluation of microRNAs-29a, 92a and 145 in colorectal carcinoma as candidate diagnostic markers: An Egyptian pilot study. hsa-mir-29a colorectal cancer up microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers. hsa-mir-29a gastric cancer down Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines. hsa-mir-29a gastric cancer down MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer. hsa-mir-29a gastric cancer down miR-29a suppresses growth and invasion of gastric cancer cells in vitro by targeting VEGF-A. hsa-mir-29a gastric cancer down MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability. hsa-mir-29a gastric cancer down MicroRNA-29a inhibits cell migration and invasion via targeting Roundabout homolog 1 in gastric cancer cells. hsa-mir-29a head and neck squamous cell carcinoma down Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma. hsa-mir-29a hepatocellular carcinoma down microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma. hsa-mir-29a hepatocellular carcinoma down Negative feedback of miR-29 family TET1 involves in hepatocellular cancer. hsa-mir-29a hepatocellular carcinoma down Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer. hsa-mir-29a hepatocellular carcinoma down Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. hsa-mir-29a mantle cell lymphoma down microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. hsa-mir-29a mesenchymal cancer down miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR. hsa-mir-29a monocytic leukemia down Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia. hsa-mir-29a neuroblastoma down Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis. hsa-mir-29a non-small cell lung cancer down Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer. hsa-mir-29a oral squamous cell carcinoma down MicroRNA-29a upregulates MMP2 in oral squamous cell carcinoma to promote cancer invasion and anti-apoptosis. hsa-mir-29a-3p gastric cancer down Reduced miR-29a-3p expression is linked to the cell proliferation and cell migration in gastric cancer. hsa-mir-29b chronic lymphocytic leukemia down Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia. hsa-mir-29b colorectal cancer down miR-29b suppresses tumor growth and metastasis in colorectal cancer via downregulating Tiam1 expression and inhibiting epithelial-mesenchymal transition. hsa-mir-29b esophageal squamous cell carcinoma down miR-29b inhibits the progression of esophageal squamous cell carcinoma by targeting MMP-2. hsa-mir-29b gastric cancer down MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability. hsa-mir-29b gastric cancer down25428377 MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability. hsa-mir-29b gastric cancer down Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer. hsa-mir-29b glioblastoma down miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma. hsa-mir-29b glioblastoma down miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2. hsa-mir-29b glioblastoma down Genome-wide analysis of YB-1-RNA interactions reveals a novel role of YB-1 in miRNA processing in glioblastoma multiforme. hsa-mir-29b lung adenocarcinoma down MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma. hsa-mir-29b mantle cell lymphoma down microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. hsa-mir-29b monocytic leukemia down Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia. hsa-mir-29b non-small cell lung cancer down Preclinical rationale for combining an EGFR antibody with cisplatin/gemcitabine for the treatment of NSCLC. hsa-mir-29b non-small cell lung cancer down Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer. hsa-mir-29b non-small cell lung cancer down MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN. hsa-mir-29b osteosarcoma down MicroRNA signatures associate with pathogenesis and progression of osteosarcoma. hsa-mir-29b prostate cancer down miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling. hsa-mir-29b-1 breast cancer up microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer. hsa-mir-29b-1 gastric cancer down Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines. hsa-mir-29b-1 head and neck squamous cell carcinoma down Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma. hsa-mir-29b-1 hepatocellular carcinoma down Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. hsa-mir-29b-1 hepatocellular carcinoma down Negative feedback of miR-29 family TET1 involves in hepatocellular cancer. hsa-mir-29b-1 hepatocellular carcinoma down Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer. hsa-mir-29b-1 mesenchymal cancer down miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR. hsa-mir-29b-1-5p mesenchymal cancer down miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR. hsa-mir-29b-2 breast cancer up microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer. hsa-mir-29b-2 gastric cancer down Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines. hsa-mir-29b-2 head and neck squamous cell carcinoma down Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma. hsa-mir-29b-2 hepatocellular carcinoma down Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. hsa-mir-29b-2 hepatocellular carcinoma down Negative feedback of miR-29 family TET1 involves in hepatocellular cancer. hsa-mir-29b-2 hepatocellular carcinoma down Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer. hsa-mir-29b-2 mesenchymal cancer down miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR. hsa-mir-29c bladder cancer down Down-regulation of miR-29c in human bladder cancer and the inhibition of proliferation in T24 cell via PI3K-AKT pathway. hsa-mir-29c breast cancer up microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer. hsa-mir-29c esophageal squamous cell carcinoma down miR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression. hsa-mir-29c gastric cancer down Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines. hsa-mir-29c gastric cancer down Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer. hsa-mir-29c gastric cancer down The tumor suppressor microRNA-29c is downregulated and restored by celecoxib in human gastric cancer cells. hsa-mir-29c gastric cancer down MiR-29c is downregulated in gastric carcinomas and regulates cell proliferation by targeting RCC2. hsa-mir-29c gastric cancer down [Relationship between the expression level of miR-29c and biological behavior of gastric cancer]. hsa-mir-29c gastric cancer down MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1. hsa-mir-29c gastric cancer down MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability. hsa-mir-29c glioma down MiR-29c inhibits glioma cell proliferation, migration, invasion and angiogenesis. hsa-mir-29c head and neck squamous cell carcinoma down Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma. hsa-mir-29c hepatocellular carcinoma down Negative feedback of miR-29 family TET1 involves in hepatocellular cancer. hsa-mir-29c hepatocellular carcinoma down Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer. hsa-mir-29c hepatocellular carcinoma down A suppressive role of ionizing radiation-responsive miR-29c in the development of liver carcinoma via targeting WIP1. hsa-mir-29c hepatocellular carcinoma down Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. hsa-mir-29c hepatocellular carcinoma down PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells. hsa-mir-29c hepatocellular carcinoma down MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma. hsa-mir-29c lung cancer down miRNA-29c Suppresses Lung Cancer Cell Adhesion to Extracellular Matrix and Metastasis by Targeting Integrin ?1 and Matrix Metalloproteinase2 (MMP2). hsa-mir-29c mantle cell lymphoma down microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. hsa-mir-29c mesenchymal cancer down miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR. hsa-mir-29c nasopharyngeal cancer down Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma. hsa-mir-29c nasopharyngeal carcinoma down MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma. hsa-mir-29c non-small cell lung cancer down Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer. hsa-mir-29c non-small cell lung cancer up Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer. hsa-mir-29c non-small cell lung cancer up Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. hsa-mir-29c pancreatic cancer down miR-29c suppresses pancreatic cancer liver metastasis in an orthotopic implantation model in nude mice and affects survival in pancreatic cancer patients. hsa-mir-300 breast cancer down miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer. hsa-mir-300 head and neck squamous cell carcinoma down miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer. hsa-mir-300 osteosarcoma up Up-Regulation of MiR-300 Promotes Proliferation and Invasion of Osteosarcoma by Targeting BRD7. hsa-mir-300 osteosarcoma up Upregulation of miR-300 and downregulation of miR-125b act as potential predictor biomarkers in progression, metastasis, and poor prognosis of osteosarcoma. hsa-mir-301a colorectal cancer up MicroRNA-301a promotes migration and invasion by targeting TGFBR2 in human colorectal cancer. hsa-mir-301a colorectal cancer up MiR-301a promotes colorectal cancer cell growth and invasion by directly targeting SOCS6. hsa-mir-301a endometrial cancer down Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis. hsa-mir-301a gastric cancer up Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer. hsa-mir-301a gastric cancer up Abnormal expression of miR-301a in gastric cancer associated with progression and poor prognosis. hsa-mir-301a hepatocellular carcinoma up miR-301a Is a Candidate Oncogene that Targets the Homeobox Gene Gax in Human Hepatocellular Carcinoma. hsa-mir-301a pancreatic adenocarcinoma up miR-301a as an NF-?B activator in pancreatic cancer cells. hsa-mir-301a pancreatic cancer up miR-301a promotes pancreatic cancer cell proliferation by directly inhibiting Bim expression. hsa-mir-301a-3p pancreatic cancer up MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4. hsa-mir-301b endometrial cancer down Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis. hsa-mir-301b pancreatic carcinoma up MicroRNA-301b promotes cell invasiveness through targeting TP63 in pancreatic carcinoma cells. hsa-mir-302a colon cancer down MicroRNA-302a functions as a putative tumor suppressor in colon cancer by targeting Akt. hsa-mir-302a prostate cancer down MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer. hsa-mir-302b esophageal squamous cell carcinoma down miR-302b is a potential molecular marker of esophageal squamous cell carcinoma and functions as a tumor suppressor by targeting ErbB4. hsa-mir-302b gastric adenocarcinoma down Down-regulation of miR-302b, an ESC-specific microRNA, in Gastric Adenocarcinoma. hsa-mir-302b hepatocellular carcinoma down miR-302b suppresses cell invasion and metastasis by directly targeting AKT2 in human hepatocellular carcinoma cells. hsa-mir-302b hepatocellular carcinoma down MicroRNA-302b suppresses cell proliferation by targeting EGFR in human hepatocellular carcinoma SMMC-7721 cells. hsa-mir-302b hepatocellular carcinoma down miRNA-302b Suppresses Human Hepatocellular Carcinoma by Targeting AKT2. hsa-mir-302c hepatocellular carcinoma down MiR-302c inhibits tumor growth of hepatocellular carcinoma by suppressing the endothelial-mesenchymal transition of endothelial cells. hsa-mir-302f gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-30a breast cancer down MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin. hsa-mir-30a breast cancer down miR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2. hsa-mir-30a breast cancer down MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer. hsa-mir-30a breast cancer down Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer. hsa-mir-30a chondrosarcoma down Association of SOX4 regulated by tumor suppressor miR-30a with poor prognosis in low-grade chondrosarcoma. hsa-mir-30a colorectal carcinoma down miR-30a suppresses cell migration and invasion through downregulation of PIK3CD in colorectal carcinoma. hsa-mir-30a hepatocellular carcinoma down Effects of microRNA-30a on migration, invasion and prognosis of hepatocellular carcinoma. hsa-mir-30a non-small cell lung cancer down MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer. hsa-mir-30a non-small cell lung cancer down MiR-30a suppresses non-small cell lung cancer progression through AKT signaling pathway by targeting IGF1R. hsa-mir-30a non-small cell lung cancer down Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer. hsa-mir-30a prostate cancer down miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. hsa-mir-30a renal cell carcinoma down MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib. hsa-mir-30a-3p colorectal cancer down Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation. hsa-mir-30a-3p hepatocellular carcinoma down MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma. hsa-mir-30a-5p colon carcinoma down MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL. hsa-mir-30a-5p esophageal squamous cell carcinoma up Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. hsa-mir-30a-5p gastric cancer down miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-mir-30a-5p glioma up MiR-30a-5p is induced by Wnt/?-catenin pathway and promotes glioma cell invasion by repressing NCAM. hsa-mir-30a-5p glioma up Analysis of hsa-miR-30a-5p Expression in Human Gliomas. hsa-mir-30a-5p head and neck squamous cell carcinoma up Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. hsa-mir-30b colorectal cancer down MiR-30b regulates migration and invasion of human colorectal cancer via SIX1. hsa-mir-30b esophageal cancer down Differential expression of miRNAs in esophageal cancer tissue. hsa-mir-30b gastric cancer down MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer. hsa-mir-30b gastric cancer down miR-30b, Down-Regulated in Gastric Cancer, Promotes Apoptosis and Suppresses Tumor Growth by Targeting Plasminogen Activator Inhibitor-1. hsa-mir-30b medulloblastoma up Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma. hsa-mir-30b non-small cell lung cancer down MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18. hsa-mir-30b prostate cancer down miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. hsa-mir-30b-5p pancreatic ductal adenocarcinoma up Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas. hsa-mir-30c acute myeloid leukemia down Transcription factor C/EBP?-induced microRNA-30c inactivates Notch1 during granulopoiesis and is downregulated in acute myeloid leukemia. hsa-mir-30c endometrial cancer down microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1. hsa-mir-30c endometrial cancer down Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancer. hsa-mir-30c non-small cell lung cancer down Low expression of microRNA-30c promotes invasion by inducing epithelial mesenchymal transition in non-small cell lung cancer. hsa-mir-30c non-small cell lung cancer down MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18. hsa-mir-30c renal cell carcinoma down Hypoxia-induced downregulation of miR-30c promotes epithelial-mesenchymal transition in human renal cell carcinoma. hsa-mir-30c-1 prostate cancer down miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. hsa-mir-30c-2 prostate cancer down miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. hsa-mir-30d hepatocellular carcinoma up MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. hsa-mir-30d lung cancer up Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients. hsa-mir-30d medulloblastoma up Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma. hsa-mir-30d non-small cell lung cancer down Clinical evaluation of microRNA expression profiling in non small cell lung cancer. hsa-mir-30d prostate cancer down miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. hsa-mir-30d prostate cancer down Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1. hsa-mir-30d renal cell carcinoma down Proliferation inhibition and the underlying molecular mechanisms of microRNA-30d in renal carcinoma cells. hsa-mir-30d-5p non-small cell lung cancer down MicroRNA-30d-5p inhibits tumour cell proliferation and motility by directly targeting CCNE2 in non-small cell lung cancer. hsa-mir-30e chronic myelogenous leukemia down MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL protein. hsa-mir-30e glioma up Ionizing radiation-inducible miR-30e promotes glioma cell invasion through EGFR stabilization by directly targeting CBL-B. hsa-mir-30e prostate cancer down miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. hsa-mir-30e* glioma up MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-?B/I?B? negative feedback loop. hsa-mir-30e-5p non-small cell lung cancer down Clinical evaluation of microRNA expression profiling in non small cell lung cancer. hsa-mir-31 breast cancer down Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis. hsa-mir-31 breast cancer down miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. hsa-mir-31 cervical cancer up MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A. hsa-mir-31 cervical cancer up miR-31 functions as an oncogene in cervical cancer. hsa-mir-31 chordoma down MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas. hsa-mir-31 chronic myelogenous leukemia down Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells. hsa-mir-31 colon cancer up The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer. hsa-mir-31 colorectal cancer up Elevated microRNA-31 expression regulates colorectal cancer progression by repressing its target gene SATB2. hsa-mir-31 colorectal cancer up Identification of microRNA-135b in Stool as a Potential Noninvasive Biomarker for Colorectal Cancer and Adenoma. hsa-mir-31 colorectal cancer up Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. hsa-mir-31 colorectal cancer up SATB1 and 2 in colorectal cancer. hsa-mir-31 colorectal cancer up Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. hsa-mir-31 colorectal cancer up The potential role of microRNA-31 expression in early colorectal cancer. hsa-mir-31 colorectal cancer up MicroRNA signatures: novel biomarker for colorectal cancer? hsa-mir-31 colorectal cancer up Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer. hsa-mir-31 esophageal cancer up Differential expression of miRNAs in esophageal cancer tissue. hsa-mir-31 esophageal squamous cell carcinoma up The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. hsa-mir-31 gastric cancer down Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance. hsa-mir-31 glioblastoma down Human miR-31 targets radixin and inhibits migration and invasion of glioma cells. hsa-mir-31 glioblastoma down Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III. hsa-mir-31 head and neck squamous cell carcinoma up Co-targeting of multiple microRNAs on factor-inhibiting hypoxia-inducible factor (FIH) gene for the pathogenesis of head and neck carcinomas. hsa-mir-31 hepatocellular carcinoma up Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno hsa-mir-31 intrahepatic cholangiocarcinoma up miR-31 promotes oncogenesis in intrahepatic cholangiocarcinoma cells via the direct suppression of RASA1. hsa-mir-31 liver cancer down MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer. hsa-mir-31 lung adenocarcinoma up MicroRNA-31 Predicts the Presence of Lymph Node Metastases and Survival in Patients with Lung Adenocarcinoma. hsa-mir-31 lung adenocarcinoma down MicroRNA-31 inhibits lung adenocarcinoma stem-like cells via down-regulation of MET-PI3K-Akt signaling pathway. hsa-mir-31 malignant melanoma down Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma. hsa-mir-31 malignant melanoma down Regulation of cancer aggressive features in melanoma cells by microRNAs. hsa-mir-31 medulloblastoma down MicroRNA-31 suppresses medulloblastoma cell growth by inhibiting DNA replication through minichromosome maintenance 2. hsa-mir-31 non-small cell lung cancer up Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application. hsa-mir-31 oral carcinoma up Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma. hsa-mir-31 oral carcinoma up Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma. hsa-mir-31 oral squamous cell carcinoma up miR-31 is up-regulated in oral premalignant epithelium and contributes to the immortalization of normal oral keratinocytes. hsa-mir-31 oral squamous cell carcinoma up EGF up-regulates miR-31 through the C/EBP? signal cascade in oral carcinoma. hsa-mir-31 pancreatic ductal adenocarcinoma up Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas. hsa-mir-31 prostate cancer up Screening Biomarkers of Prostate Cancer by Integrating microRNA and mRNA Microarrays. hsa-mir-31 prostate cancer down Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31. hsa-mir-31 prostate cancer down Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells. hsa-mir-3127 hepatocellular carcinoma up MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation. hsa-mir-3189-3p astrocytoma down Anti-Tumoral Effects of miR-3189-3p in Glioblastoma. hsa-mir-3189-3p glioblastoma down Anti-Tumoral Effects of miR-3189-3p in Glioblastoma. hsa-mir-32 acute myeloid leukemia up MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis. hsa-mir-32 colorectal cancer up The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer. hsa-mir-32 hepatocellular carcinoma up MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN. hsa-mir-32 non-small cell lung cancer down Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival. hsa-mir-32 non-small cell lung cancer down Tanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer. hsa-mir-32 non-small cell lung cancer down miR-32 functions as a tumor suppressor and directly targets SOX9 in human non-small cell lung cancer. hsa-mir-32 oral squamous cell carcinoma down MiR-32 functions as a tumor suppressor and directly targets EZH2 in human oral squamous cell carcinoma. hsa-mir-32 osteosarcoma down MicroRNA-32 inhibits osteosarcoma cell proliferation and invasion by targeting Sox9. hsa-mir-320 colon cancer down miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1. hsa-mir-320 glioblastoma down miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients. hsa-mir-320 glioma down MicroRNA-320 inhibits cell proliferation in glioma by targeting E2F1. hsa-mir-320 osteosarcoma down MicroRNA-320 inhibits osteosarcoma cells proliferation by directly targeting fatty acid synthase. hsa-mir-320a colon cancer down MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting ?-catenin. hsa-mir-320a colorectal cancer down miR-320a suppresses colorectal cancer progression by targeting Rac1. hsa-mir-320a colorectal cancer down [Corrigendum] microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer. hsa-mir-320a colorectal cancer down Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma. hsa-mir-320a colorectal cancer down microRNA-320a inhibits tumor invasion by targeting neuropilin?1 and is associated with liver metastasis in colorectal cancer. hsa-mir-320a glioblastoma down MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R. hsa-mir-320a nasopharyngeal carcinoma down MicroRNA-320a inhibits cell proliferation, migration and invasion by targeting BMI-1 in nasopharyngeal carcinoma. hsa-mir-320a osteosarcoma up Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma. hsa-mir-320b colorectal cancer up MicroRNA-320b promotes colorectal cancer proliferation and invasion by competing with its homologous microRNA-320a. hsa-mir-320c bladder cancer down MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6. hsa-mir-323 prostate cancer down MiR-323 Inhibits Prostate Cancer Vascularization Through Adiponectin Receptor. hsa-mir-323-5p oral squamous cell carcinoma down Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer. hsa-mir-324-3p nasopharyngeal carcinoma down MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B. hsa-mir-324-3p nasopharyngeal carcinoma down [The expression and significance of miRNA-324-3p and WNT2B in nasopharyngeal carcinoma]. hsa-mir-324-5p hepatocellular carcinoma down MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1. hsa-mir-325 hepatocellular carcinoma down The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1. hsa-mir-326 chronic myelogenous leukemia down Targeting of the signal transducer Smo links microRNA-326 to the oncogenic Hedgehog pathway in CD34(+) CML stem/progenitor cells. hsa-mir-326 colorectal cancer up MicroRNA-326 functions as a tumor suppressor in colorectal cancer by targeting the nin one binding protein. hsa-mir-326 glioblastoma down Expression and clinical significance of microRNA-326 in human glioma miR-326 expression in glioma. hsa-mir-326 glioma down Targeting the SMO oncogene by miR-326 inhibits glioma biological behaviors and stemness. hsa-mir-326 glioma down Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326. hsa-mir-326 glioma down The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors. hsa-mir-326 glioma down MicroRNA-326 functions as a tumor suppressor in glioma by targeting the Nin one binding protein (NOB1). hsa-mir-328 acute myeloid leukemia down Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia. hsa-mir-328 colorectal cancer down MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer. hsa-mir-328 gastric cancer down Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation. hsa-mir-328 glioma up MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation. hsa-mir-328 glioma down microRNA-328 is a favorable prognostic marker in human glioma via suppressing invasive and proliferative phenotypes of malignant cells. hsa-mir-328 non-small cell lung cancer up Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC. hsa-mir-329 breast cancer down Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer. hsa-mir-329 gastric cancer down By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth. hsa-mir-329 oral squamous cell carcinoma down Downregulated miR-329 and miR-410 promote the proliferation and invasion of oral squamous cell carcinoma by targeting Wnt-7b. hsa-mir-330 glioblastoma down Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III. hsa-mir-330 prostate cancer down MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation. hsa-mir-330 prostate cancer down microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells. hsa-mir-330-3p esophageal squamous cell carcinoma up MicroRNA-330-3p functions as an oncogene in human esophageal cancer by targeting programmed cell death 4. hsa-mir-330-3p non-small cell lung cancer up miR-330-3p controls cell proliferation by targeting early growth response 2 in non-small-cell lung cancer. hsa-mir-331 acute myeloid leukemia up Expression of microRNA-331 can be used as a predictor for response to therapy and survival in acute myeloid leukemia patients. hsa-mir-331-3p gastric cancer down miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer. hsa-mir-331-3p glioblastoma down miR-331-3p regulates expression of neuropilin-2 in glioblastoma. hsa-mir-331-3p hepatocellular carcinoma up Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma. hsa-mir-331-3p hepatocellular carcinoma up Hsa-miR-331-3p inhibits VHL expression by directly targeting its mRNA 3'-UTR in HCC cell lines. hsa-mir-331-3p prostate cancer down miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer. hsa-mir-331-3p prostate cancer down Regulation of Expression of Deoxyhypusine Hydroxylase (DOHH), the Enzyme That Catalyzes the Activation of eIF5A, by miR-331-3p and miR-642-5p in Prostate Cancer Cells. hsa-mir-335 adrenal cortical carcinoma down miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer. hsa-mir-335 astrocytoma up Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells. hsa-mir-335 breast cancer down Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. hsa-mir-335 breast cancer down MiR-335 inhibits migration of breast cancer cells through targeting oncoprotein c-Met. hsa-mir-335 breast cancer down MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. hsa-mir-335 cervical cancer down MicroRNA-335 represents an independent prognostic marker in cervical cancer. hsa-mir-335 chondrosarcoma down Analysis of microRNAs expressions in chondrosarcoma. hsa-mir-335 glioma up Tumor microRNA-335 expression is associated with poor prognosis in human glioma. hsa-mir-335 hepatocellular carcinoma down Epigenetic silencing of miR-335 and its host gene MEST in hepatocellular carcinoma. hsa-mir-335 hepatocellular carcinoma down MiR-335 acts as a potential tumor suppressor miRNA via downregulating ROCK1 expression in hepatocellular carcinoma. hsa-mir-335 meningioma up miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas. hsa-mir-335 mesenchymal cancer down MicroRNA Expression Profiles in Kaposi's Sarcoma. hsa-mir-335 neuroblastoma down MiRNA-335 Suppresses Neuroblastoma Cell Invasiveness By Direct Targeting of Multiple Genes from the non-Canonical TGF-? Signalling Pathway. hsa-mir-335 non-small cell lung cancer down Effect of miR-335 upregulation on the apoptosis and invasion of lung cancer cell A549 and H1299. hsa-mir-335 osteosarcoma down miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells. hsa-mir-335 ovarian cancer down miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w. hsa-mir-335 ovarian cancer down Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research. hsa-mir-335 pancreatic cancer down miR-335 functions as a tumor suppressor in pancreatic cancer by targeting OCT4. hsa-mir-335 primary gallbladder carcinoma down Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma. hsa-mir-335 renal clear cell carcinoma down miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. hsa-mir-335-5p gastric cancer down The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis. hsa-mir-337 pancreatic ductal adenocarcinoma down miR-337 regulates the proliferation and invasion in pancreatic ductal adenocarcinoma by targeting HOXB7. hsa-mir-337-3p gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-337-3p neuroblastoma down miRNA-337-3p suppresses neuroblastoma progression by repressing the transcription of matrix metalloproteinase 14. hsa-mir-338 gastric cancer down MicroRNA-338 Inhibits Growth, Invasion and Metastasis of Gastric Cancer by Targeting NRP1 Expression. hsa-mir-338 nasopharyngeal carcinoma down MicroRNA-338 inhibits migration and proliferation by targeting hypoxia-induced factor 1? in nasopharyngeal carcinoma. hsa-mir-338 oral squamous cell carcinoma down miR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1. hsa-mir-338-3p colorectal cancer down Relationship between miRNA-338-3p expression and progression and prognosis of human colorectal carcinoma. hsa-mir-338-3p colorectal carcinoma down MicroRNA-338-3p Inhibits Colorectal Carcinoma Cell Invasion and Migration by Targeting Smoothened. hsa-mir-338-3p gastric cancer down Epigenetic silencing of miR-338-3p contributes to tumorigenicity in gastric cancer by targeting SSX2IP. hsa-mir-338-3p gastric cancer down miR-338-3p Suppresses Gastric Cancer Progression through a PTEN-AKT Axis by Targeting P-REX2a. hsa-mir-338-3p gastric cancer down MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling. hsa-mir-338-3p hepatocellular carcinoma down miR-338-3p Is Down-Regulated by Hepatitis B Virus X and Inhibits Cell Proliferation by Targeting the 3'-UTR Region of CyclinD1. hsa-mir-338-3p hepatocellular carcinoma down MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1?. hsa-mir-338-3p hepatocellular carcinoma down MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4). hsa-mir-338-3p liver cancer down miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened. hsa-mir-338-3p neuroblastoma down miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a. hsa-mir-338-3p non-small cell lung cancer down microRNA-338-3p functions as a tumor suppressor in human non?small?cell lung carcinoma and targets Ras-related protein 14. hsa-mir-339 non-small cell lung cancer up Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC. hsa-mir-339-5p breast cancer down MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis. hsa-mir-339-5p hepatocellular carcinoma down Effects of miR-339-5p on invasion and prognosis of hepatocellular carcinoma. hsa-mir-339-5p papillary thyroid carcinoma up microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake. hsa-mir-33a glioma up miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways. hsa-mir-33a hepatocellular carcinoma down Aflatoxin B1 Negatively Regulates Wnt/?-Catenin Signaling Pathway through Activating miR-33a. hsa-mir-33a lung cancer down MicroRNA-33a inhibits lung cancer cell proliferation and invasion by regulating the expression of ?-catenin. hsa-mir-33a lung cancer down MircoRNA-33a inhibits epithelial-to-mesenchymal transition and metastasis and could be a prognostic marker in non-small cell lung cancer. hsa-mir-33a malignant melanoma down miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1?. hsa-mir-33a pancreatic cancer down miR-33a suppresses the nuclear translocation of ?-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells. hsa-mir-33b breast cancer down MicroRNA-33b Inhibits Breast Cancer Metastasis by Targeting HMGA2, SALL4 and Twist1. hsa-mir-33b colorectal cancer down MicroRNA-33b inhibits tumor cell growth and is associated with prognosis in colorectal cancer patients. hsa-mir-33b osteosarcoma down MicroRNA-33b suppresses migration and invasion by targeting c-Myc in osteosarcoma cells. hsa-mir-340 esophageal squamous cell carcinoma down MicroRNA-340 Inhibits Esophageal Cancer Cell Growth and Invasion by Targeting Phosphoserine Aminotransferase 1. hsa-mir-340 glioblastoma up miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients. hsa-mir-340 glioblastoma down miR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2. hsa-mir-340 glioblastoma down miR-340 suppresses glioblastoma multiforme. hsa-mir-340 non-small cell lung cancer down miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer. hsa-mir-340 osteosarcoma down MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1. hsa-mir-340* gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-342 acute promyelocytic leukemia down A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes. hsa-mir-342 colorectal cancer down MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. hsa-mir-342 glioblastoma down Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation. hsa-mir-342-3p cervical cancer down miR-342-3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer. hsa-mir-342-3p non-small cell lung cancer down miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells. hsa-mir-345 colorectal cancer down MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. hsa-mir-345 oral squamous cell carcinoma up Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia. hsa-mir-345 prostate cancer down MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer. hsa-mir-346 follicular thyroid carcinoma up A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. hsa-mir-346 ovarian cancer up MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance. hsa-mir-34a b-cell lymphoma down The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells. hsa-mir-34a bladder cancer down MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44. hsa-mir-34a breast cancer down Targeted Expression of miR-34a Using the T-VISA System Suppresses Breast Cancer Cell Growth and Invasion. hsa-mir-34a breast cancer down MicroRNA-34a Suppresses Cell Proliferation by Targeting LMTK3 in Human Breast Cancer MCF-7 Cell Line. hsa-mir-34a breast cancer down MicroRNA-34a suppresses the breast cancer stem cell-like characteristics by downregulating Notch1 pathway. hsa-mir-34a breast cancer down Circulating miR-34a levels are reduced in colorectal cancer. hsa-mir-34a breast cancer down MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. hsa-mir-34a cervical carcinoma down MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. hsa-mir-34a cholangiocarcinoma down microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway. hsa-mir-34a chordoma down MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET. hsa-mir-34a choriocarcinoma down MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. hsa-mir-34a choriocarcinoma down MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1. hsa-mir-34a clear cell renal cell cancer up The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels. hsa-mir-34a colon cancer down Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF. hsa-mir-34a colon cancer down MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. hsa-mir-34a colorectal cancer down Novel evidence for curcumin and boswellic acid induced chemoprevention through regulation of miR-34a and miR-27a in colorectal cancer. hsa-mir-34a colorectal cancer down MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer. hsa-mir-34a colorectal cancer down Circulating miR-34a levels are reduced in colorectal cancer. hsa-mir-34a colorectal cancer down Dysregulation of MicroRNA-34a Expression in Colorectal Cancer Inhibits the Phosphorylation of FAK Via VEGF. hsa-mir-34a endometrial cancer down Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma. hsa-mir-34a esophageal squamous cell carcinoma down miR-34a inhibits the migration and invasion of esophageal squamous cell carcinoma by targeting Yin Yang-1. hsa-mir-34a extrahepatic cholangiocarcinoma down microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway. hsa-mir-34a gastric cancer down Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a. hsa-mir-34a gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-34a gastric cancer down The prognostic value of miR-34a expression in completely resected gastric cancer: tumor recurrence and overall survival. hsa-mir-34a gastric cancer down Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells. hsa-mir-34a gastric cancer down Evaluation of MicroRNA Expression Pattern of Gastric Adenocarcinoma Associated with Socioeconomic, Environmental and Lifestyle Factors in Northwestern Hungary. hsa-mir-34a gastric cancer down microRNA-34a Inhibits the Growth, Invasion and Metastasis of Gastric Cancer by Targeting PDGFR and MET Expression. hsa-mir-34a gastric cancer down MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in gastric cancer. hsa-mir-34a glioblastoma down MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. hsa-mir-34a glioblastoma down MicroRNA-34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme. hsa-mir-34a glioblastoma down miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme. hsa-mir-34a glioma down MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. hsa-mir-34a glioma down microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. hsa-mir-34a glioma down MicroRNA-34a induces apoptosis in the human glioma cell line, A172, through enhanced ROS production and NOX2 expression. hsa-mir-34a head and neck squamous cell carcinoma down Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis. hsa-mir-34a hepatocellular carcinoma down Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer. hsa-mir-34a hepatocellular carcinoma down miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. hsa-mir-34a hepatocellular carcinoma down Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model. hsa-mir-34a hepatocellular carcinoma down Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET. hsa-mir-34a hepatocellular carcinoma down MicroRNA-34a Targets Bcl-2 and Sensitizes Human Hepatocellular Carcinoma Cells to Sorafenib Treatment. hsa-mir-34a lung cancer down Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. hsa-mir-34a malignant melanoma down MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. hsa-mir-34a malignant melanoma down Regulation of cancer aggressive features in melanoma cells by microRNAs. hsa-mir-34a malignant melanoma down Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene. hsa-mir-34a malignant melanoma down Identification of FLOT2 as a novel target for microRNA-34a in melanoma. hsa-mir-34a neuroblastoma down MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. hsa-mir-34a neuroblastoma down A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. hsa-mir-34a non-small cell lung cancer down Restoration of p53/miR-34a regulatory axis decreases survival advantage and ensures Bax-dependent apoptosis of non-small cell lung carcinoma cells. hsa-mir-34a non-small cell lung cancer down The microRNA miR-34a Inhibits Non-Small Cell Lung Cancer (NSCLC) Growth and the CD44hi Stem-Like NSCLC Cells. hsa-mir-34a non-small cell lung cancer up Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer. hsa-mir-34a oral cancer down MiR-34a inhibits oral cancer progression partially by repression of interleukin-6-receptor. hsa-mir-34a osteosarcoma down MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether à go-go 1 expression. hsa-mir-34a osteosarcoma down Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements. hsa-mir-34a osteosarcoma down MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo. hsa-mir-34a ovarian cancer down Frequent downregulation of miR-34 family in human ovarian cancers. hsa-mir-34a ovarian cancer down MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL. hsa-mir-34a pancreatic cancer down MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. hsa-mir-34a pancreatic cancer down Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells. hsa-mir-34a pancreatic ductal adenocarcinoma up MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma. hsa-mir-34a papillary thyroid carcinoma up MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway. hsa-mir-34a prostate cancer down Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. hsa-mir-34a prostate cancer down The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. hsa-mir-34a prostate cancer down MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells. hsa-mir-34a prostate cancer down LEF1 Targeting EMT in Prostate Cancer Invasion is Regulated by miR-34a. hsa-mir-34a rectal cancer up The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer. hsa-mir-34a renal cell carcinoma down MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma. hsa-mir-34a renal cell carcinoma down Tumor suppressor microRNA-34a inhibits cell proliferation by targeting Notch1 in renal cell carcinoma. hsa-mir-34a renal cell carcinoma down MicroRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cell. hsa-mir-34a retinoblastoma down Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells. hsa-mir-34a squamous carcinoma up Unique MicroRNA Expression Profiles in Cervical Cancer. hsa-mir-34a uveal melanoma down MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. hsa-mir-34a-5p colorectal cancer down miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer. hsa-mir-34b breast cancer down MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. hsa-mir-34b breast cancer down The Regulation and Function of miR-21-FOXO3a-miR-34b/c Signaling in Breast Cancer. hsa-mir-34b chronic lymphocytic leukemia down Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia. hsa-mir-34b endometrial serous adenocarcinoma down MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma. hsa-mir-34b gastric cancer down Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. hsa-mir-34b hepatocellular carcinoma down Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer. hsa-mir-34b lung cancer down Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. hsa-mir-34b non-small cell lung cancer down MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met. hsa-mir-34b osteosarcoma down Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements. hsa-mir-34b ovarian cancer down Frequent downregulation of miR-34 family in human ovarian cancers. hsa-mir-34b ovarian carcinoma down MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. hsa-mir-34b pancreatic cancer down MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. hsa-mir-34b pancreatic cancer down MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3. hsa-mir-34b papillary thyroid carcinoma down MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma. hsa-mir-34b prostate cancer down miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways. hsa-mir-34b uveal melanoma down MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets. hsa-mir-34c breast cancer down Expression of miR-34c induces G2/M cell cycle arrest in breast cancer cells. hsa-mir-34c breast cancer down The Regulation and Function of miR-21-FOXO3a-miR-34b/c Signaling in Breast Cancer. hsa-mir-34c breast cancer down MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. hsa-mir-34c chronic lymphocytic leukemia down Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia. hsa-mir-34c colon cancer down Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF. hsa-mir-34c endometrial cancer down miR-34c plays a role of tumor suppressor in HEC?1-B cells by targeting E2F3 protein. hsa-mir-34c endometrial cancer down MiR-34c oligonucleotide enhances chemosensitivity of Ishikawa cell to cisplatin by inducing apoptosis. hsa-mir-34c gastric cancer down Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel. hsa-mir-34c lung cancer down Uncovering growth-suppressive MicroRNAs in lung cancer. hsa-mir-34c lung cancer down Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. hsa-mir-34c malignant melanoma down Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene. hsa-mir-34c nasopharyngeal carcinoma down MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET. hsa-mir-34c osteosarcoma down MiR-34c inhibits osteosarcoma metastasis and chemoresistance. hsa-mir-34c osteosarcoma down Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements. hsa-mir-34c ovarian cancer down Frequent downregulation of miR-34 family in human ovarian cancers. hsa-mir-34c ovarian carcinoma down MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. hsa-mir-34c pancreatic cancer down MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. hsa-mir-34c prostate cancer down miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions. hsa-mir-34c uveal melanoma down MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets. hsa-mir-34c-3p glioma down Differential effects of miR-34c-3p and miR-34c-5p on the proliferation, apoptosis and invasion of glioma cells. hsa-mir-34c-3p non-small cell lung cancer down MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway. hsa-mir-34c-5p glioma down Differential effects of miR-34c-3p and miR-34c-5p on the proliferation, apoptosis and invasion of glioma cells. hsa-mir-361-3p non-small cell lung cancer down Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors. hsa-mir-361-5p colorectal cancer down MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1. hsa-mir-361-5p gastric cancer down MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1. hsa-mir-362 renal cell carcinoma up A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma. hsa-mir-362-3p breast cancer down Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer. hsa-mir-362-3p gastric cancer up Erratum to: Anti-miR-362-3p Inhibits Migration and Invasion of Human Gastric Cancer Cells by Its Target CD82. hsa-mir-362-3p gastric cancer up Anti-miR-362-3p Inhibits Migration and Invasion of Human Gastric Cancer Cells by Its Target CD82. hsa-mir-362-3p hepatocellular carcinoma up Upregulation of miR-362-3p modulates proliferation and anchorage-independent growth by directly targeting Tob2 in hepatocellular carcinoma. hsa-mir-362-5p hepatocellular carcinoma up MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma. hsa-mir-362-5p neuroblastoma down miR-362-5p inhibits proliferation and migration of neuroblastoma cells by targeting phosphatidylinositol 3-kinase-C2?. hsa-mir-363 head and neck squamous cell carcinoma down Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin. hsa-mir-363 hepatocellular carcinoma down Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1. hsa-mir-363-3p gastric cancer down Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer. hsa-mir-365 colon cancer down microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2. hsa-mir-365 hepatocellular carcinoma down Prognostic significance and anti-proliferation effect of microRNA-365 in hepatocellular carcinoma. hsa-mir-365 lung cancer down MicroRNA-365 regulates NKX2-1, a key mediator of lung cancer. hsa-mir-365 malignant melanoma down MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression. hsa-mir-365 non-small cell lung cancer down Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer. hsa-mir-365 non-small cell lung cancer down Associations of deregulation of mir-365 and its target mRNA TTF-1 and survival in patients with NSCLC. hsa-mir-365b-3p retinoblastoma down MiR-365b-3p, down-regulated in retinoblastoma, regulates cell cycle progression and apoptosis of human retinoblastoma cells by targeting PAX6. hsa-mir-3662 lung cancer up Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers. hsa-mir-367 gastric cancer down The microRNA-367 Inhibits the Invasion and Metastasis of Gastric Cancer by Directly Repressing Rab23. hsa-mir-367 medulloblastoma up miR-367 promotes proliferation and stem-like traits in medulloblastoma cells. hsa-mir-367 pancreatic cancer up miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-? signalling pathway. hsa-mir-369-5p pancreatic ductal adenocarcinoma up Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas. hsa-mir-370 acute myeloid leukemia up Integration of SNP and mRNA arrays with microRNA profiling reveals that MiR-370 is upregulated and targets NF1 in acute myeloid leukemia. hsa-mir-370 bladder cancer down Up-regulation of p21(WAF1/CIP1) by miRNAs and its implications in bladder cancer cells. hsa-mir-370 gastric cancer up Overexpression of miR-370 and downregulation of its novel target TGF?-RII contribute to the progression of gastric carcinoma. hsa-mir-370 gastric cancer up Upregulation of miR-370 contributes to the progression of gastric carcinoma via suppression of FOXO1. hsa-mir-370 hepatocellular carcinoma down Perturbation of miR-370-LIN28A-NF-?B regulatory circuit contributes to the development of hepatocellular carcinoma. hsa-mir-370 laryngeal squamous cell carcinoma down miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC). hsa-mir-370 non-small cell lung cancer down MicroRNA-370 inhibits the progression of non-small cell lung cancer by downregulating oncogene TRAF4. hsa-mir-370 oral squamous cell carcinoma down miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma. hsa-mir-371-5p hepatocellular carcinoma up miR-371-5p down-regulates pre mRNA processing factor 4 homolog B (PRPF4B) and facilitates the G1/S transition in human hepatocellular carcinoma cells. hsa-mir-372 cervical cancer down MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis. hsa-mir-372 colorectal cancer up Serum miR-372 is a diagnostic and prognostic biomarker in patients with early colorectal cancer. hsa-mir-372 epithelial ovarian cancer up Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells. hsa-mir-372 glioma up Correlation of microrna-372 upregulation with poor prognosis in human glioma. hsa-mir-372 head and neck squamous cell carcinoma up miR-372 inhibits p62 in head and neck squamous cell carcinoma in vitro and in vivo. hsa-mir-372 hepatocellular carcinoma up Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma. hsa-mir-372 hepatocellular carcinoma down miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis. hsa-mir-372 oral squamous cell carcinoma up Upregulation of miR-372 and -373 associates with lymph node metastasis and poor prognosis of oral carcinomas. hsa-mir-372 renal cell carcinoma down miR-372 suppresses tumour proliferation and invasion by targeting IGF2BP1 in renal cell carcinoma. hsa-mir-373 breast cancer up The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. hsa-mir-373 breast cancer up MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1?-TWIST signaling axis in breast cancer. hsa-mir-373 breast cancer up Epigenetic Silencing of ITGA2 by MiR-373 Promotes Cell Migration in Breast Cancer. hsa-mir-373 cervical carcinoma up MicroRNA-373 functions as an oncogene and targets YOD1 gene in cervical cancer. hsa-mir-373 colon cancer down Epigenetic silencing of microRNA-373 plays an important role in regulating cell proliferation in colon cancer. hsa-mir-373 epithelial ovarian cancer up Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells. hsa-mir-373 esophageal squamous cell carcinoma up MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer. hsa-mir-373 gastric adenocarcinoma up MicroRNA-373 is upregulated and targets TNFAIP1 in human gastric cancer, contributing to tumorigenesis. hsa-mir-373 hepatocellular carcinoma up MicroRNA-373, a new regulator of protein phosphatase?6, functions as an oncogene in hepatocellular carcinoma. hsa-mir-373 non-small cell lung cancer down Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes. hsa-mir-373 oral squamous cell carcinoma up Upregulation of miR-372 and -373 associates with lymph node metastasis and poor prognosis of oral carcinomas. hsa-mir-373 pancreatic cancer down Micro RNA-373 is Down-regulated in Pancreatic Cancer and Inhibits Cancer Cell Invasion. hsa-mir-374a breast cancer down Effects of Differential Distribution of Microvessel Density, Possibly Regulated by miR-374a, on Breast Cancer Prognosis. hsa-mir-374a esophageal cancer up MicroRNA-374a promotes esophageal cancer cell proliferation via Axin2 suppression. hsa-mir-374a gastric cancer up miR-374a promotes cell proliferation, migration and invasion by targeting SRCIN1 in gastric cancer. hsa-mir-374a-5p osteosarcoma up Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma. hsa-mir-374b prostate cancer down Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients. hsa-mir-374b t-cell lymphoblastic lymphoma down MicroRNA-374b suppresses proliferation and promotes apoptosis in T-cell lymphoblastic lymphoma by repressing AKT1 and Wnt-16. hsa-mir-375 cervical squamous cell carcinoma down miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. hsa-mir-375 colorectal cancer down Identification and functional screening of microRNAs highly deregulated in colorectal cancer. hsa-mir-375 colorectal cancer down MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA. hsa-mir-375 colorectal cancer down Expression levels of microRNA-375 in colorectal carcinoma. hsa-mir-375 esophageal cancer down Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer. hsa-mir-375 esophageal cancer down The expression of miR-21 and miR-375 predict prognosis of esophageal cancer. hsa-mir-375 esophageal squamous cell carcinoma down Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. hsa-mir-375 esophageal squamous cell carcinoma down Cell-specific detection of miR-375 downregulation for predicting the prognosis of esophageal squamous cell carcinoma by miRNA in situ hybridization. hsa-mir-375 esophageal squamous cell carcinoma down Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma. hsa-mir-375 gastric cancer down MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. hsa-mir-375 gastric cancer down MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. hsa-mir-375 gastric cancer down miR-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expression. hsa-mir-375 gastric cancer down Snail-regulated MiR-375 inhibits migration and invasion of gastric cancer cells by targeting JAK2. hsa-mir-375 glioma down Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma. hsa-mir-375 head and neck squamous cell carcinoma down MicroRNA-375 Suppresses Extracellular Matrix Degradation and Invadopodial Activity in Head and Neck Squamous Cell Carcinoma. hsa-mir-375 head and neck squamous cell carcinoma down Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. hsa-mir-375 hepatocellular carcinoma down miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. hsa-mir-375 hepatocellular carcinoma down MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. hsa-mir-375 laryngeal squamous cell carcinoma down miR-375 Suppresses IGF1R Expression and Contributes to Inhibition of Cell Progression in Laryngeal Squamous Cell Carcinoma. hsa-mir-375 nasopharyngeal carcinoma down Significance of dysregulated metadherin and microRNA-375 in head and neck cancer. hsa-mir-375 non-small cell lung cancer down Decreased expression of microRNA-375 in nonsmall cell lung cancer and its clinical significance. hsa-mir-375 non-small cell lung cancer up Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer. hsa-mir-375 oral cancer down MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma. hsa-mir-375 oral cancer down Anti-Cancer Drugs Reactivate Tumor Suppressor miR-375 Expression in Tongue Cancer Cells. hsa-mir-375 oral carcinoma down Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma. hsa-mir-375 osteosarcoma down MicroRNA-375 functions as a tumor suppressor in osteosarcoma by targeting PIK3CA. hsa-mir-375 pancreatic cancer down MicroRNA-375 is downregulated in pancreatic cancer and inhibits cell proliferation in vitro. hsa-mir-375 pancreatic cancer down Expression levels of microRNA-375 in pancreatic cancer. hsa-mir-375 pancreatic carcinoma down MicroRNA-375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signaling pathway. hsa-mir-375 pancreatic ductal adenocarcinoma down Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma. hsa-mir-375 pancreatic ductal adenocarcinoma down Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas. hsa-mir-375 squamous carcinoma down Tumor suppressive microRNA-375 regulates lactate dehydrogenase B in maxillary sinus squamous cell carcinoma. hsa-mir-376a chondrosarcoma down Analysis of microRNAs expressions in chondrosarcoma. hsa-mir-376a glioblastoma down Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation. hsa-mir-376a hepatocellular carcinoma down miR-376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma. hsa-mir-376a malignant melanoma down Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor. hsa-mir-376a pancreatic ductal adenocarcinoma up Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas. hsa-mir-376c malignant melanoma down Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor. hsa-mir-376c osteosarcoma down MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. hsa-mir-376c osteosarcoma down MicroRNA-376c Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting to Transforming Growth Factor-Alpha. hsa-mir-377 gastric cancer up MicroRNA-377 predicts poor clinical outcome of gastric cancer and induces tumorigenesis by targeting multiple tumor-suppressor genes. hsa-mir-377 hepatocellular carcinoma down MicroRNA-377 Suppresses Cell Proliferation and Invasion by Inhibiting TIAM1 Expression in Hepatocellular Carcinoma. hsa-mir-377 renal clear cell carcinoma down miR-377 functions as a tumor suppressor in human clear cell renal cell carcinoma by targeting ETS1. hsa-mir-378 acute myeloid leukemia up Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia. hsa-mir-378 breast cancer up Association between mir-24 and mir-378 in formalin-fixed paraffin-embedded tissues of breast cancer. hsa-mir-378 colorectal cancer down Identification and functional screening of microRNAs highly deregulated in colorectal cancer. hsa-mir-378 colorectal cancer down MicroRNA-378 inhibits cell growth and enhances l-OHP-induced apoptosis in human colorectal cancer. hsa-mir-378 gastric cancer down MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer. hsa-mir-378 gastric cancer down MicroRNA profiling of human gastric cancer. hsa-mir-378 glioma down Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma. hsa-mir-378 nasopharyngeal carcinoma down MicroRNA-378 functions as an onco-miR in nasopharyngeal carcinoma by repressing TOB2 expression. hsa-mir-378 ovarian cancer up MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer. hsa-mir-378 ovarian cancer up Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells. hsa-mir-378 renal cell carcinoma down A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma. hsa-mir-378a-3p colorectal cancer down Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer. hsa-mir-378a-5p colorectal cancer down Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer. hsa-mir-379 breast cancer down miR-379 regulates cyclin B1 expression and is decreased in breast cancer. hsa-mir-381 breast cancer down Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. hsa-mir-381 colon cancer down Down-regulation of MicroRNA-381 promotes cell proliferation and invasion in colon cancer through up-regulation of LRH-1. hsa-mir-381 lung adenocarcinoma down MicroRNA-381 represses ID1 and is deregulated in lung adenocarcinoma. hsa-mir-382 osteosarcoma down miR-382 Inhibits Osteosarcoma Metastasis and Relapse by Targeting Y Box-Binding Protein 1. hsa-mir-382 osteosarcoma down miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma. hsa-mir-383 breast cancer down MicroRNA-383 Regulates the Apoptosis of Tumor Cells through Targeting Gadd45g. hsa-mir-383 glioma down Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor. hsa-mir-383 glioma down MicroRNA-383 inhibits anchorage-independent growth and induces cell cycle arrest of glioma cells by targeting CCND1. hsa-mir-383 glioma down MicroRNA-383 expression regulates proliferation, migration, invasion, and apoptosis in human glioma cells. hsa-mir-383 medulloblastoma down MiR-383 is Downregulated in Medulloblastoma and Targets Peroxiredoxin 3 (PRDX3). hsa-mir-3928 osteosarcoma down Down-Regulation of miR-3928 Promoted Osteosarcoma Growth. hsa-mir-409-3p bladder cancer down MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met. hsa-mir-409-3p colorectal cancer down MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression. hsa-mir-409-3p gastric cancer down MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers. hsa-mir-409-3p gastric cancer down MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer. hsa-mir-409-3p lung adenocarcinoma down MicroRNA-409-3p functions as a tumor suppressor in human lung adenocarcinoma by targeting c-Met. hsa-mir-409-3p ovarian cancer down Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells. hsa-mir-410 gastric cancer down MicroRNA-410 Suppresses Migration and Invasion by Targeting MDM2 in Gastric Cancer. hsa-mir-410 non-small cell lung cancer up MicroRNA-410 promotes cell proliferation by targeting BRD7 in non-small cell lung cancer. hsa-mir-410 oral squamous cell carcinoma down Downregulated miR-329 and miR-410 promote the proliferation and invasion of oral squamous cell carcinoma by targeting Wnt-7b. hsa-mir-410 pancreatic cancer down MicroRNA-410 functions as a tumor suppressor by targeting angiotensin II type 1 receptor in pancreatic cancer. hsa-mir-411 ovarian cancer down Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells. hsa-mir-421 gastric cancer up MiR-421 regulates apoptosis of BGC-823 gastric cancer cells by targeting caspase-3. hsa-mir-421 gastric cancer up MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer. hsa-mir-421 gastric cancer up Increased expression of miR-421 in human gastric carcinoma and its clinical association. hsa-mir-421 nasopharyngeal carcinoma up miR-421 induces cell proliferation and apoptosis resistance in human nasopharyngeal carcinoma via downregulation of FOXO4. hsa-mir-421 neuroblastoma up Downregulation of tumor suppressor menin by miR-421 promotes proliferation and migration of neuroblastoma. hsa-mir-422a colorectal cancer down Identification and functional screening of microRNAs highly deregulated in colorectal cancer. hsa-mir-422a hepatocellular carcinoma down A double-negative feedback loop between MicroRNA-422a and FOXG1/Q1/E1 regulates hepatocellular carcinoma tumor growth and metastasis. hsa-mir-423 breast cancer up Genetic analysis and preliminary function study of miR-423 in breast cancer. hsa-mir-423 hepatocellular carcinoma up MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma. hsa-mir-423-3p laryngeal carcinoma up microRNA-423-3p promotes tumor progression via modulation of AdipoR2 in laryngeal carcinoma. hsa-mir-423-5p colorectal cancer down Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma. hsa-mir-424 bladder cancer down DNMT1-dependent suppression of microRNA424 regulates tumor progression in human bladder cancer. hsa-mir-424 cervical cancer down Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. hsa-mir-424 chronic lymphocytic leukemia down miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in chronic lymphocytic leukemia. hsa-mir-424 chronic myelogenous leukemia up Restoration of miR-424 suppresses BCR-ABL activity and sensitizes CML cells to imatinib treatment. hsa-mir-424 colon cancer down MiR-424/503-Mediated Rictor Upregulation Promotes Tumor Progression. hsa-mir-424 colorectal cancer up Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. hsa-mir-424 endometrial cancer down MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7. hsa-mir-424 hepatocellular carcinoma down MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma. hsa-mir-424 hepatocellular carcinoma down MicroRNA-424 is down-regulated in hepatocellular carcinoma and suppresses cell migration and invasion through c-Myb. hsa-mir-424 osteosarcoma down Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase. hsa-mir-424 ovarian cancer up MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance. hsa-mir-424-5p hepatocellular carcinoma down MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression. hsa-mir-424-5p pancreatic cancer up MicroRNA-424-5p Suppresses the Expression of SOCS6 in Pancreatic Cancer. hsa-mir-425 breast cancer down Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. hsa-mir-425 gastric cancer up NF-kappaB-dependent MicroRNA-425 upregulation promotes gastric cancer cell growth by targeting PTEN upon IL-1? induction. hsa-mir-425-5p gastric cancer up microRNA-425-5p is upregulated in human gastric cancer and contributes to invasion and metastasis in vitro and in vivo. hsa-mir-429 bladder cancer down Expression of microRNAs in the Urine of Patients With Bladder Cancer. hsa-mir-429 breast cancer up Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. hsa-mir-429 breast cancer down miR-429 inhibits migration and invasion of breast cancer cells in vitro. hsa-mir-429 colon cancer down MicroRNA-429 inhibits the migration and invasion of colon cancer cells by targeting PAK6/cofilin signaling. hsa-mir-429 colorectal cancer down MiR-200 suppresses metastases of colorectal cancer through ZEB1. hsa-mir-429 colorectal cancer up MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2. hsa-mir-429 colorectal carcinoma down miR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma. hsa-mir-429 gastric cancer down miR-429 modulates the expression of c-myc in human gastric carcinoma cells. hsa-mir-429 gastric cancer up Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer. hsa-mir-429 glioma down miR-429 inhibits glioma invasion through BMK1 suppression. hsa-mir-429 hepatocellular carcinoma up MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis. hsa-mir-429 hepatocellular carcinoma up Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4. hsa-mir-429 lung adenocarcinoma down miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. hsa-mir-429 lung cancer up MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation. hsa-mir-429 malignant melanoma up MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion. hsa-mir-429 mesenchymal cancer down MicroRNA Expression Profiles in Kaposi's Sarcoma. hsa-mir-429 non-small cell lung cancer down Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer. hsa-mir-429 oral squamous cell carcinoma down MiR-429 inhibits oral squamous cell carcinoma growth by targeting ZEB1. hsa-mir-429 osteosarcoma down Tumor-Suppressing Effects of miR-429 on Human Osteosarcoma. hsa-mir-429 ovarian cancer down A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. hsa-mir-429 ovarian cancer down Ectopic over-expression of miR-429 induces mesenchymal-to-epithelial transition (MET) and increased drug sensitivity in metastasizing ovarian cancer cells. hsa-mir-429 prostate cancer up Downregulation of microRNA-429 inhibits cell proliferation by targeting p27Kip1 in human prostate cancer cells. hsa-mir-429 renal cell carcinoma down MicroRNA-429 suppresses cell proliferation, epithelial-mesenchymal transition, and metastasis by direct targeting of BMI1 and E2F3 in renal cell carcinoma. hsa-mir-4295 anaplastic thyroid carcinoma up miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1A. hsa-mir-432 ovarian cancer down Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells. hsa-mir-433 gastric cancer down Down-regulated miR-9 and miR-433 in human gastric carcinoma. hsa-mir-433 gastric cancer down The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer. hsa-mir-433 hepatocellular carcinoma down MicroRNA-433 inhibits cell proliferation in hepatocellular carcinoma by targeting p21 activated kinase (PAK4). hsa-mir-433 liver cancer down The microRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element binding protein. hsa-mir-433 oral squamous cell carcinoma down miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6. hsa-mir-4423 lung cancer up MicroRNA 4423 is a primate-specific regulator of airway epithelial cell differentiation and lung carcinogenesis. hsa-mir-4458 hepatocellular carcinoma down Tumor-suppressing effect of miR-4458 on human hepatocellular carcinoma. hsa-mir-448 hepatocellular carcinoma down Low Expression of miR-448 Induces EMT and Promotes Invasion by Regulating ROCK2 in Hepatocellular Carcinoma. hsa-mir-448 ovarian cancer down miR-448 negatively regulates ovarian cancer cell growth and metastasis by targeting CXCL12. hsa-mir-4487 colorectal cancer down Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer. hsa-mir-449 gastric cancer down miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. hsa-mir-449a endometrial cancer down MiR-449a functions as a tumor suppressor in endometrial cancer by targeting CDC25A. hsa-mir-449a gastric adenocarcinoma down microRNA-449a functions as a tumor-suppressor in gastric adenocarcinoma by targeting Bcl-2. hsa-mir-449a gastric cancer down miR-449a Regulates Proliferation and Chemosensitivity to Cisplatin by Targeting Cyclin D1 and BCL2 in SGC7901 Cells. hsa-mir-449a gastric cancer down miR-449a and CDK6 in gastric carcinoma. hsa-mir-449a glioblastoma down MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein. hsa-mir-449a lung cancer down Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer. hsa-mir-449a lung cancer down MicroRNA-449a inhibits cell growth in lung cancer and regulates long noncoding RNA nuclear enriched abundant transcript 1. hsa-mir-449a neuroblastoma down microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest. hsa-mir-449a non-small cell lung cancer down MicroRNA-449a Is Downregulated in Non-Small Cell Lung Cancer and Inhibits Migration and Invasion by Targeting c-Met. hsa-mir-449a non-small cell lung cancer down microRNA-449a Suppresses Non-small Cell Lung Cancer. hsa-mir-449a osteosarcoma down miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2. hsa-mir-449a ovarian cancer down MicroRNA-449a reduces cell survival and enhances cisplatin-induced cytotoxicity via downregulation of NOTCH1 in ovarian cancer cells. hsa-mir-449a prostate cancer down miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. hsa-mir-449a prostate cancer down miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. hsa-mir-449b lung cancer down Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer. hsa-mir-449c gastric cancer down MiR-449c inhibits gastric carcinoma growth. hsa-mir-4500 non-small cell lung cancer down Down-regulation of miR-4500 promoted non-small cell lung cancer growth. hsa-mir-450a hepatocellular carcinoma down microRNA-450a targets DNA methyltransferase 3a in hepatocellular carcinoma. hsa-mir-450b-3p breast cancer down Targeting HER3 with miR-450b-3p suppresses breast cancer cells proliferation. hsa-mir-451 bladder cancer down miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT. hsa-mir-451 colorectal carcinoma down MicroRNA-451 Inhibits Growth of Human Colorectal Carcinoma Cells via Downregulation of Pi3k/Akt Pathway. hsa-mir-451 esophageal carcinoma down Effect of miR-451 on the Biological Behavior of the Esophageal Carcinoma Cell Line EC9706. hsa-mir-451 glioma down MiRNA-451 plays a role as tumor suppressor in human glioma cells. hsa-mir-451 glioma down MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma. hsa-mir-451 hepatocellular carcinoma down MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. hsa-mir-451 hepatocellular carcinoma down miR-451 Inhibits Cell Proliferation in Human Hepatocellular Carcinoma through Direct Suppression of IKK-? hsa-mir-451 hepatocellular carcinoma down miR-451: Potential role as tumor suppressor of human hepatoma cell growth and invasion. hsa-mir-451 hepatocellular carcinoma down MicroRNA-451 regulates activating transcription factor?2 expression and inhibits liver cancer cell migration. hsa-mir-451 lung adenocarcinoma down Acquisition of radioresistance in docetaxel-resistant human lung adenocarcinoma cells is linked with dysregulation of miR-451/c-Myc-survivin/rad-51 signaling. hsa-mir-451 nasopharyngeal carcinoma down MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma. hsa-mir-451 non-small cell lung cancer down The expression and function of miRNA-451 in non-small cell lung cancer. hsa-mir-451 non-small cell lung cancer down Clinical evaluation of microRNA expression profiling in non small cell lung cancer. hsa-mir-451 non-small cell lung cancer down MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). hsa-mir-451 osteosarcoma down Tumor-Suppressing Effects of miR451 in Human Osteosarcoma. hsa-mir-451 osteosarcoma down MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients hsa-mir-451 osteosarcoma down Suppression of liver receptor homolog-1 by microRNA-451 represses the proliferation of osteosarcoma cells. hsa-mir-451a breast cancer down miR-451a Inhibited Cell Proliferation and Enhanced Tamoxifen Sensitive in Breast Cancer via Macrophage Migration Inhibitory Factor. hsa-mir-451a hypopharyngeal squamous cell carcinoma down Identification of tumour suppressive microRNA-451a in hypopharyngeal squamous cell carcinoma based on microRNA expression signature. hsa-mir-452 esophageal cancer up Differential expression of miRNAs in esophageal cancer tissue. hsa-mir-452 glioma down Downregulation of miR-452 Promotes Stem-Like Traits and Tumorigenicity of Gliomas. hsa-mir-452 hepatocellular carcinoma up MicroRNA-452 promotes tumorigenesis in hepatocellular carcinoma by targeting cyclin-dependent kinase inhibitor 1B. hsa-mir-454 esophageal cancer down Differential expression of miRNAs in esophageal cancer tissue. hsa-mir-454 glioblastoma down MiR-454 inhibited cell proliferation of human glioblastoma cells by suppressing PDK1 expression. hsa-mir-454 hepatocellular carcinoma up miR-454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinoma. hsa-mir-454 osteosarcoma down miR-454 is down-regulated in osteosarcomas and suppresses cell proliferation and invasion by directly targeting c-Met. hsa-mir-454 uveal melanoma up MicroRNA-454 functions as an oncogene by regulating PTEN in uveal melanoma. hsa-mir-455 colon cancer down MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase. hsa-mir-455-5p malignant melanoma up Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis. hsa-mir-4649-3p nasopharyngeal carcinoma down MicroRNA-4649-3p inhibits cell proliferation by targeting protein tyrosine phosphatase SHP-1 in nasopharyngeal carcinoma cells. hsa-mir-4723-5p prostate cancer down MicroRNA-4723 Inhibits Prostate Cancer Growth through Inactivation of the Abelson Family of Nonreceptor Protein Tyrosine Kinases. hsa-mir-4782-3p non-small cell lung cancer down miR-4782-3p Inhibited Non-Small Cell Lung Cancer growth via USP14. hsa-mir-483 colorectal cancer down Extracellular metabolic energetics can promote cancer progression. hsa-mir-483-3p adrenal cortical carcinoma up The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. hsa-mir-483-3p hepatocellular carcinoma up Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-? stimulated HSCs in transgenic mice. hsa-mir-483-5p adrenal cortical carcinoma up miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer. hsa-mir-483-5p adrenal cortical carcinoma up The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. hsa-mir-483-5p glioblastoma down MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1. hsa-mir-483-5p glioma down MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1. hsa-mir-483-5p hepatocellular carcinoma up Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-? stimulated HSCs in transgenic mice. hsa-mir-483-5p hepatocellular carcinoma up Serum miR-483-5p as a potential biomarker to detect hepatocellular carcinoma. hsa-mir-483-5p oral squamous cell carcinoma up Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma. hsa-mir-484 colon cancer down MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase. hsa-mir-485-3p hepatocellular carcinoma up MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma. hsa-mir-485-5p hepatocellular carcinoma down Involvement of miR-485-5p in hepatocellular carcinoma progression targeting EMMPRIN. hsa-mir-486 esophageal cancer down Differential expression of miRNAs in esophageal cancer tissue. hsa-mir-486 glioma up miR-486 sustains NF-?B activity by disrupting multiple NF-?B-negative feedback loops. hsa-mir-486-3p retinoblastoma down Computational and in vitro Investigation of miRNA-Gene Regulations in Retinoblastoma Pathogenesis: miRNA Mimics Strategy. hsa-mir-486-5p hepatocellular carcinoma down MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1. hsa-mir-486-5p lung cancer down Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer. hsa-mir-490-3p gastric cancer down Epigenetic Silencing of miR-490-3p Reactivates the Chromatin Remodeler SMARCD1 to Promote Helicobacter pylori-Induced Gastric Carcinogenesis. hsa-mir-490-3p hepatocellular carcinoma up miR-490-3p Modulates Cell Growth and Epithelial to Mesenchymal Transition of Hepatocellular Carcinoma Cells by Targeting Endoplasmic Reticulum-Golgi Intermediate Compartment Protein 3 (ERGIC3). hsa-mir-490-3p osteosarcoma down MicroRNA-490-3p regulates cell proliferation and apoptosis by targeting HMGA2 in osteosarcoma. hsa-mir-490-5p bladder cancer down MicroRNA expression signatures of bladder cancer revealed by deep sequencing. hsa-mir-490-5p bladder cancer down MicroRNA-490-5p inhibits proliferation of bladder cancer by targeting c-Fos. hsa-mir-490-5p bladder cancer down MicroRNA-490-5p is a novel tumor suppressor targeting c-FOS in human bladder cancer. hsa-mir-491 esophageal cancer down Low Expression of miR-491 Promotes Esophageal Cancer Cell Invasion by Targeting TPX2. hsa-mir-491-5p cervical cancer down MicroRNA-491-5p suppresses cervical cancer cell growth by targeting hTERT. hsa-mir-492 hepatoblastoma up MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma. hsa-mir-493 bladder cancer down Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4. hsa-mir-493 pituitary carcinoma up MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas. hsa-mir-494 breast cancer down miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/?-catenin signaling pathway. hsa-mir-494 cervical cancer up MicroRNA-494 promotes cervical cancer proliferation through the regulation of PTEN. hsa-mir-494 colorectal cancer up miR?494 is an independent prognostic factor and promotes cell migration and invasion in colorectal cancer by directly targeting PTEN. hsa-mir-494 esophageal squamous cell carcinoma down Upregulation of miR-494 Inhibits Cell Growth and Invasion and Induces Cell Apoptosis by Targeting Cleft Lip and Palate Transmembrane 1-Like in Esophageal Squamous Cell Carcinoma. hsa-mir-494 gastric cancer down miR-494 acts as an anti-oncogene in gastric carcinoma by targeting c-myc. hsa-mir-494 glioma up Ionizing radiation-inducible miR-494 promotes glioma cell invasion through EGFR stabilization by targeting p190B RhoGAP. hsa-mir-494 hepatocellular carcinoma up miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN. hsa-mir-494 hepatocellular carcinoma up MiR-494 within an oncogenic MicroRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of MCC. hsa-mir-494 hepatocellular carcinoma up MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors. hsa-mir-494 nasopharyngeal carcinoma down Upregulation of miR-21 and downregulation of miR-494 may serve as emerging molecular biomarkers for prediagnostic samples of subjects who developed nasopharyngeal carcinoma associates with lymph node hsa-mir-494 non-small cell lung cancer up Expression and clinical evidence of miR-494 and PTEN in non-small cell lung cancer. hsa-mir-494 non-small cell lung cancer up Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer. hsa-mir-494 oral cancer down miR-494 represses HOXA10 expression and inhibits cell proliferation in oral cancer. hsa-mir-494 ovarian cancer down Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells. hsa-mir-494 pancreatic ductal adenocarcinoma down Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and ?-catenin signaling in pancreatic ductal adenocarcinoma cells. hsa-mir-495 breast cancer up miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1. hsa-mir-495 breast cancer down Downregulated miR-45 Inhibits the G1-S Phase Transition by Targeting Bmi-1 in Breast Cancer. hsa-mir-495 glioma down MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6. hsa-mir-495 glioma down miR-495 mediates metabolic shift in glioma cells via targeting Glut1. hsa-mir-495 hepatocellular carcinoma up MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma. hsa-mir-495 medulloblastoma down MiR-495 is a Predictive Biomarker that Downregulates GFI1 Expression in Medulloblastoma. hsa-mir-497 adrenal cortical carcinoma down The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. hsa-mir-497 breast cancer down Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. hsa-mir-497 breast cancer down26338045 microRNA-497 induces cell apoptosis by negatively regulating Bcl-2 protein expression at the posttranscriptional level in human breast cancer. hsa-mir-497 cervical cancer down MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor. hsa-mir-497 colorectal cancer up MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis. hsa-mir-497 colorectal cancer up MiR-497 promotes metastasis of colorectal cancer cells through Nrdp1 inhibition. hsa-mir-497 colorectal cancer down MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer. hsa-mir-497 colorectal cancer down MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis. hsa-mir-497 gastric cancer down The putative tumor suppressor microRNA-497 modulates gastric cancer cell proliferation and invasion by repressing eIF4E. hsa-mir-497 glioma up Hypoxia-induced miR-497 decreases glioma cell sensitivity to TMZ by inhibiting apoptosis. hsa-mir-497 hepatocellular carcinoma down Checkpoint kinase 1 is negatively regulated by miR-497 in hepatocellular carcinoma. hsa-mir-497 hepatocellular carcinoma down MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1. hsa-mir-497 kidney cancer down Down-regulation of miR-497 is associated with poor prognosis in renal cancer. hsa-mir-497 non-small cell lung cancer down MiR-497 Suppresses YAP1 and Inhibits Tumor Growth in Non-Small Cell Lung Cancer. hsa-mir-497 non-small cell lung cancer down Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancer. hsa-mir-497 osteosarcoma down The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma. hsa-mir-497 ovarian cancer down MicroRNA-497 inhibition of ovarian cancer cell migration and invasion through targeting of SMAD specific E3 ubiquitin protein ligase 1. hsa-mir-497 ovarian cancer down MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer. hsa-mir-497 pancreatic cancer down Insulin-like growth factor 1 receptor (IGF-1R) as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer. hsa-mir-497 pancreatic cancer down MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis. hsa-mir-497 prostate cancer down MicroRNA-497 Suppresses Proliferation and Induces Apoptosis in Prostate Cancer Cells. hsa-mir-497 prostate cancer down Tumor-suppressive microRNA-497 targets IKK? to regulate NF-?B signaling pathway in human prostate cancer cells. hsa-mir-498 colorectal cancer down Downregulation of microRNA-498 in colorectal cancers and its cellular effects. hsa-mir-498 non-small cell lung cancer down MicroRNA-498 is downregulated in non-small cell lung cancer and correlates with tumor progression. hsa-mir-498 ovarian cancer down 1,25-Dihydroxyvitamin D3 Suppresses Telomerase Expression and Human Cancer Growth through MicroRNA-498. hsa-mir-498 ovarian cancer down MiR-498 regulated FOXO3 expression and inhibited the proliferation of human ovarian cancer cells. hsa-mir-499-5p colorectal cancer up MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4. hsa-mir-499a-5p oral squamous cell carcinoma down The association between miR-499a polymorphism and oral squamous cell carcinoma progression. hsa-mir-500 gastric cancer up MicroRNA-500 sustains nuclear factor-?B activation and induces gastric cancer cell proliferation and resistance to apoptosis. hsa-mir-500 hepatocellular carcinoma up MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. hsa-mir-500a hepatocellular carcinoma up Serum miR-483-5p as a potential biomarker to detect hepatocellular carcinoma. hsa-mir-501 hepatocellular carcinoma up MicroRNA-501 promotes HBV replication by targeting HBXIP. hsa-mir-501-5p hepatocellular carcinoma up MiR-501-5p regulates CYLD expression and promotes cell proliferation in human hepatocellular carcinoma. hsa-mir-502 colon cancer down Inhibition of autophagy and tumor growth in colon cancer by miR-502. hsa-mir-502 hepatocellular carcinoma down miR-502 inhibits cell proliferation and tumor growth in hepatocellular carcinoma through suppressing phosphoinositide 3-kinase catalytic subunit gamma. hsa-mir-502-5p breast cancer down Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2. hsa-mir-503 breast cancer up MiR-503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression. hsa-mir-503 colon cancer down MiR-424/503-Mediated Rictor Upregulation Promotes Tumor Progression. hsa-mir-503 esophageal cancer up MicroRNA-503 promotes tumor progression and acts as a novel biomarker for prognosis in oesophageal cancer. hsa-mir-503 gastric cancer down MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2. hsa-mir-503 gastric cancer down microRNA-503 inhibits gastric cancer cell growth and epithelial-to-mesenchymal transition. hsa-mir-503 glioblastoma down MicroRNA-503 acts as a tumor suppressor in glioblastoma for multiple antitumor effects by targeting IGF-1R. hsa-mir-503 hepatocellular carcinoma down MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma. hsa-mir-503 hepatocellular carcinoma down miR-503 suppresses metastasis of hepatocellular carcinoma cell by targeting PRMT1. hsa-mir-503 non-small cell lung cancer down Epigenetic silencing of MicroRNA-503 regulates FANCA expression in non-small cell lung cancer cell. hsa-mir-503 non-small cell lung cancer down Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC. hsa-mir-503 oral squamous cell carcinoma down Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer. hsa-mir-503 osteosarcoma down MicroRNA-503 acts as a tumor suppressor in osteosarcoma by targeting L1CAM. hsa-mir-503 osteosarcoma down Downregulation of miR-133b/miR-503 acts as efficient prognostic and diagnostic factors in patients with osteosarcoma and these predictor biomarkers are correlated with overall survival. hsa-mir-503 ovarian cancer up MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance. hsa-mir-503 prostate cancer down miR-503 suppresses tumor cell proliferation and metastasis by directly targeting RNF31 in prostate cancer. hsa-mir-504 hypopharyngeal squamous cell carcinoma down Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma. hsa-mir-504 hypopharyngeal squamous cell carcinoma down microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma. hsa-mir-506 gastric cancer down MicroRNA-506 inhibits gastric cancer proliferation and invasion by directly targeting Yap1. hsa-mir-506 hepatocellular carcinoma down MiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3'UTR. hsa-mir-506 nasopharyngeal carcinoma down MiR-506 suppresses tumor proliferation and invasion by targeting FOXQ1 in nasopharyngeal carcinoma. hsa-mir-506 oral squamous cell carcinoma down MicroRNA-506 suppresses growth and metastasis of oral squamous cell carcinoma via targeting GATA6. hsa-mir-506 renal clear cell carcinoma down MiR-506 is down-regulated in clear cell renal cell carcinoma and inhibits cell growth and metastasis via targeting FLOT1. hsa-mir-506 renal clear cell carcinoma down Correction: MiR-506 Is Down-Regulated in Clear Cell Renal Cell Carcinoma and Inhibits Cell Growth and Metastasis via Targeting FLOT1. hsa-mir-508-3p kidney cancer down Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma. hsa-mir-509-3p kidney cancer down Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma. hsa-mir-509-3p renal cell carcinoma down MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma. hsa-mir-509-5p renal cell carcinoma down Tumor suppressive miR-509-5p contributes to cell migration, proliferation and antiapoptosis in renal cell carcinoma. hsa-mir-510 breast cancer up MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer. hsa-mir-510-5p renal cell carcinoma down Downregulated microRNA-510-5p acts as a tumor suppressor in renal cell carcinoma. hsa-mir-5100 lung cancer up miR-5100 promotes tumor growth in lung cancer by targeting Rab6. hsa-mir-511 lung adenocarcinoma down miR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2. hsa-mir-512-3p non-small cell lung cancer down Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer. hsa-mir-513b gastric cancer down Upregulation of miR-513b inhibits cell proliferation, migration, and promotes apoptosis by targeting high mobility group-box 3 protein in gastric cancer. hsa-mir-517a breast cancer down Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines. hsa-mir-518a-3p colorectal cancer down Downregulation of miR-518a-3p activates the NIK-dependent NF-?B pathway in colorectal cancer. hsa-mir-518b esophageal squamous cell carcinoma down miR-518b is down-regulated, and involved in cell proliferation and invasion by targeting Rap1b in esophageal squamous cell carcinoma. hsa-mir-519d breast cancer down miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression. hsa-mir-519d hepatocellular carcinoma down MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703. hsa-mir-519d hepatocellular carcinoma up In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. hsa-mir-519d osteosarcoma down CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d. hsa-mir-519d ovarian cancer down MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP. hsa-mir-520a hepatocellular carcinoma down MicroRNA-218 and microRNA-520a inhibit cell proliferation by downregulating E2F2 in hepatocellular carcinoma. hsa-mir-520a-3p non-small cell lung cancer down The microRNA-520a-3p inhibits proliferation, apoptosis and metastasis by targeting MAP3K2 in non-small cell lung cancer. hsa-mir-520b hepatocellular carcinoma down MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA. hsa-mir-520c breast cancer up The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. hsa-mir-520c-3p gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-520c-3p hepatocellular carcinoma down MicroRNA-520c-3p inhibits hepatocellular carcinoma cell proliferation and invasion through induction of cell apoptosis by targeting glypican-3. hsa-mir-520d-3p gastric cancer down MicroRNA 520d-3p inhibits gastric cancer cell proliferation, migration, and invasion by downregulating EphA2 expression. hsa-mir-520d-5p colorectal cancer down SP1-mediated microRNA-520d-5p suppresses tumor growth and metastasis in colorectal cancer by targeting CTHRC1. hsa-mir-520g hepatocellular carcinoma up MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7. hsa-mir-525-3p liver cancer up MiR-525-3p Enhances the Migration and Invasion of Liver Cancer Cells by Downregulating ZNF395. hsa-mir-526b breast cancer up COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation. hsa-mir-526b non-small cell lung cancer down By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer. hsa-mir-532-5p malignant melanoma up Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma. hsa-mir-532-5p ovarian carcinoma down MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features. hsa-mir-532-5p retinoblastoma down Computational and in vitro Investigation of miRNA-Gene Regulations in Retinoblastoma Pathogenesis: miRNA Mimics Strategy. hsa-mir-539 osteosarcoma down MicroRNA-539 suppresses osteosarcoma cell invasion and migration in vitro and targeting Matrix metallopeptidase-8. hsa-mir-539 thyroid cancer down MiR-539 inhibits thyroid cancer cell migration and invasion by directly targeting CARMA1. hsa-mir-541 pancreatic ductal adenocarcinoma up Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas. hsa-mir-542-3p astrocytoma down MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma. hsa-mir-542-3p gastric cancer down MicroRNA-542-3p suppresses cell growth of gastric cancer cells via targeting oncogene astrocyte-elevated gene-1. hsa-mir-542-3p glioblastoma down MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma. hsa-mir-543 endometrial cancer down MicroRNA-543 suppresses endometrial cancer oncogenicity via targeting FAK and TWIST1 expression. hsa-mir-544 cervical cancer down Transcription factor KLF4 regulates microRNA-544 that targets YWHAZ in cervical cancer. hsa-mir-544 gastric cancer up Oncogenic miR-544 is an Important Molecular Target in Gastric Cancer. hsa-mir-545 lung cancer down MicroRNA-545 Suppresses Cell Proliferation by Targeting Cyclin D1 and CDK4 in Lung Cancer Cells. hsa-mir-551a colorectal cancer down Extracellular metabolic energetics can promote cancer progression. hsa-mir-551b-3p gastric cancer down Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer. hsa-mir-564 chronic myelogenous leukemia down Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells. hsa-mir-566 glioma up MicroRNA-566 activates EGFR signaling and its inhibition sensitizes glioblastoma cells to nimotuzumab. hsa-mir-570 lung cancer up MicroRNA-570 promotes lung carcinoma proliferation through targeting tumor suppressor KLF9. hsa-mir-572 ovarian cancer up Upregulation of MiR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression. hsa-mir-572 renal cell carcinoma up A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma. hsa-mir-573 hepatocellular carcinoma up The miR-573/apoM/Bcl2A1-dependent signal transduction pathway is essential for hepatocyte apoptosis and hepatocarcinogenesis. hsa-mir-573 malignant melanoma down miR-573 regulates melanoma progression by targeting the melanoma cell adhesion molecule. hsa-mir-574-3p breast cancer down Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines. hsa-mir-574-3p esophageal cancer down Differential expression of miRNAs in esophageal cancer tissue. hsa-mir-574-3p hepatocellular carcinoma up Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. hsa-mir-574-5p colorectal cancer down Hsa-miR-574-5p negatively regulates MACC-1 expression to suppress colorectal cancer liver metastasis. hsa-mir-575 gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-576-3p bladder cancer down MicroRNA-576-3p Inhibits Proliferation in Bladder Cancer Cells by Targeting Cyclin D1. hsa-mir-576-5p glioblastoma up miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients. hsa-mir-577 glioblastoma down miR-577 inhibits glioblastoma tumor growth via the Wnt signaling pathway. hsa-mir-582-5p hepatocellular carcinoma down miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3. hsa-mir-584 glioma down MicroRNA-584 functions as a tumor suppressor and targets PTTG1IP in glioma. hsa-mir-590-5p cervical cancer up MicroRNA-590 Promotes Cervical Cancer Cell Growth and Invasion by Targeting CHL1. hsa-mir-590-5p hepatocellular carcinoma up MicroRNA-590-5p regulates proliferation and invasion in human hepatocellular carcinoma cells by targeting TGF-? RII. hsa-mir-590-5p hepatocellular carcinoma down MiR-590-5P Inhibits Growth of HepG2 Cells via Decrease of S100A10 Expression and Inhibition of the Wnt Pathway. hsa-mir-592 colorectal cancer up Up-regulation of miR-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer. hsa-mir-601 gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-603 glioma up miR-603 promotes glioma cell growth via Wnt/?-catenin pathway by inhibiting WIF1 and CTNNBIP1. hsa-mir-608 chordoma down MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET. hsa-mir-610 hepatocellular carcinoma down Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/?-catenin signaling in human hepatocellular carcinoma. hsa-mir-610 lung cancer down [miR-610 suppresses lung cancer cell proliferation and invasion by targeting GJA3]. hsa-mir-612 hepatocellular carcinoma down miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma. hsa-mir-613 papillary thyroid carcinoma down Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma. hsa-mir-614 lung cancer down [MiR-614 Inhibited Lung Cancer Cell Invasion and Proliferation via Targeting PSA]. hsa-mir-615-5p pancreatic cancer down MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2. hsa-mir-615-5p pancreatic ductal adenocarcinoma down miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma. hsa-mir-615-5p pancreatic ductal adenocarcinoma down Correction: MiRNA-615-5p Functions as a Tumor Suppressor in Pancreatic Ductal Adenocarcinoma by Targeting AKT2. hsa-mir-616* gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-622 gastric cancer down Down-regulation of miR-622 in gastric cancer promotes cellular invasion and tumor metastasis by targeting ING1 gene. hsa-mir-622 glioma down miR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells. hsa-mir-625 colorectal cancer down Decreased expression of microRNA-625 is associated with tumor metastasis and poor prognosis in patients with colorectal cancer. hsa-mir-625 gastric cancer down Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK. hsa-mir-625 hepatocellular carcinoma down miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma. hsa-mir-625* non-small cell lung cancer down Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors. hsa-mir-625-3p colorectal carcinoma up MiR-625-3p promotes cell migration and invasion via inhibition of SCAI in colorectal carcinoma cells. hsa-mir-626 glioblastoma up miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients. hsa-mir-627 colonic adenocarcinoma down MicroRNA-627 Mediates the Epigenetic Mechanisms of Vitamin D to Suppress Proliferation of Human Colorectal Cancer Cells and Growth of Xenograft Tumors in Mice. hsa-mir-628-5p prostate cancer down Circulatory miR-628-5p is downregulated in prostate cancer patients. hsa-mir-630 colorectal cancer up MicroRNA-630 is a prognostic marker for patients with colorectal cancer. hsa-mir-630 hepatocellular carcinoma up miR-630 Overexpression in Hepatocellular Carcinoma Tissues is Positively Correlated with alpha-Fetoprotein. hsa-mir-630 lung cancer down MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells. hsa-mir-630 non-small cell lung cancer down miR-630 targets LMO3 to regulate cell growth and metastasis in lung cancer. hsa-mir-630 pancreatic cancer down Upregulation of miR-150* and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R. hsa-mir-630 renal clear cell carcinoma up Up-regulation of miR-630 in clear cell renal cell carcinoma is associated with lower overall survival. hsa-mir-632 oral squamous cell carcinoma down Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer. hsa-mir-637 hepatocellular carcinoma down Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling. hsa-mir-638 breast cancer down miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple negative breast cancer. hsa-mir-638 colorectal cancer down MicroRNA-638 inhibits cell proliferation, invasion and regulates cell cycle by targeting tetraspanin 1 in human colorectal carcinoma. hsa-mir-638 gastric cancer down MicroRNA profiling of human gastric cancer. hsa-mir-638 gastric cancer down miR-638 Suppresses Cell Proliferation in Gastric Cancer by Targeting Sp2. hsa-mir-638 gastric cancer down MicroRNA-638 inhibits cell proliferation by targeting phospholipase D1 in human gastric carcinoma. hsa-mir-638 malignant melanoma up miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy. hsa-mir-639 bladder cancer up Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer? hsa-mir-642a-5p prostate cancer down Regulation of Expression of Deoxyhypusine Hydroxylase (DOHH), the Enzyme That Catalyzes the Activation of eIF5A, by miR-331-3p and miR-642-5p in Prostate Cancer Cells. hsa-mir-646 oral squamous cell carcinoma down Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer. hsa-mir-646 osteosarcoma down miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 (FGF2). hsa-mir-646 osteosarcoma down Downregulation of microRNA-217 and microRNA-646 acts as potential predictor biomarkers in progression, metastasis, and unfavorable prognosis of human osteosarcoma. hsa-mir-646 renal cell carcinoma down Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1). hsa-mir-650 gastric cancer up MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity. hsa-mir-650 glioma up MicroRNA-650 expression in glioma is associated with prognosis of patients. hsa-mir-650 hepatocellular carcinoma up Upregulation of miR-650 is correlated with down-regulation of ING4 and progression of hepatocellular carcinoma. hsa-mir-652-3p breast cancer down Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR. hsa-mir-655 esophageal squamous cell carcinoma down Mir-655 up-regulation suppresses cell invasion by targeting pituitary tumor-transforming gene-1 in esophageal squamous cell carcinoma. hsa-mir-655 ovarian cancer down Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells. hsa-mir-656 glioma down miR-656 inhibits glioma tumorigenesis through repression of BMPR1A. hsa-mir-657 hepatocellular carcinoma up MiR-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through NF-?B pathways. hsa-mir-660 lung cancer down Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction. hsa-mir-661 ovarian cancer up MiR-661 contributed to cell proliferation of human ovarian cancer cells by repressing INPP5J expression. hsa-mir-663 gastric cancer down Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells. hsa-mir-663 glioblastoma down miR-663 suppresses oncogenic function of CXCR4 in glioblastoma. hsa-mir-663 lung cancer up MicroRNA-663 targets TGFB1 and regulates lung cancer proliferation. hsa-mir-663 nasopharyngeal carcinoma up MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma. hsa-mir-664 hepatocellular carcinoma up MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma. hsa-mir-668 oral squamous cell carcinoma down Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer. hsa-mir-675 colon cancer up Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. hsa-mir-675 glioma up Long Non-Coding RNA H19 Promotes Glioma Cell Invasion by Deriving miR-675. hsa-mir-675 hepatocellular carcinoma down Downregulation of LncRNAH19 and MiR-675 promotes migration and invasion of human hepatocellular carcinoma cells through AKT/GSK-3?/Cdc25A signaling pathway. hsa-mir-675-5p non-small cell lung cancer up Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer. hsa-mir-7 breast cancer down MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression. hsa-mir-7 cervical cancer down MicroRNA-7 inhibits metastasis and invasion through targeting focal adhesion kinase in cervical cancer. hsa-mir-7 colorectal cancer down miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2. hsa-mir-7 epithelial ovarian cancer down Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells. hsa-mir-7 gastric cancer down MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. hsa-mir-7 glioblastoma down microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. hsa-mir-7 glioblastoma down Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III. hsa-mir-7 glioblastoma down miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways. hsa-mir-7 glioma down MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism. hsa-mir-7 glioma down MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas. hsa-mir-7 hepatocellular carcinoma down MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells. hsa-mir-7 hepatocellular carcinoma down miR-7 inhibits tumor growth and metastasis by targeting the PI3K/AKT pathway in hepatocellular carcinoma. hsa-mir-7 hepatocellular carcinoma down Downregulation of miR-7 upregulates Cullin 5 (CUL5) to facilitate G1/S transition in human hepatocellular carcinoma cells. hsa-mir-7 lung cancer up EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. hsa-mir-7 non-small cell lung cancer down MicroRNA-7 inhibits the malignant phenotypes of non?small cell lung cancer in vitro by targeting Pax6. hsa-mir-7 pancreatic cancer up Curcumin inhibits cell growth and invasion through up-regulation of miR-7 in pancreatic cancer cells. hsa-mir-7 prostate cancer down MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway. hsa-mir-7 renal cell carcinoma up Identification of miR-7 as an oncogene in renal cell carcinoma. hsa-mir-7-5p glioblastoma down MiR-7-5p is frequently downregulated in glioblastoma microvasculature and inhibits vascular endothelial cell proliferation by targeting RAF1. hsa-mir-7-5p glioblastoma down miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients. hsa-mir-7-5p malignant melanoma down miRNA-7-5p inhibits melanoma cell migration and invasion. hsa-mir-708 hepatocellular carcinoma down MicroRNA-708 is downregulated in hepatocellular carcinoma and suppresses tumor invasion and migration. hsa-mir-720 acute myeloid leukemia down [DNA methylation-mediated epigenetic silencing of miR-720 contributes to leukemogenesis in acute myeloid leukemia]. hsa-mir-720 breast cancer down miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1. hsa-mir-720 colorectal cancer up Evaluation of miR-720 prognostic significance in patients with colorectal cancer. hsa-mir-744 nasopharyngeal carcinoma up MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5. hsa-mir-7515 lung cancer down The Novel miR-7515 Decreases the Proliferation and Migration of Human Lung Cancer Cells by Targeting c-Met. hsa-mir-761 non-small cell lung cancer up MiR-761 Promotes Progression and Metastasis of Non-Small Cell Lung Cancer by Targeting ING4 and TIMP2. hsa-mir-765 prostate cancer down Hsa-miRNA-765 as a Key Mediator for Inhibiting Growth, Migration and Invasion in Fulvestrant-Treated Prostate Cancer. hsa-mir-802 breast cancer down MicroRNA-802 suppresses breast cancer proliferation through downregulation of FoxM1. hsa-mir-802 osteosarcoma up MicroRNA-802 promotes osteosarcoma cell proliferation by targeting p27. hsa-mir-873 breast cancer down MiR-873 regulates ER? transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells. hsa-mir-873 glioblastoma down MiRNA-873 Inhibits Glioblastoma Tumorigenesis and Metastasis by Suppressing the Expression of IGF2BP1. hsa-mir-874 breast cancer down MicroRNA-874 inhibits cell proliferation and induces apoptosis in human breast cancer by targeting CDK9. hsa-mir-874 gastric cancer down miR-874 Inhibits cell proliferation, migration and invasion through targeting aquaporin-3 in gastric cancer. hsa-mir-874 gastric cancer down miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer. hsa-mir-874 head and neck squamous cell carcinoma down Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma. hsa-mir-877 hepatocellular carcinoma down Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1. hsa-mir-877 oral squamous cell carcinoma down Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer. hsa-mir-885-5p hepatocellular carcinoma up Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. hsa-mir-885-5p neuroblastoma down MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival. hsa-mir-886-3p thyroid cancer down MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer. hsa-mir-886-5p cervical carcinoma down MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells. hsa-mir-892a colorectal cancer up miR-892a regulated PPP2R2A expression and promoted cell proliferation of human colorectal cancer cells. hsa-mir-9 bladder cancer up miR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer. hsa-mir-9 esophageal squamous cell carcinoma up MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma. hsa-mir-9 gastric adenocarcinoma down Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. hsa-mir-9 gastric cancer down microRNA-9 Suppresses the Proliferation, Invasion and Metastasis of Gastric Cancer Cells through Targeting Cyclin D1 and Ets1. hsa-mir-9 gastric cancer down Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo. hsa-mir-9 gastric cancer down Down-regulated miR-9 and miR-433 in human gastric carcinoma. hsa-mir-9 gastric cancer down Aberrant hypermethylation of miR-9 genes in gastric cancer. hsa-mir-9 gastric cancer down Development of a novel microRNA promoter microarray for ChIP-on-chip assay to identify epigenetically regulated microRNAs. hsa-mir-9 glioma up [MiR-9 regulates the expression of CBX7 in human glioma]. hsa-mir-9 glioma up The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells. hsa-mir-9 glioma up Increased expression of microRNA-9 predicts an unfavorable prognosis in human glioma. hsa-mir-9 hepatocellular carcinoma up Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma. hsa-mir-9 laryngeal squamous cell carcinoma up MicroRNA-9 as a novel prognostic biomarker in human laryngeal squamous cell carcinoma. hsa-mir-9 malignant melanoma down MicroRNA-9 up-regulates E-cadherin through inhibition of NF-?B1-Snail1 pathway in melanoma. hsa-mir-9 nasopharyngeal carcinoma down miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma. hsa-mir-9 non-small cell lung cancer up Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer. hsa-mir-9 oral squamous cell carcinoma down MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/?-catenin signaling pathway. hsa-mir-9 osteosarcoma up miR-9 Modulates Osteosarcoma Cell Growth by Targeting the GCIP Tumor Suppressor. hsa-mir-9 osteosarcoma up Serum miR-9 as a prognostic biomarker in patients with osteosarcoma. hsa-mir-9 ovarian cancer down MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1. hsa-mir-9 ovarian cancer up MicroRNA-9 promotes tumorigenesis and mediates sensitivity to cisplatin in primary epithelial ovarian cancer cells. hsa-mir-9 uveal melanoma down MicroRNA-9 suppresses uveal melanoma cell migration and invasion through the NF-?B1 pathway. hsa-mir-92 colorectal cancer up Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. hsa-mir-92 gastric cancer up miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-mir-92 gastric cancer up MicroRNA-92 promotes gastric cancer cell proliferation and invasion through targeting FXR. hsa-mir-92 medulloblastoma up The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. hsa-mir-92 neuroblastoma up MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma. hsa-mir-92 pancreatic cancer up MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene. hsa-mir-92a acute promyelocytic leukemia up Inhibition of MicroRNA miR-92a Inhibits Cell Proliferation in Human Acute Promyelocytic Leukemia. hsa-mir-92a b-cell lymphoma up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. hsa-mir-92a breast cancer down Downregulation of miR-92a is associated with aggressive breast cancer features and increased tumour macrophage infiltration. hsa-mir-92a breast cancer down Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer. hsa-mir-92a breast cancer down MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment. hsa-mir-92a breast carcinoma up MiR-93 enhances angiogenesis and metastasis by targeting LATS2. hsa-mir-92a cervical cancer up miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7. hsa-mir-92a cholangiocarcinoma up miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator. hsa-mir-92a cholangiocarcinoma up miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator. hsa-mir-92a colorectal cancer up Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. hsa-mir-92a colorectal cancer up Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer. hsa-mir-92a colorectal cancer up MicroRNA-92a Functions as an Oncogene in Colorectal Cancer by Targeting PTEN. hsa-mir-92a colorectal cancer up MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. hsa-mir-92a colorectal cancer up MicroRNA signatures: novel biomarker for colorectal cancer? hsa-mir-92a esophageal squamous cell carcinoma up microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. hsa-mir-92a esophageal squamous cell carcinoma up TNF-? is a novel target of miR-19a. hsa-mir-92a hepatocellular carcinoma up MiR-17-92 cluster promotes hepatocarcinogenesis. hsa-mir-92a hepatocellular carcinoma up MicroRNA-92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7. hsa-mir-92a hepatocellular carcinoma up Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development. hsa-mir-92a lung cancer up A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. hsa-mir-92a lung cancer up Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. hsa-mir-92a lung cancer up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. hsa-mir-92a malignant melanoma up Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. hsa-mir-92a mantle cell lymphoma up The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. hsa-mir-92a osteosarcoma up Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma. hsa-mir-92b glioblastoma up The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas. hsa-mir-92b glioma up MiR-92b inhibitor promoted glioma cell apoptosis via targeting DKK3 and blocking the Wnt/beta-catenin signaling pathway. hsa-mir-92b non-small cell lung cancer up MiR-92b regulates the cell growth, cisplatin chemosensitivity of A549 non small cell lung cancer cell line and target PTEN. hsa-mir-92b non-small cell lung cancer up Inhibition of miR-92b suppresses nonsmall cell lung cancer cells growth and motility by targeting RECK. hsa-mir-93 colon cancer down Clinical significance of microRNA-93 downregulation in human colon cancer. hsa-mir-93 colorectal cancer up Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. hsa-mir-93 colorectal carcinoma down MicroRNA-93 suppress colorectal cancer development via Wnt/?-catenin pathway downregulating. hsa-mir-93 endometrial cancer up TSA Suppresses miR-106b-93-25 Cluster Expression through Downregulation of MYC and Inhibits Proliferation and Induces Apoptosis in Human EMC. hsa-mir-93 esophageal squamous cell carcinoma up Micro ribonucleic acid-93 promotes proliferation and migration of esophageal squamous cell carcinoma by targeting disabled 2. hsa-mir-93 glioma up [Overexpressed microRNA-93 inhibits the proliferation and promotes apoptosis of A172 glioma cells]. hsa-mir-93 glioma up miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway. hsa-mir-93 head and neck squamous cell carcinoma up Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. hsa-mir-93 head and neck squamous cell carcinoma up Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma. hsa-mir-93 laryngeal squamous cell carcinoma up MicroRNA-93 regulates cyclin G2 expression and plays an oncogenic role in laryngeal squamous cell carcinoma. hsa-mir-93 nasopharyngeal carcinoma up MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2. hsa-mir-93 non-small cell lung cancer up Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer. hsa-mir-93 osteosarcoma up microRNA-93 promotes cell proliferation via targeting of PTEN in Osteosarcoma cells. hsa-mir-93-5p hepatocellular carcinoma up Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. hsa-mir-940 gastric cancer up MicroRNA-940 promotes tumor cell invasion and metastasis by downregulating ZNF24 in gastric cancer. hsa-mir-940 hepatocellular carcinoma down MiR-940 inhibits hepatocellular carcinoma growth and correlates with prognosis of hepatocellular carcinoma patients. hsa-mir-940 prostate cancer down MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1. hsa-mir-941 hepatocellular carcinoma down DNA Methylation-mediated Repression of miR-941 Enhances Lysine (K)-specific Demethylase 6B Expression in Hepatoma Cells. hsa-mir-942 esophageal squamous cell carcinoma up miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/?-catenin signalling pathway. hsa-mir-944 breast cancer up MiR-944 functions as a novel oncogene and regulates the chemoresistance in breast cancer. hsa-mir-944 cervical cancer up Novel functions and targets of miR-944 in human cervical cancer cells. hsa-mir-944 lung cancer up Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers. hsa-mir-95 colorectal cancer up MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma. hsa-mir-95 colorectal carcinoma up MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma. hsa-mir-95 non-small cell lung cancer up MiR-95 induces proliferation and chemo- or radioresistance through directly targeting sorting nexin1 (SNX1) in non-small cell lung cancer. hsa-mir-9500 lung cancer down The novel miR-9500 regulates the proliferation and migration of human lung cancer cells by targeting Akt1. hsa-mir-96 bladder cancer up MicroRNA expression signatures of bladder cancer revealed by deep sequencing. hsa-mir-96 bladder cancer up Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells. hsa-mir-96 breast cancer up Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a. hsa-mir-96 breast cancer up miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer. hsa-mir-96 chronic myelogenous leukemia up Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. hsa-mir-96 colorectal cancer up Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer. hsa-mir-96 colorectal cancer up MicroRNA-96 promotes the proliferation of colorectal cancer cells and targets tumor protein p53 inducible nuclear protein 1, forkhead box protein O1 (FOXO1) and FOXO3a. hsa-mir-96 esophageal cancer up MiR-96 promotes proliferation and chemo- or radioresistance by down-regulating RECK in esophageal cancer. hsa-mir-96 glioma up The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas. hsa-mir-96 glioma up miR-96/HBP1/Wnt/?-catenin regulatory circuitry promotes glioma growth. hsa-mir-96 hepatocellular carcinoma up OncomiR miR-96 and miR-182 promote cell proliferation and invasion through targeting ephrinA5 in hepatocellular carcinoma. hsa-mir-96 hepatocellular carcinoma up Wnt/?-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion. hsa-mir-96 hepatocellular carcinoma up Inhibition of miR-96 expression reduces cell proliferation and clonogenicity of HepG2 hepatoma cells. hsa-mir-96 non-small cell lung cancer down Expression of microRNA-96 and its potential functions by targeting FOXO3 in non-small cell lung cancer. hsa-mir-96 ovarian cancer up The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimul hsa-mir-96 ovarian cancer up Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells. hsa-mir-96 pancreatic cancer down miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer. hsa-mir-96 prostate cancer up Transforming growth factor-? promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway. hsa-mir-96 prostate cancer up miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells. hsa-mir-96 prostate cancer up miR-96 promotes cell proliferation and clonogenicity by down-regulating of FOXO1 in prostate cancer cells. hsa-mir-96-5p colorectal cancer down MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients. hsa-mir-98 breast cancer down Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122. hsa-mir-98 bronchioloalveolar carcinoma down let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis. hsa-mir-98 colon cancer down let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. hsa-mir-98 esophageal squamous cell carcinoma down Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. hsa-mir-98 esophageal squamous cell carcinoma down MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma. hsa-mir-98 esophageal squamous cell carcinoma down Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma. hsa-mir-98 gastric cancer up MicroRNA profiling of human gastric cancer. hsa-mir-98 glioma down Overexpression of RKIP inhibits cell invasion in glioma cell lines through upregulation of miR-98. hsa-mir-98 hepatocellular carcinoma down MicroRNAs in Hepatobiliary and Pancreatic Cancers. hsa-mir-98 lung cancer down Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. hsa-mir-98 lung cancer down Reduced expression of Dicer associated with poor prognosis in lung cancer patients. hsa-mir-98 lung cancer down Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells. hsa-mir-98 malignant melanoma down miR-98 suppresses melanoma metastasis through a negative feedback loop with its target gene IL-6. hsa-mir-98 nasopharyngeal carcinoma down MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. hsa-mir-98 neuroblastoma down LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. hsa-mir-98 ovarian cancer down EZH2-specific microRNA-98 inhibits human ovarian cancer stem cell proliferation via regulating the pRb-E2F pathway. hsa-mir-98 pancreatic ductal adenocarcinoma down let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. hsa-mir-99a bladder cancer down microRNA-99a inhibiting cell proliferation, migration and invasion by targeting fibroblast growth factor receptor 3 in bladder cancer. hsa-mir-99a bladder cancer down microRNA-99a acts as a tumor suppressor and is down-regulated in bladder cancer. hsa-mir-99a breast cancer down MiR-99a antitumor activity in human breast cancer cells through targeting of mTOR expression. hsa-mir-99a cervical cancer down miR-99a and -99b inhibit cervical cancer cell proliferation and invasion by targeting mTOR signaling pathway. hsa-mir-99a cervical carcinoma down miR-99 inhibits cervical carcinoma cell proliferation by targeting TRIB2. hsa-mir-99a esophageal squamous cell carcinoma down MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma. hsa-mir-99a gastric cancer up miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. hsa-mir-99a hepatocellular carcinoma down MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. hsa-mir-99a hepatocellular carcinoma down Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression. hsa-mir-99a lung adenocarcinoma down Clinic significance of microRNA-99a expression in human lung adenocarcinoma. hsa-mir-99a mesenchymal cancer down MicroRNA Expression Profiles in Kaposi's Sarcoma. hsa-mir-99a non-small cell lung cancer down miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway. hsa-mir-99a non-small cell lung cancer down microRNA-99a is downregulated and promotes proliferation, migration and invasion in non-small cell lung cancer A549 and H1299 cells. hsa-mir-99a pancreatic cancer up Antagonism of microRNA-99a promotes cell invasion and down-regulates E-cadherin expression in pancreatic cancer cells by regulating mammalian target of rapamycin. hsa-mir-99b cervical cancer down miR-99a and -99b inhibit cervical cancer cell proliferation and invasion by targeting mTOR signaling pathway. hsa-mir-99b cervical carcinoma down miR-99 inhibits cervical carcinoma cell proliferation by targeting TRIB2. hsa-mir-99b esophageal cancer up Differential expression of miRNAs in esophageal cancer tissue. hsa-mir-99b hepatocellular carcinoma up miR-99b promotes metastasis of hepatocellular carcinoma through inhibition of claudin 11 expression and may serve as a prognostic marker. hsa-mir-99b lung cancer down microRNA-99b acts as a tumor suppressor in non-small cell lung cancer by directly targeting fibroblast growth factor receptor 3. hsa-mir-99b-3p oral squamous cell carcinoma down miRNA-99b-3p functions as a potential tumor suppressor by targeting glycogen synthase kinase-3? in oral squamous cell carcinoma Tca-8113 cells. mir-17 b-cell lymphoma up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. mir-17 breast carcinoma up MiR-93 enhances angiogenesis and metastasis by targeting LATS2. mir-17 colorectal cancer up MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. mir-17 esophageal squamous cell carcinoma up TNF-? is a novel target of miR-19a. mir-17 hepatocellular carcinoma up MiR-17-92 cluster promotes hepatocarcinogenesis. mir-17 lung cancer up A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. mir-17 lung cancer up Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. mir-17 lung cancer up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. mir-17 mantle cell lymphoma up The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. mir-17 osteosarcoma up Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma. mir-18a b-cell lymphoma up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. mir-18a breast carcinoma up MiR-93 enhances angiogenesis and metastasis by targeting LATS2. mir-18a colorectal cancer up MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. mir-18a esophageal squamous cell carcinoma up TNF-? is a novel target of miR-19a. mir-18a hepatocellular carcinoma up MiR-17-92 cluster promotes hepatocarcinogenesis. mir-18a lung cancer up A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. mir-18a lung cancer up Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. mir-18a lung cancer up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. mir-18a mantle cell lymphoma up The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. mir-18a osteosarcoma up Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma. mir-19a b-cell lymphoma up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. mir-19a breast carcinoma up MiR-93 enhances angiogenesis and metastasis by targeting LATS2. mir-19a colorectal cancer up MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. mir-19a esophageal squamous cell carcinoma up TNF-? is a novel target of miR-19a. mir-19a hepatocellular carcinoma up MiR-17-92 cluster promotes hepatocarcinogenesis. mir-19a lung cancer up A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. mir-19a lung cancer up Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. mir-19a lung cancer up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. mir-19a mantle cell lymphoma up The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. mir-19a osteosarcoma up Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma. mir-19b b-cell lymphoma up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. mir-19b breast carcinoma up MiR-93 enhances angiogenesis and metastasis by targeting LATS2. mir-19b colorectal cancer up MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. mir-19b esophageal squamous cell carcinoma up TNF-? is a novel target of miR-19a. mir-19b hepatocellular carcinoma up MiR-17-92 cluster promotes hepatocarcinogenesis. mir-19b lung cancer up A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. mir-19b lung cancer up Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. mir-19b lung cancer up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. mir-19b mantle cell lymphoma up The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. mir-19b osteosarcoma up Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma. mir-20a b-cell lymphoma up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. mir-20a breast carcinoma up MiR-93 enhances angiogenesis and metastasis by targeting LATS2. mir-20a colorectal cancer up MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. mir-20a esophageal squamous cell carcinoma up TNF-? is a novel target of miR-19a. mir-20a hepatocellular carcinoma up MiR-17-92 cluster promotes hepatocarcinogenesis. mir-20a lung cancer up A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. mir-20a lung cancer up Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. mir-20a lung cancer up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. mir-20a mantle cell lymphoma up The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. mir-20a osteosarcoma up Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma. mir-92a b-cell lymphoma up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. mir-92a breast carcinoma up MiR-93 enhances angiogenesis and metastasis by targeting LATS2. mir-92a colorectal cancer up MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. mir-92a esophageal squamous cell carcinoma up TNF-? is a novel target of miR-19a. mir-92a hepatocellular carcinoma up MiR-17-92 cluster promotes hepatocarcinogenesis. mir-92a lung cancer up A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. mir-92a lung cancer up Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. mir-92a lung cancer up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. mir-92a mantle cell lymphoma up The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. mir-92a osteosarcoma up Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma. mmu-mir-290-3p breast cancer down Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b. mmu-mir-290-5p breast cancer down Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b.